Compositions and methods for producing tobacco plants and products having altered alkaloid levels with desirable leaf quality
Tobacco plants engineered with an ODC-repressing promoter and targeted genome modifications achieve reduced nicotine levels while maintaining or improving leaf quality and insect resistance, addressing the limitations of existing cultivars like LA Burley 21.
Patent Information
- Application Number
- JP2024124145
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2018-03-05
- Filing Date
- 2024-07-31
- Publication Date
- 2024-11-06
- Estimated Expiration
- 2039-03-04
AI Technical Summary
Existing tobacco cultivars face challenges in achieving reduced nicotine levels without compromising leaf quality, yield, and susceptibility to insect damage, as mutations like LA Burley 21 exhibit unfavorable phenotypes such as low yield, delayed maturation, and poor quality.
Development of tobacco plants with an inducible promoter linked to a transcribable DNA sequence encoding a non-coding RNA that represses the ornithine decarboxylase (ODC) gene, combined with targeted genome modifications to alter nicotine levels and improve leaf quality traits.
The solution results in tobacco plants with significantly reduced nicotine levels while maintaining or enhancing leaf quality, polyamine levels, chlorophyll content, mesophyll cell density, and resistance to insect damage, comparable to or exceeding that of control plants.
Smart Images

Figure 2024156794000001_ABST
Abstract
Description
[Technical field]
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to U.S. Provisional Patent Application No. 62 / 638,928, filed March 5, 2018, which is incorporated by reference in its entirety.
[0002] Inclusion of sequence listing The sequence listing contained in an ASCII file entitled "P34584WO00_SL.txt", which is 88,011 bytes (measured in MS-Windows®) and was created on March 4, 2019, is submitted electronically herewith and is incorporated by reference in its entirety.
[0003] Field The present disclosure includes tobacco plants having altered total alkaloid and nicotine levels and commercially acceptable leaf grades, the development of said tobacco plants through breeding or transgenic approaches, and the production of tobacco products from said tobacco plants. [Background technology]
[0004] background Tobacco is one of the most widely grown non-food crops in the world, with a global production of over 7.4 million tonnes (FAOSTAT, Food and Agriculture Organization of the United Nations (FAO)(2014), faostat.fao.org) and a resulting annual global market size of 770 billion US dollars for tobacco products (Euromonitor International, 2016). Nicotine is the major alkaloid that accumulates in tobacco leaves. Nicotine and other trace alkaloids are also precursors of tobacco-specific nitrosamines (TSNAs). There is a demand for the development of tobacco cultivars with low levels of nicotine.
[0005] In commercial tobacco cultivars, nicotine accounts for 90-95% of the total alkaloid pool, or 2-5% of the total leaf dry weight (Saitoh F, Nona M, Kawashima N (1985). The alkaloid contents of sixty Nicotiana species. Phytochem. 24: 477-480). Nicotine is synthesized in the roots (Dawson RF (1942) Accumulation of nicotine in reciprocal grafts of tomato and tobacco. Am. J. Bot. 29: 66-71) and transported through the xylem (Baldwin IT (1988). The alkaloidal responses of wild tobacco to real and simulated herbivory. Oecologia 77: 378-381) to the aerial parts of the plant (Hildreth SB, Gehman EA, Yang H, Lu RH, Ritesh KC, Harich KC, Yu S, Lin J, Sandoe JL, Okumoto S, Murphyd, AS, Jeleskoaet JG (2011). Tobacco nicotine uptake permease (NUP1) affects alkaloid metabolism. Proc. Natl. Acad. Sci. USA 108: 18179-18184), where it accumulates in the leaves and is exuded by spike-like structures in response to insect feeding (Kessler A, Baldwin IT (2002). Plant responses to insect herbivory: the emerging molecular analysis. Annu Rev. Plant Biol. 53: 299-328).Nicotine biosynthesis is affected by genetic factors, plant development, biotic and abiotic stresses, plant hormone signals, and agricultural management practices, such as topping and division (Wang SS, Shi QM, Li WQ, Niu JF, Li CJ, Zhang FS (2008). Nicotine concentration in leaves of flue-cured tobacco plants as affected by removal of the shoot apex and lateral buds. J. Integr. Plant Bio. 50: 958-964; Shoji T, Hashimoto T (2015). Stress-induced expression of NICOTINE2-locus genes and their homologs encoding Ethylene Response Factor transcription factors in tobacco. Phytochem.113: 41-49). Genetic regulation of nicotine biosynthesis is correlated with two independent genetic loci, Nic1 and Nic2, which exert synergistic effects on nicotine levels, but the effect of Nic1 is approximately 2.4-fold stronger than that of Nic2 (Legg PD, Collins GB (1971). Inheritance of percent total alkaloids in Nicotiana tabacum L. II. Genetic effects of two loci in Burley 21 x LA Burley 21 populations. Can. J. Genet. Cytol. 13: 287-291).Both loci also affect the expression of numerous other genes not related to the nicotine biosynthetic pathway (Kidd SK, Melillo AA, Lu RH, Reed DG, Kuno N, Uchida K, Furuya M, Jelesko JG (2006). The A and B loci in tobacco regulate a network of stress response genes, few of which are associated with nicotine biosynthesis. Plant Mol. Biol. 60: 699-716; Shoji T, Kajikawa M, Hashimoto T (2010) Clustered transcription factor genes regulate nicotine biosynthesis in tobacco. Plant Cell 22: 3390-3409). Transcriptional analysis has revealed that the Nic2 locus is a cluster of genes encoding at least seven ethylene-responsive transcription factors (ERFs) (Shoji et al. 2010).
[0006] Homozygous mutations at one or both loci can be used to produce near-isogenic Burley 21 lines with reduced alkaloid levels, i.e., high-intermediate (HI) varieties with genotype nic2, low-intermediate (LI) varieties with genotype nic1, and low alkaloid (LA) varieties with genotype nic1nic2 (Legg PD, Chaplin JF, Collins GB (1969). Inheritance of percent total alkaloids in Nicotiana tabacum LJ Hered. 60: 213-217; Legg et al. 1971). LA Burley 21 plants contain only about 5.7% of the total alkaloid levels found in normal alkaloid (NA) wild-type varieties (Legg PD, Collins GB, Littion CC (1970). Registration of LA Burley 21 tobacco germplasm. Crop. Sci. 10: 212). In LA plants, the synergistic action of the nic1 and nic2 mutations also causes an unfavorable leaf phenotype characterized by low yield, delayed maturation and senescence, high susceptibility to insect feeding, and poor quality of the end product after curing (Chaplin JF, Weeks WW (1976). Association between percent total alkaloids and other traits in flue-cured tobacco. Crop Sci. 16: 416-418; Legg et al. 1970; Chaplin JF, Burk LG (1983). Agronomic, chemical, and smoke characteristics of flue-cured tobacco lines with different levels of total alkaloids. Crop Sci. 75: 133-136).
[0007] There is a need to identify genes that restore undesirable leaf phenotypes in LA varieties of tobacco plants, and to develop tobacco plants and products that contain altered nicotine levels (e.g., reduced nicotine) while maintaining (if not superior) tobacco leaf quality. Summary of the Invention
[0008] overview In one aspect, the present disclosure provides a tobacco plant comprising an inducible promoter operably linked to a transcribable DNA sequence encoding a non-coding RNA for repressing an ornithine decarboxylase (ODC) gene.
[0009] In another aspect, the present disclosure provides a tobacco plant or portion thereof comprising a first genomic modification that provides a lower level of nicotine or total alkaloids compared to a control tobacco plant, and a second genomic modification that provides an equivalent level of one or more traits, the traits being selected from the group consisting of total leaf polyamine levels, total root polyamine levels, total leaf chlorophyll levels, mesophyll cell number per unit leaf area, and leaf epidermal cell size, and wherein the control plant does not have both the first genomic modification and the second genomic modification.
[0010] In one aspect, the present disclosure provides a method for improving leaf quality in a reduced alkaloid tobacco plant, the method comprising growing a tobacco plant, reducing putrescine levels in the tobacco plant, and harvesting leaves from the tobacco plant.
[0011] In another aspect, the present disclosure provides a method for improving leaf quality in a reduced alkaloid tobacco plant, the method comprising growing a tobacco plant, suppressing expression or activity of an ornithine decarboxylase (ODC) gene in the tobacco plant, and harvesting leaves from the tobacco plant.
[0012] In one aspect, tobacco plants are provided in which MYB8 activity is suppressed through transgene suppression, mutagenesis, or targeted genome editing. [The present invention 1001] A tobacco plant comprising an inducible promoter operably linked to a transcribable DNA sequence encoding a non-coding RNA for repressing an ornithine decarboxylase (ODC) gene. [The present invention 1002] 1001. A tobacco plant of the present invention capable of producing leaves containing levels of one or more polyamines that are at least 20% of the levels of comparable leaves of a control plant that does not contain the mutation or transgene. [The present invention 1003] 1001. A tobacco plant of the present invention capable of producing leaves containing chlorophyll levels within at least 20% of comparable leaves of a control plant containing no mutation or transgene. [The present invention 1004] 1001. A tobacco plant of the present invention capable of producing leaves containing a number of mesophyll cells per unit leaf area that is at least 20% or less than that of a comparable leaf of a control plant that does not contain a mutation or a transgene. [The present invention 1005] 1001. A tobacco plant of the present invention capable of producing leaves containing epidermal cell sizes at least within 20% of comparable leaves of a control plant containing no mutation or transgene. [The present invention 1006] 1001. A tobacco plant of the present invention comprising a leaf yield that is at least 20% or less compared to a comparable leaf of a control plant that does not contain the mutation or transgene. [The present invention 1007] The tobacco plant of the present invention, wherein the ornithine decarboxylase (ODC) gene encodes a polypeptide sequence having at least 80% identity to a sequence selected from the group consisting of SEQ ID NO:29, 30, 31, 32, 33, and 34. [The present invention 1008] The tobacco plant of the present invention, wherein the ODC gene comprises a nucleotide sequence having at least 90% identity to a sequence selected from the group consisting of SEQ ID NOs: 23, 24, 25, 26, 27, and 28. [The present invention 1009] The tobacco plant of the present invention, wherein the inducible promoter comprises a sequence selected from the group consisting of SEQ ID NO:1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, and 21. [The present invention 1010] The tobacco plant of the present invention, wherein the non-coding RNA comprises a nucleotide sequence having at least 90% identity to a sequence selected from the group consisting of SEQ ID NO:35 and 36. [The present invention 1011] The tobacco plant of the present invention, wherein the non-coding RNA is provided in an ODC RNAi construct comprising a nucleotide sequence having at least 90% identity to SEQ ID NO:22. [The present invention 1012] Compared to control tobacco plants, a. a first genomic modification that provides a low level of nicotine or total alkaloids; b. Providing equivalent levels of one or more traits, the traits being: i. whole leaf polyamine levels, ii. whole root polyamine levels; iii. total leaf chlorophyll levels; iv. number of mesophyll cells per unit leaf area, and v. Leaf epidermal cell size A second genome modification selected from the group consisting of: 1. A tobacco plant or part thereof comprising: The tobacco plant or part thereof, wherein the control plant does not have both the first genomic modification and the second genomic modification. [The present invention 1013] 1012. The tobacco plant or part thereof of the present invention, wherein said tobacco plant comprises a reduced amount of total free polyamines in the leaves or roots compared to said control tobacco plant. [The present invention 1014] The tobacco plant or part thereof of the present invention, wherein said tobacco plant is capable of producing leaves having a leaf grade equivalent to the leaf grade of leaves derived from said control plant. [The present invention 1015] A cured tobacco material derived from the tobacco plant of the present invention. [The present invention 1016] A tobacco product comprising the dried tobacco material of the present invention 1015. [The present invention 1017] The tobacco product of the present invention 1016 is selected from the group consisting of cigarettes, cigarillos, non-ventilated recess filter cigarettes, ventilated recess filter cigarettes, cigars, snuff, pipe tobacco, cigar tobacco, cigarette tobacco, chewing tobacco, leaf tobacco, shredded tobacco, loose leaf chewing tobacco, plug chewing tobacco, moist snuff, nasal snuff, and cut tobacco. [The present invention 1018] A cured tobacco material derived from the tobacco plant of the present invention. [The present invention 1019] A tobacco product comprising the dried tobacco material of the present invention. [The present invention 1020] The tobacco product of the present invention 1019 is selected from the group consisting of cigarettes, cigarillos, non-ventilated recess filter cigarettes, ventilated recess filter cigarettes, cigars, snuff, pipe tobacco, cigar tobacco, cigarette tobacco, chewing tobacco, leaf tobacco, shredded tobacco, loose leaf chewing tobacco, plug chewing tobacco, moist snuff, nasal snuff, and cut tobacco. [Brief description of the drawings]
[0013] [Figure 1]Phenotypic characterization of greenhouse-grown N. tabacum L. cv. Burleyi 21 normal alkaloid (NA) wild-type plants and three mutant cultivars. Figure 1A: Total chlorophyll content of greenhouse-grown wild-type (NA) high-intermediate (HI, nic2), low-intermediate (LI, nic1), and low alkaloid (LA, nic1nic2) strains. Chlorophyll in all leaves longer than 15 cm was measured twice per leaf at different developmental stages: pre-flowering (2.5 weeks before pinching), at pinching, 1 week after pinching (WPT), 2.5 WPT, and at harvest. Values are the average of four biological replicates. Figure 1B: Representative photographs of NA and LA plants at harvest. Figure 1C: Time course assessment of mesophyll cell number in leaf 15. Figure 1D: Microscopic images of leaf 15 mesophyll cells from NA and LA plants at different plant developmental stages. Bar = 100 μm. Values in A and C are the average of six biological replicates. Error bars represent the standard deviation of the mean. Statistical differences versus NA are indicated. *p<0.05. [Diagram 2] Polyamine analysis in field and greenhouse grown NA and LA plants. Figure 2A: Free (F) and complexed (C) putrescine (Put), spermidine (Spd), and spermine (Spm) contents from five fully expanded upper leaves of NA and LA plants (three biological replicates grown in the field) one week after topping. Figure 2B: Time course monitoring of total polyamine contents in greenhouse grown NA and LA plants. Leaf samples were collected from leaves at the same developmental stage: before flowering (leaf 12), at topping (leaf 19), and at harvest (leaf 24). Root samples were collected at topping and at harvest. Values are the average of three (A) / four (B) biological replicates. Error bars represent standard deviation of the mean. Statistical differences from NA were indicated: *p<0.05; **p<0.005. PA: polyamines; FW: fresh weight. [Diagram 3]Polyamine content in leaves and roots of NA, HI, LI, and LA plants grown in the greenhouse. Free (F) and complexed (C) putrescine (Put), spermidine (Spd), and spermine (Spm) fractions in leaves (Fig. 3A) and roots (Fig. 3B) of NA, HI, LI, and LA plants before flowering (leaf 6), at topping (young leaves 23, root), and at harvest (mature leaves 23, root) are shown. Samples were collected after 4 h of light exposure, immediately frozen in liquid nitrogen, and analyzed by LC-MS / MS. Values are the average of three biological replicates. Error bars represent the standard deviation of the mean. Statistical differences were indicated: *p<0.05; **p<0.001, indicating that LI and LA plants are significantly different from NA plants under the same conditions. For roots, only samples from topping and harvest were available. FW: fresh weight. [Figure 4] Activity of polyamine biosynthetic enzymes. Analysis of arginine decarboxylase (ADC) (Figure 4A) and ornithine decarboxylase (ODC) (Figure 4B) activities in leaves and roots of NA and LA plants at topping (young leaves 23, roots) and harvesting (mature leaves 23, roots). Values are the average of three biological replicates. Error bars represent the standard deviation of the mean. Statistical differences from NA were indicated: *p<0.05; **p<0.001. [Diagram 5] Representative photographs of leaves 23 from untreated NA and LA plants, and from LA plants treated with polyamine biosynthesis inhibitors and / or plant growth regulators at harvest. D-arginine (5 mM) is an inhibitor of ADC. DFMO (difluoromethylornithine, 2 mM) is an inhibitor of ODC. ETH (Ethephon®, 0.5 mM) is a growth regulator. [Figure 6]Treatment of LA plants with polyamine biosynthesis inhibitors and / or Ethephon®. Comparison of total, free, and complexed polyamines in leaves (FIG. 6A) and roots (FIG. 6B) of untreated and treated LA plants at topping and harvest. Tobacco plants were grown in the greenhouse in the absence (NA and LA) or presence (LA) of polyamine biosynthesis inhibitors and / or Ethephon® (5 mM D-arginine, 2 mM DFMO, 2 mM DFMO / 0.5 mM Ethephon®, or 0.5 mM Ethephon® alone). D-arginine and DFMO were applied three times a week for 6 weeks from pre-flowering until harvest. In contrast, Ethephon® treatments were started after topping (2.5 weeks later) until harvest. Samples were collected from leaves23 or roots of four biological replicates per genotype or treatment after 4 hours of light. Fold changes between the mean polyamine content from untreated LA plants (gray bars) or plants treated with D-arginine (black bars), DFMO (white bars), DFMO / Ethephon® (bars with horizontal line), and Ethephon® (bars with divots) were plotted. Error bars indicate standard deviation of the mean (n=4). Statistical differences from the LA / NA mean were indicated: *p<0.05. Red line represents polyamine content in NA. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0014] A brief description of the sequence SEQ ID NOs:1-11 show exemplary promoter sequences for pinching-responsive root-specific or root-preferred expression.
[0015] SEQ ID NOs:11-21 show exemplary promoter sequences for pinching-responsive leaf-specific or leaf-preferential expression.
[0016] SEQ ID NO:22 shows the sequence of an exemplary DNA construct encoding a non-coding RNA that inhibits ornithine decarboxylase (ODC).
[0017] SEQ ID NOs:23-28 show the cDNA sequences of exemplary tobacco ODC genes.
[0018] SEQ ID NOs:29-34 show the amino acid sequences encoded by exemplary ODC genes.
[0019] SEQ ID NOs:35 and 36 show two miRNA sequences that target the ODC gene according to the present disclosure.
[0020] Various sequences include "N" in the nucleotide sequence or "X" in the amino acid sequence. "N" may be any nucleotide, e.g., A, T, G, C, or a deletion or insertion of one or more nucleotides. In some cases, a stretch of "N" is shown. The number of "N"s does not necessarily correlate with the actual number of undetermined nucleotides at that position. The actual nucleotide sequence may be longer or shorter than the indicated segment of "N". Similarly, "X" may be any amino acid residue, or a deletion or insertion of one or more amino acids. Again, the number of "X"s does not necessarily correlate with the actual number of undetermined amino acids at that position. The actual amino acid sequence may be longer or shorter than the indicated segment of "X". Despite the use of A, T, G, C (compared to A, U, G, C) in the description of SEQ IDs in the sequence listing, this SEQ ID may also refer to RNA sequences depending on the context in which the SEQ ID is referred to.
[0021] Detailed Description Unless otherwise defined, scientific and technical terms used herein have the same meaning as commonly understood by those skilled in the art. Those skilled in the art will recognize that many methods can be used in the practice of the present disclosure. Indeed, the present disclosure is not limited to the methods and materials described. For the purposes of this disclosure, the following terms are defined below.
[0022] For example, any references cited herein, including all patents and publications, are incorporated by reference in their entirety.
[0023] As used herein, the singular forms "a," "an," and "the" include plural references unless the context clearly dictates otherwise. For example, the term "a compound" or "at least one compound" may include a plurality of compounds, including mixtures thereof.
[0024] The term "about" is used herein to mean approximately, roughly, in the region of, or within the region. When the term "about" is used in conjunction with a numerical range, it modifies that range by extending the boundaries above and below the numerical values set forth. To avoid any doubt, when terms or phrases such as "about," "at least," "at least about," "up to," "less than," "more than," "within," etc. are used herein when followed by a series of lists of numerical percentage values, such terms or phrases are deemed to modify every numerical percentage in the series or list.
[0025] As used herein, tobacco plants include Nicotiana tabacum, Nicotiana amplexicaulis PI 271989; Nicotiana benthamiana PI 555478; Nicotiana bigelovii PI 555485; Nicotiana debneyi; Nicotiana excelsior PI 224063; Nicotiana glutinosa PI 555507; Nicotiana goodspeedii PI 241012; Nicotiana gossei PI 230953; Nicotiana hesperis PI 230953; hesperis)PI 271991;Nicotiana knightianaPI 555527;Nicotiana maritimaPI 555535;Nicotiana megalosiphonPI 555536;Nicotiana nudicaulisPI 555540;Nicotiana paniculataPI 555545;Nicotiana plumbaginifoliaPI 555548;Nicotiana repandaPI 555552;Nicotiana rustica;Nicotiana suaveolensPI 230960;Nicotiana sylvestris PI 555569;Nicotiana tomentosa PI 266379;Nicotiana tomentosiformis;and Nicotiana trigonophylla PI 555572.
[0026] In one aspect, the present disclosure provides a tobacco plant or part thereof, comprising an inducible promoter operably linked to a transcribable DNA sequence encoding a non-coding RNA for repressing an ornithine decarboxylase (ODC) gene. In one aspect, the tobacco plant comprises a mutation or transgene that confers a reduced level of nicotine. In one aspect, the tobacco plant is a low-alkaloid tobacco plant. In one aspect, the tobacco plant of the present disclosure comprises a nic1 mutation, a nic2 mutation, or both. In one aspect, the tobacco plant contains a level of nicotine that is less than 1%, 2%, 5%, 8%, 10%, 12%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, or 80% of the nicotine level of a control plant when grown under similar growth conditions, the control plant sharing essentially the same genetic background as the tobacco plant, except for the mutation or transgene that confers low nicotine. In another aspect, the tobacco plant contains levels of nicotine or total alkaloids that are less than 1%, 2%, 5%, 8%, 10%, 12%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, or 80% of the nicotine or total alkaloid levels of a control plant when grown under similar growth conditions. In another aspect, the tobacco plant comprises a total alkaloid level selected from the group consisting of less than 3%, less than 2.75%, less than 2.5%, less than 2.25%, less than 2.0%, less than 1.75%, less than 1.5%, less than 1.25%, less than 1%, less than 0.9%, less than 0.8%, less than 0.7%, less than 0.6%, less than 0.5%, less than 0.4%, less than 0.3%, less than 0.2%, less than 0.1%, and less than 0.05% of the nicotine level of a control plant when grown under similar growth conditions, the control plant sharing essentially the same genetic background as said tobacco plant except for the mutation or transgene that confers low nicotine.In another aspect, the tobacco plant comprises a nicotine or total alkaloid level selected from the group consisting of less than 3%, less than 2.75%, less than 2.5%, less than 2.25%, less than 2.0%, less than 1.75%, less than 1.5%, less than 1.25%, less than 1%, less than 0.9%, less than 0.8%, less than 0.7%, less than 0.6%, less than 0.5%, less than 0.4%, less than 0.3%, less than 0.2%, less than 0.1%, and less than 0.05% of the nicotine or total alkaloid level of a control plant when grown under similar growth conditions.
[0027] In one aspect, the tobacco plant is provided with a novel methyltransferase (MPO) that is capable of expressing a number of transcription factors, including aspartate oxidase, agmatine deiminase (AIC), arginase, diamine oxidase, arginine decarboxylase (ADC), methylputrescine oxidase (MPO), NADH dehydrogenase, ornithine decarboxylase (ODC), phosphoribosylanthranilate isomerase (PRAI), putrescine N-methyltransferase (PMT), quinolate phosphoribosyltransferase (QPT), S-adenosyl-methionine synthase (SAMS), A622, NBB1, BBL, MYC2, nic1, nic2, ethylene response factor (ERF) transcription factors, nicotine uptake permease (NICA), and methyltransferase (MPO). and transgenes or mutations that directly suppress the expression or activity of one or more, two or more, three or more, four or more, five or more, six or more, seven or more, eight or more, nine or more, ten or more, eleven or more, twelve or more, thirteen or more, fourteen or more, fifteen or more, sixteen or more, seventeen or more, eighteen or more, nineteen or more, twenty or more, or all twenty-one genes or loci encoding proteins selected from the group consisting of: mitochondrial permease (NUP), mitochondrial permease (MATE), and MATE transporters. See Dewey and Xie, Molecular genetics of alkaloid biosynthesis in Nicotiana tabacum, Phytochemistry 94 (2013) 10-27.
[0028] In one aspect, the tobacco plant further comprises one or more mutations in one or more, two or more, three or more, four or more, five or more, six or more, seven or more, eight or more, nine or more, or all ten genes selected from the group consisting of ERF32, ERF34, ERF39, ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168. In one aspect, the tobacco plant further comprises one or more mutations in ERF189, ERF115, or both. In one aspect, the tobacco plant further comprises one or more transgenes that target and suppress genes encoding one or more, two or more, three or more, four or more, five or more, six or more, seven or more, eight or more, nine or more, or all ten proteins selected from the group consisting of ERF32, ERF34, ERF39, ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168.
[0029] In one aspect, the tobacco plant, when cured, is capable of producing leaves having a USDA grade index value selected from the group consisting of a value of 55 or greater, a value of 60 or greater, a value of 65 or greater, a value of 70 or greater, a value of 75 or greater, a value of 80 or greater, a value of 85 or greater, a value of 90 or greater, and a value of 95 or greater. In another aspect, the tobacco plant, when cured, is capable of producing leaves having a USDA grade index value that is equivalent to the USDA grade index value of a control plant, when grown and cured in similar conditions, the control plant sharing essentially the same genetic background as the tobacco plant except for the mutation or transgene that confers low nicotine. In a further aspect, the tobacco plant is capable of producing leaves that, when cured, have a USDA grade index value that is at least about 65%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 95%, or at least about 98% of the USDA grade index value of a control plant when grown under similar conditions, the control plant sharing essentially the same genetic background as the tobacco plant except for the mutation or transgene that confers low nicotine. In a further aspect, the tobacco plant, when dried, can produce leaves having a USDA grade index value of 65%-130%, 70%-130%, 75%-130%, 80%-130%, 85%-130%, 90%-130%, 95%-130%, 100%-130%, 105%-130%, 110%-130%, 115%-130%, or 120%-130% of the USDA grade index value of the control plant. In a further aspect, the tobacco plant, when dried, can produce leaves having a USDA grade index value of 70%-125%, 75%-120%, 80%-115%, 85%-110%, or 90%-100% of the USDA grade index value of the control plant.
[0030] In another aspect, the tobacco plant, when dried, is capable of producing leaves having a USDA grade index value selected from the group consisting of 55 or greater, 60 or greater, 65 or greater, 70 or greater, 75 or greater, 80 or greater, 85 or greater, 90 or greater, and 95 or greater. In another aspect, the tobacco plant, when dried, is capable of producing leaves having a USDA grade index value selected from the group consisting of 50-95, 55-95, 60-95, 65-95, 70-95, 75-95, 80-95, 85-95, 90-95, 55-90, 60-85, 65-80, 70-75, 50-55, 55-60, 60-65, 65-70, 70-75, 75-80, 80-85, 85-90, and 90-95. In further aspects, the tobacco plant, when dried, can produce a leaf having a USDA grade index value of at least about 65%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 95%, or at least about 98% of the USDA grade index value of the control plant. In further aspects, the tobacco plant, when dried, can produce a leaf having a USDA grade index value of 65%-130%, 70%-130%, 75%-130%, 80%-130%, 85%-130%, 90%-130%, 95%-130%, 100%-130%, 105%-130%, 110%-130%, 115%-130%, or 120%-130% of the USDA grade index value of the control plant. In further aspects, the tobacco plants can produce leaves that, when dried, have a USDA grade index value of 70% to 125%, 75% to 120%, 80% to 115%, 85% to 110%, or 90% to 100% of the USDA grade index value of a control plant.
[0031] In one aspect, the present disclosure also provides a tobacco variety, cultivar, or line comprising a mutation selected from the group consisting of a nic1 mutation, a nic2 mutation, and combinations thereof, wherein the tobacco variety, cultivar, or line has a leaf grade equivalent to a leaf grade of a control tobacco variety, cultivar, or line when grown under similar growing conditions, and the control tobacco variety shares essentially the same genetic background as the tobacco variety, cultivar, or line except for the mutation.
[0032] In one aspect, the disclosure further provides a non-transgenic tobacco plant or portion thereof comprising a nicotine or total alkaloid level selected from the group consisting of less than 3%, less than 2.75%, less than 2.5%, less than 2.25%, less than 2.0%, less than 1.75%, less than 1.5%, less than 1.25%, less than 1%, less than 0.9%, less than 0.8%, less than 0.7%, less than 0.6%, less than 0.5%, less than 0.4%, less than 0.3%, less than 0.2%, less than 0.1%, and less than 0.05%, wherein the non-transgenic tobacco plant is capable of producing leaves having a USDA grade index value of 50 or greater, 55 or greater, 60 or greater, 65 or greater, 70 or greater, 75 or greater, 80 or greater, 85 or greater, 90 or greater, and 95 or greater when cured. In another aspect, such non-transgenic tobacco plants are capable of producing leaves containing nicotine levels of less than 2.0% and, when cured, having a USDA grade index value of 70 or greater. In a further aspect, such non-transgenic tobacco plants are capable of producing leaves containing nicotine levels of less than 1.0% and, when cured, having a USDA grade index value of 70 or greater.
[0033] In one aspect, the disclosure also provides a tobacco plant or portion thereof that includes a non-transgenic mutation that reduces the nicotine or total alkaloid levels of the tobacco plant to less than 1%, less than 2%, less than 5%, less than 8%, less than 10%, less than 12%, less than 15%, less than 20%, less than 25%, less than 30%, less than 40%, less than 50%, less than 60%, less than 70%, or less than 80% of the nicotine level of a control plant when grown under similar growing conditions, wherein the tobacco plant, when cured, is capable of producing leaves having a USDA grade index value equivalent to the USDA grade index value of the control plant, and wherein the control plant shares essentially the same genetic background as the tobacco plant except for the non-transgenic mutation.
[0034] In one aspect, the present disclosure provides a tobacco plant or part thereof comprising a mutation in a gene or locus, the mutation not present in LA Burley 21. In one aspect, the tobacco plant provided herein comprises a shorter chromosome introgression at a locus of interest compared to LA Burley 21. In another aspect, the tobacco plant provided herein does not comprise a complete gene deletion or a complete gene coding sequence deletion at a locus of interest. In one aspect, the tobacco plant provided herein is homozygous at a locus of interest. In another aspect, the tobacco plant provided herein is heterozygous at a locus of interest. In one aspect, the tobacco plant provided herein comprises a mutation selected from the group consisting of point mutation, deletion, insertion, duplication, and inversion at a gene or locus of interest. In one aspect, the mutation in the tobacco plant provided herein is introduced by an approach selected from the group consisting of random mutagenesis and targeted mutagenesis. In another aspect, the mutations in the tobacco plants provided herein are introduced by a targeted mutagenesis approach selected from the group consisting of meganucleases, zinc finger nucleases, TALENs, and CRISPRs.
[0035] As used herein, a mutation refers to a heritable genetic modification that is introduced into a gene to change the expression or activity of the product encoded by the gene. Such a modification can be in any sequence region of the gene, for example, in the promoter, 5'UTR, exon, intron, 3'UTR, or terminator region. In one aspect, the mutation reduces, inhibits, or eliminates the expression or activity of the gene product. In another aspect, the mutation increases, elevates, enhances, or increases the expression or activity of the gene product. In one aspect, the mutation is not a natural polymorphism that exists in a particular tobacco variety or cultivar. As used herein, a "mutant allele" refers to an allele from a locus that contains a mutation. As used herein, "mutagenesis" refers to generating a mutation without involving a transgene or without the mutation-related transgene remaining in the final mutant. In one aspect, the mutagenesis is cisgenic. In another aspect, the mutagenesis is via gene or genome editing. In a further aspect, mutagenesis is via random mutagenesis, for example, chemical (eg, EMS) or physical (irradiation) mutagenesis.
[0036] In one aspect, the tobacco plants provided herein comprise one or more mutations in one or more genes comprising a coding sequence having at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 98%, at least 99%, or 100% identity to a sequence selected from the group consisting of SEQ ID NOs:23-28 and fragments thereof. In one aspect, the one or more mutations reduce expression or activity of one or more genes comprising a coding sequence having at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 98%, at least 99%, or 100% identity to a sequence selected from the group consisting of SEQ ID NOs:23-28 and fragments thereof.
[0037] In one aspect, the tobacco plants provided herein comprise one or more mutations in one or more genes encoding a polypeptide having at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 98%, at least 99%, or 100% identity to a sequence selected from the group consisting of SEQ ID NOs:29-34 and fragments thereof. In one aspect, the one or more mutations reduce expression or activity of the one or more genes encoding a polypeptide having at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 98%, at least 99%, or 100% identity to a sequence selected from the group consisting of SEQ ID NOs:29-34 and fragments thereof.
[0038] LA Burley 21 (also referred to as LA BU21) is a low total alkaloid tobacco line produced by the incorporation of low alkaloid genes from Cuban Cigar cultivars into Burley 21 through several backcrosses (Legg et al. 1970). It has about 0.2% total alkaloids (dry weight) compared to about 3.5% (dry weight) of its parent Burley 21. LA BU21 has a leaf grade that is significantly lower than commercially acceptable standards. LA BU21 also exhibits other unfavorable leaf phenotypes characterized by lower yield, delayed maturation and senescence, higher susceptibility to insect herbivory, and poor end-product quality after curing (Chaplin and Weeks, 1976; Legg et al. 1970; Chaplin and Burk, 1983). Leaves of LA BU21 further exhibit traits such as higher polyamine content, higher chlorophyll content, and more mesophyll cells per unit leaf area.
[0039] Polyamines are reportedly involved in developmental, physiological, and metabolic processes in plants, such as cell growth and division, stress resistance, vascular differentiation, lignin polymerization, pathogen defense, senescence, and maturation (Fariduddin Q, Varshney P, Yusuf M, Ahmad A (2013) Polyamines: potent modulators of plant responses to stress. J. Plant Interac. 8: 1-16; Kusano T, Suzuki H (2015). Polyamines a universal molecular nexus for growth, survival and specialized metabolism. Tokyo: Springer.). Several studies have linked polyamines to the regulation of plant cell senescence (Sobieszczuk-Nowicka, E., Kubala, S., Zmienko, A., Malecka, A., Legocka, J. 2016. From accumulation to degradation: Reprogramming polyamine metabolism facilitates dark-induced senescence in Barley leaf cells. Front. Plant Sci. doi: 10.3389 / fpls.2015.01198).In fruits and vegetative tissues, polyamines act as anti-senescence and anti-ripening regulators that prevent the breakdown of chloroplast photosystem complexes and changes in cell wall / membrane composition (Lester GE (2000). Polyamines and their cellular anti-senescence properties in honey dew musk melon fruit. Plant Sci. 160: 105-112; Mattoo AK, Handa AK (2008). Higher polyamines restore and enhance metabolic memory in ripening fruit. Plant Sci. 174: 386-393; Serafini-Fracassini D, Di Sandro A, Del Duca S (2010). Spermine delays leaf senescence in Lactuca sativa and prevents the decay of chloroplast photosystems. Plant Physiol. Biochem. 48: 602-611).High levels of polyamines extend the lifespan of tomato vines (Mehta RA, Cassol T, Li N, Ali N, Handa AK, Mattoo AK (2002). Engineered polyamine accumulation in tomato enhances phytonutrient content, juice quality and vine life. Nat. Biotechnol. 20: 613-618), and delayed ripening and leaf senescence was observed in transgenic tomato plants overexpressing yeast spermidine synthase (Nambeesan S, Datsenka T, Ferruzzi MG, Malladi A, Mattoo AK, Handa AK (2010). Overexpression of yeast spermidine synthase impacts ripening, senescence and decay symptoms in tomato. Plant J. 63: 836-847). Polyamines can act directly by stabilizing cell walls or through crosstalk with plant hormones such as ethylene, abscisic acid, cytokinins, and gibberellins (Kussano and Suzuki 2015).
[0040] In most plants, putrescine can be synthesized directly from ornithine by ornithine decarboxylase (ODC) or from arginine through three enzymatic steps beginning with arginine decarboxylase (ADC) (Michael AJ, Furze JM, Rhodes MJ, Burtin D (1996). Molecular cloning and functional identification of a plant ornithine decarboxylase cDNA. Biochem. J. 314: 241-248; Piotrowski M, Janowitz T, Kneifel H (2003). Plant CN hydrolases and the identification of a plant N-carbamoylputrescine amidohydrolase involved in polyamine biosynthesis J. Biol. Chem. 278: 1708-1712; Illingworth C, Mayer MJ, Elliot K, Hanfrey C, Walton NJ, Michael AJ (2003). The diverse bacterial origins of the Arabidopsis polyamine biosynthetic pathway FEBS Letters 549: 26-30). Previous studies have shown that the ADC pathway to putrescine has only a minor effect on the alkaloid profile of tobacco, whereas the ODC pathway plays a major role in nicotine biosynthesis (Chintapakorn Y, Hamill JD (2007). Antisense-mediated reduction in ADC activity causes minor alterations in the alkaloid profile of cultured hairy root and regenerated transgenic plants of Nicotiana tabacum. Phytochem.68: 2465-2479; DeBoer KD, Dalton HL, Edward FJ, Hamill JD (2011). RNAi-mediated down-regulation of ornithine decarboxylase (ODC) leads to reduced nicotine and increased anatabine levels in transgenic Nicotiana tabacum L. Phytochem. 72: 344-355; DeBoer KD, Dalton HL, Edward FJ, Ryan SM, Hamill JD (2013). RNAi-mediated down-regulation of ornithine decarboxylase (ODC) impedes wound-stress stimulation of anabasine synthesis in Nicotiana glauca. Phytochem. 86: 21-28; Dalton HL, Blomstedt CK, Neale AD, Gleadow R, DeBoer KD, Hamill JD (2016). Effects of down-regulating ornithine decarboxylase upon putrescine-associated metabolism and growth in Nicotiana tabacum LJ Exp. Bot. 67: 3367-3381). Putrescine is converted to spermidine by successive additions of aminopropyl groups derived from decarboxylated S-adenosylmethionine (SAM) in a reaction catalyzed by the enzyme spermidine synthase, and then to spermine in a reaction catalyzed by spermine synthase. SAM is also a substrate for ethylene biosynthesis (Tiburcio AF, Altabella T, Bitrian M, Alcazar R (2014). The roles of polyamines during the lifespan of plants: from development to stress.Planta 240: 1-18), and ethylene regulates senescence and fruit ripening (Fluhr R, Mattoo AK (1996). Ethylene - biosynthesis and perception. Crit. Rev. Plant Sci. 15:479-523). Polyamine and ethylene biosynthetic pathways compete for a common precursor, SAM, but have opposing developmental actions, especially during the developmental switch from vegetative growth to maturation / senescence. (Nambeesan S, Handa AK, Mattoo AK (2008). Polyamines and regulation of ripening and senescence. In: Paliyath G, Murr DP, Handa AK, Lurie S (eds) Postharvest biology and technology of fruits, vegetables and flowers. Willey-Blackwell Publ, Ames. pp 319-340, Harpaz-Saad S, Yoon GM, Mattoo AK, Kieber JJ (2012). The formation of ACC and competition between polyamines and ethylene for SAM. Annu. Plant Reviews. 44: 53-81, Gupta A, Pal RK, Rajam MV (2013). Delayed ripening and improved fruit processing quality in tomato by RNAi-mediated silencing of three homologs of 1-aminopropane-1-carboxylate synthase gene. J. Plant Physiol. 170: 987-995). Tomato (Saftner RA, Baldi BG (1990). Polyamine levels and tomato fruit development: possible interaction with ethylene. Plant Physiol.92: 547-550; Morilla A, Garcia JM, Albi MA (1996). Free polyamine contents and decarboxylase activities during tomato development and ripening. J. Agri. Food Chem. 44: 2608-2611) and avocado (Kushad MM, Yelenosky G, Knight R (1988). Interrelationship of polyamine and ethylene biosynthesis during avocado fruit development and ripening. Plant Physiol. 87:463-467). This reflects their mutually antagonistic effects on polyamine biosynthesis and vice versa (Harpaz-Saad et al. 2012; Anwar R, Mattoo A, HandaA (2015). Polyamine interactions with plant hormones: crosstalk at several levels in Kusano T, Suzuki H (eds). Polyamines a Universal Molecular Nexus for Growth, Survival and Specialized Metabolism. Tokyo: Springer. pp 267-303). However, transgenic tomato plants expressing yeast S-adenosylmethionine decarboxylase (SAMDC) under the control of the ripening-specific E8 promoter simultaneously produced high levels of ethylene and polyamines during fruit ripening, indicating that there is no competition for SAM in this system (Mehta RA, Cassol T, Li N, Ali N, Handa AK, Mattoo AK (2002).Engineered polyamine accumulation in tomato enhances phytonutrient content, juice quality and vine life. Nat. Biotechnol. 20: 613-618). .
[0041] Without being bound by any scientific theory, the inhibition of nicotine biosynthesis in LA tobacco plants affects the crosstalk between the nicotine pathway, the polyamine pathway, and the ethylene pathway, resulting in the accumulation of putrescine, which would result in the inhibition of ethylene biosynthesis and at the same time increase the metabolic flux towards the higher polyamines spermidine and spermine, which would have a dramatic effect on leaf maturation and senescence.
[0042] In one aspect, the disclosure provides a tobacco plant or portion thereof that contains a mutation or transgene that confers low nicotine or low alkaloids and is capable of producing leaves that contain equivalent levels of one or more polyamines compared to equivalent leaves of a control plant that does not contain the same mutation or transgene. In one aspect, the equivalent levels of one or more polyamines are within 20%, within 17.5%, within 15%, within 12.5%, within 10%, within 7.5%, within 5%, within 2.5%, or within 1% of the levels in equivalent leaves of a control plant that does not contain the same mutation or transgene. In one aspect, the equivalent level of one or more polyamines is 0.5%-1%, 1%-2%, 2%-3%, 3%-4%, 4%-5%, 5%-6%, 6%-7%, 7%-8%, 8%-9%, 9%-10%, 11%-12%, 12%-13%, 13%-14%, 14%-15%, 15%-16%, 16%-17%, 17%-18%, 18%-19%, or 19%-20% of the level in an equivalent leaf of a control plant not containing the same mutation or transgene. In a further aspect, the equivalent level of one or more polyamines is 0.5%-5%, 5%-10%, or 10%-20% of the level in an equivalent leaf of a control plant not containing the same mutation or transgene.
[0043] In one aspect, the present disclosure provides a tobacco plant or portion thereof that contains a mutation or transgene that confers low nicotine or low alkaloids and is capable of producing leaves that contain equivalent chlorophyll levels compared to equivalent leaves of a control plant that does not contain the same mutation or transgene, in one aspect, equivalent chlorophyll levels are within 20%, within 17.5%, within 15%, within 12.5%, within 10%, within 7.5%, within 5%, within 2.5%, or within 1% of the levels in equivalent leaves of a control plant that does not contain the same mutation or transgene. In one aspect, the equivalent chlorophyll level is 0.5%-1%, 1%-2%, 2%-3%, 3%-4%, 4%-5%, 5%-6%, 6%-7%, 7%-8%, 8%-9%, 9%-10%, 11%-12%, 12%-13%, 13%-14%, 14%-15%, 15%-16%, 16%-17%, 17%-18%, 18%-19%, or 19%-20% of the level in an equivalent leaf of a control plant that does not contain the same mutation or transgene. In a further aspect, the equivalent chlorophyll level is 0.5%-5%, 5%-10%, or 10%-20% of the level in an equivalent leaf of a control plant that does not contain the same mutation or transgene.
[0044] In one aspect, the disclosure provides a tobacco plant or portion thereof that contains a mutation or transgene that confers low nicotine or low alkaloids and is capable of producing leaves that contain a comparable number of mesophyll cells per unit leaf area as compared to a comparable leaf of a control plant that does not contain the same mutation or transgene. In one aspect, the comparable number of mesophyll cells per unit leaf area is within 20%, within 17.5%, within 15%, within 12.5%, within 10%, within 7.5%, within 5%, within 2.5%, or within 1% of the level in a comparable leaf of a control plant that does not contain the same mutation or transgene. In one aspect, the number of mesophyll cells per equivalent unit leaf area is 0.5%-1%, 1%-2%, 2%-3%, 3%-4%, 4%-5%, 5%-6%, 6%-7%, 7%-8%, 8%-9%, 9%-10%, 11%-12%, 12%-13%, 13%-14%, 14%-15%, 15%-16%, 16%-17%, 17%-18%, 18%-19%, or 19%-20% of the level in an equivalent leaf of a control plant that does not contain the same mutation or transgene. In a further aspect, the number of mesophyll cells per equivalent unit leaf area is 0.5%-5%, 5%-10%, or 10%-20% of the level in an equivalent leaf of a control plant that does not contain the same mutation or transgene.
[0045] In one aspect, the disclosure provides a tobacco plant or portion thereof that contains a mutation or transgene that confers low nicotine or low alkaloids and is capable of producing a leaf that contains a comparable epidermal cell size compared to a comparable leaf of a control plant that does not contain the same mutation or transgene, in one aspect, a comparable epidermal cell size is within 20%, within 17.5%, within 15%, within 12.5%, within 10%, within 7.5%, within 5%, within 2.5%, or within 1% of the level in a comparable leaf of a control plant that does not contain the same mutation or transgene. In one aspect, the equivalent epidermal cell size is 0.5%-1%, 1%-2%, 2%-3%, 3%-4%, 4%-5%, 5%-6%, 6%-7%, 7%-8%, 8%-9%, 9%-10%, 11%-12%, 12%-13%, 13%-14%, 14%-15%, 15%-16%, 16%-17%, 17%-18%, 18%-19%, or 19%-20% of the level in an equivalent leaf of a control plant that does not contain the same mutation or transgene. In a further aspect, the equivalent epidermal cell size is 0.5%-5%, 5%-10%, or 10%-20% of the level in an equivalent leaf of a control plant that does not contain the same mutation or transgene.
[0046] In one aspect, the disclosure provides a tobacco plant or portion thereof that includes a mutation or transgene that confers low nicotine or low alkaloids and is capable of producing a leaf that includes a comparable leaf yield compared to a comparable leaf of a control plant that does not include the same mutation or transgene, in one aspect, a comparable leaf yield is within 20%, within 17.5%, within 15%, within 12.5%, within 10%, within 7.5%, within 5%, within 2.5%, or within 1% of the level in a comparable leaf of a control plant that does not include the same mutation or transgene. In one aspect, the equivalent leaf yield is 0.5%-1%, 1%-2%, 2%-3%, 3%-4%, 4%-5%, 5%-6%, 6%-7%, 7%-8%, 8%-9%, 9%-10%, 11%-12%, 12%-13%, 13%-14%, 14%-15%, 15%-16%, 16%-17%, 17%-18%, 18%-19%, or 19%-20% of the level in an equivalent leaf of a control plant not containing the same mutation or transgene. In a further aspect, the equivalent leaf yield is 0.5%-5%, 5%-10%, or 10%-20% of the level in an equivalent leaf of a control plant not containing the same mutation or transgene.
[0047] In one aspect, the disclosure provides a tobacco plant or portion thereof that contains a mutation or transgene that confers low nicotine or low alkaloids and exhibits equivalent insect feeding susceptibility relative to an equivalent leaf of a control plant that does not contain the same mutation or transgene, in one aspect, equivalent insect feeding susceptibility is within 20%, within 17.5%, within 15%, within 12.5%, within 10%, within 7.5%, within 5%, within 2.5%, or within 1% of the level in an equivalent leaf of a control plant that does not contain the same mutation or transgene. In one aspect, the equivalent insect feeding susceptibility is 0.5%-1%, 1%-2%, 2%-3%, 3%-4%, 4%-5%, 5%-6%, 6%-7%, 7%-8%, 8%-9%, 9%-10%, 11%-12%, 12%-13%, 13%-14%, 14%-15%, 15%-16%, 16%-17%, 17%-18%, 18%-19%, or 19%-20% of the level in an equivalent leaf of a control plant that does not contain the same mutation or transgene. In a further aspect, the equivalent insect feeding susceptibility is 0.5%-5%, 5%-10%, or 10%-20% of the level in an equivalent leaf of a control plant that does not contain the same mutation or transgene.
[0048] Insect feeding susceptibility levels can be assayed by methods known in the art, for example, insect feeding assays. Briefly, a 1 / 4 inch layer of 0.7% agar in water is added to a 100 mm Petri dish and allowed to solidify. Leaf disks are cut from the Petri dish lid, placed into the plate, and gently pressed into the agar. Leaf disks are taken from plants at 4-5 leaf stage. Disks are taken from the leaf blade, excluding the midrib. One disk is taken from each of the four largest leaves of the plant to create four replicates per plant. Four plants are sampled for a total of 16 biological replicate test lines. One second instar caterpillar is added to the leaf and allowed to feed at ambient temperature for 48 hours. After 48 hours, the caterpillar larvae are weighed and the final larval weight is recorded.
[0049] Unless otherwise specified, the measurements of alkaloid, polyamine, or nicotine levels (or other leaf chemistry or characteristic features) or leaf grade index values described herein for a tobacco plant, variety, cultivar, or strain may refer to average measurements, including, for example, the average of multiple leaves of a single plant or the average measurements from a population of tobacco plants from a single variety, cultivar, or strain, depending on the context. In one aspect, the nicotine, alkaloid, or polyamine levels (or other leaf chemistry or characteristic features) of a tobacco plant are measured after top pruning in pooled leaf samples collected from leaf numbers 3, 4, and 5 after top pruning. In another aspect, the nicotine, alkaloid, or polyamine levels (or other leaf chemistry or characteristic features) of a tobacco plant are measured after top pruning in leaves with the highest levels of nicotine, alkaloid, or polyamine (or other leaf chemistry or characteristic features). In one aspect, nicotine, alkaloid, or polyamine levels of a tobacco plant are measured at leaf numbers 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30 after topping. In another aspect, nicotine, alkaloid, or polyamine levels (or another leaf chemistry or characteristic feature) of tobacco plants are measured after topping in a pool of two or more leaves having consecutive leaf numbers selected from the group consisting of leaf numbers 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, and 30. In another aspect, nicotine, alkaloid, or polyamine levels (or another leaf chemistry or characteristic feature) of tobacco plants are measured after topping in leaves having leaf numbers selected from the group consisting of 1-5, 6-10, 11-15, 16-20, 21-25, and 26-30.In another aspect, nicotine, alkaloid, or polyamine levels (or another leaf chemistry or characteristic feature) of tobacco plants are measured after topping in pools of two or more leaves having leaf numbers selected from the group consisting of 1-5, 6-10, 11-15, 16-20, 21-25, and 26-30. In another aspect, nicotine, alkaloid, or polyamine levels (or another leaf chemistry or characteristic feature) of tobacco plants are measured after topping in pools of three or more leaves having leaf numbers selected from the group consisting of 1-5, 6-10, 11-15, 16-20, 21-25, and 26-30.
[0050] Alkaloid levels can be assayed by methods known in the art, for example, gas liquid chromatography, high performance liquid chromatography, radioimmunoassay, and enzyme-linked immunosorbent assay based quantification.
[0051] As used herein, leaf numbering is based on the position of the leaf on the tobacco stem, with leaf number 1 being the oldest leaf (most base) after topping and the highest leaf number being assigned to the youngest leaf (tip).
[0052] The population of tobacco plants or collection of tobacco leaves for determining an average measurement (e.g., alkaloid or nicotine level or leaf grading) can be of any size, for example, 5, 10, 15, 20, 25, 30, 35, 40, or 50. The average measurement or grad index value is determined according to standard industry accepted protocols.
[0053] As used herein, "topping" refers to the removal of the top of the stem, including the SAM, the flower, and up to a few adjacent leaves, when the tobacco plant is near vegetative maturity and at the beginning of reproductive growth. Typically, tobacco plants are topped at the bud stage (just after the flower begins to appear). For example, greenhouse or field-grown tobacco plants can be topped when 50% of the plants have at least one open flower. Topping tobacco plants results in the loss of apical dominance and also induces increased alkaloid production.
[0054] Typically, the nicotine, alkaloid, or polyamine levels (or other leaf chemistry or characteristic features) of the tobacco plant are measured about 2 weeks after topping. Other time points may also be used. In one aspect, the nicotine, alkaloid, or polyamine levels (or other leaf chemistry or characteristic features) of the tobacco plant are measured about 1, about 2, about 3, about 4, or about 5 weeks after topping. In another aspect, the nicotine, alkaloid, or polyamine levels (or other leaf chemistry or characteristic features) of the tobacco plant are measured about 3, about 5, about 7, about 10, about 12, about 14, about 17, about 19, or about 21 days after topping.
[0055] As used herein, "similar growing conditions" refers to similar environmental conditions and / or agronomic practices for growing and making meaningful comparisons between two or more plant genotypes, where neither the environmental conditions nor the agronomic practices contribute to and account for any differences observed between the two or more plant genotypes. Environmental conditions include, for example, light, temperature, water (humidity), and nutrients (e.g., nitrogen and phosphorus). Agronomic practices include, for example, sowing, clipping, undercutting, transplanting, topping, and sucking. See Chapters 4B and 4C in Tobacco, Production, Chemistry and Technology, edited by Davis & Nielsen, Blackwell Publishing, Oxford (1999), pp 70-103.
[0056] As used herein, "comparable leaves" refers to leaves having a similar size, shape, age, and / or petiole position.
[0057] In one aspect, the present disclosure provides a tobacco plant or part thereof, comprising an inducible promoter operably linked to a transcribable DNA sequence encoding a non-coding RNA for suppressing an ornithine decarboxylase (ODC) gene. In one aspect, the inducible promoter is a pinching-inducible promoter. In one aspect, the inducible promoter is also a tissue-specific or tissue-preferred promoter. In one aspect, the tissue-specific or tissue-preferred promoter is specific to or preferred for one or more tissues or organs selected from the group consisting of shoots, roots, leaves, stems, flowers, haustoria, root tips, mesophyll cells, epidermal cells, and vasculature. In a further aspect, the pinching-inducible promoter comprises a promoter sequence derived from a tobacco nicotine demethylase gene, such as CYP82E4, CYP82E5, or CYP82E10.
[0058] Various types of promoters can be used herein. These are classified according to various criteria related to the expression pattern of a coding sequence or gene (including a transgene) operably linked to the promoter, e.g., constitutive promoters, developmental promoters, tissue-specific promoters, tissue-preferred promoters, inducible promoters, etc. A promoter that initiates transcription in all or most tissues of a plant is referred to as a "constitutive" promoter. A promoter that initiates transcription at a certain period or stage of development is referred to as a "developmental" promoter. A promoter that enhances expression in a certain plant tissue compared to other plant tissues is referred to as a "tissue-enhanced" or "tissue-preferred" promoter. Thus, a "tissue-preferred" promoter causes relatively high or preferential expression in a specific plant tissue, but low levels of expression in other plant tissues. A promoter that is expressed in a specific tissue of a plant and has little or no expression in other plant tissues is referred to as a "tissue-specific" promoter. A promoter that is expressed in a certain cell type of a plant is referred to as a "cell type-specific" promoter. An "inducible" promoter is one that initiates transcription in response to an environmental stimulus, such as cold, drought, heat, or light, or other stimuli, such as wounding or application of a chemical. Promoters may also be classified in terms of origin, such as heterologous, homologous, chimeric, synthetic, etc. A "heterologous" promoter is a promoter sequence that has a different origin than its associated transcribable sequence, coding sequence, or gene (or transgene) and / or does not naturally occur in the plant species to be transformed. The term "heterologous" more broadly includes combinations of two or more DNA molecules or sequences when such combinations are not normally found in nature. For example, two or more DNA molecules or sequences would be heterologous to each other if they are normally found in different genomes, or at different loci within the same genome, or if they are not combined identically in nature.
[0059] In one aspect, the inducible promoter provides root-specific or root-preferred expression. In one aspect, the root-specific or root-preferred inducible promoter comprises a sequence selected from the group consisting of SEQ ID NOs: 1-11, and functional fragments thereof. Table 1 shows a comparison of the estimated leaf-specific versus root-specific expression levels driven by SEQ ID NOs: 1-11.
[0060] In one aspect, the inducible promoter provides leaf-specific or leaf-preferred expression. In one aspect, the leaf-specific or leaf-preferred inducible promoter comprises a sequence selected from the group consisting of SEQ ID NOs: 12-21, and functional fragments thereof. Table 2 shows a comparison of the estimated leaf-specific versus root-specific expression levels driven by SEQ ID NOs: 12-21.
[0061] Table 1. Exemplary inducible promoters for pinching-responsive root-specific or root-preferred expression TIFF2024156794000002.tif224130
[0062] Table 2. Exemplary inducible promoters for pinching-responsive leaf-specific or leaf-preferential expression TIFF2024156794000003.tif231110
[0063] In one aspect, the inducible promoter is heterologous to the transcribable DNA sequence operably linked.In one aspect, the transcribable DNA sequence encodes a non-coding RNA selected from the group consisting of microRNA (miRNA), antisense RNA, small interfering RNA (siRNA), trans-acting siRNA (ta-siRNA), and hairpin RNA (hpRNA).In one aspect, the non-coding RNA comprises a nucleotide sequence having at least 99.9%, at least 99.5%, at least 99%, at least 98%, at least 97%, at least 96%, at least 95%, at least 94%, at least 93%, at least 92%, at least 91%, at least 90%, at least 85%, at least 80%, or at least 75% identity to the sequence selected from the group consisting of SEQ ID NO:35 and 36, and any part thereof. In one aspect, the non-coding RNA is provided in an ODC RNAi construct comprising a nucleotide sequence having at least 99%, at least 97%, at least 95%, at least 90%, at least 85%, at least 80%, or at least 75% identity to SEQ ID NO:22.
[0064] "Alkaloids" are complex nitrogen-containing compounds occurring naturally in plants that have pharmacological effects in humans and animals. "Nicotine" is the major naturally occurring alkaloid in commercial cigarette tobacco, accounting for about 90 percent of the alkaloid content in Nicotiana tabacum. Other major alkaloids in tobacco include cotinine, nornicotine, myosmine, nicotyrine, anabasine, and anatabine. Minor tobacco alkaloids include nicotine-n-oxide, N-methylanatabine, N-methylanabasine, pseudooxynicotine, 2,3 dipyridyl, and others.
[0065] In one aspect, the tobacco plant provided herein comprises a lower level of total or individual alkaloids compared to a control tobacco plant that does not have any of the nic1 and / or nic2 mutations when grown under similar growth conditions.In another aspect, the tobacco plant provided herein comprises a lower level of one or more alkaloids selected from the group consisting of cotinine, nornicotine, myosmine, nicotyrine, anabasine, and anatabine compared to a control tobacco plant when grown under similar growth conditions.In one aspect, lower alkaloid or nicotine level refers to an alkaloid or nicotine level that is less than 1%, less than 2%, less than 5%, less than 8%, less than 10%, less than 12%, less than 15%, less than 20%, less than 25%, less than 30%, less than 40%, less than 50%, less than 60%, less than 70%, or less than 80% of the alkaloid or nicotine level of the control tobacco plant. In another aspect, the lower alkaloid or nicotine level is about 0.5% to 1%, about 1% to 2%, about 2% to 3%, about 3% to 4%, about 4% to 5%, about 5% to 6%, about 6% to 7%, about 7% to 8%, about 8% to 9%, about 9% to 10%, about 11% to 12%, about 12% to 13%, about 13% to 14%, about 15% to 16%, about 17% to 18%, about 19% to 20%, about 21% to 22%, about 22% to 23%, about 23% to 24%, about 25% to 26%, about 27% to 28%, about 29% to 30%, about 30% to 31%, about 32% to 33%, about 34% to 35%, about 36% to 37%, about 38% to 39%, about 40% to 40%, about 41% to 42%, about 43% to 44%, about 45% to 46%, about 47% to 48%, about 49% to 50%, about 50% to 51%, about 52% to 53%, about 54% to 55%, about 56% to 57%, about 58% to 59%, about 60% to 61%, about 62% to 63%, about 63% to 64%, about 64% to 65%, about 65% to 66%, about 67% to 68%, about 69% to 70%, about 71% to 72%, about 73% to 74%, about 75% to 76%, about 78% to 79%, about 80% to 82%, about 85% to 86%, about The lower alkaloid or nicotine level refers to an alkaloid or nicotine level of about 4% to 15%, about 15% to 16%, about 16% to 17%, about 17% to 18%, about 18% to 19%, about 19% to 20%, about 21% to 22%, about 22% to 23%, about 23% to 24%, about 24% to 25%, about 25% to 26%, about 26% to 27%, about 27% to 28%, about 28% to 29%, or about 29% to 30% of the alkaloid or nicotine level of a control tobacco plant. In a further aspect, the lower alkaloid or nicotine level refers to an alkaloid or nicotine level of about 0.5% to 5%, about 5% to 10%, about 10% to 20%, or about 20% to 30% of the alkaloid or nicotine level of a control tobacco plant.
[0066] Alkaloid levels can be assayed by methods known in the art, such as quantification based on gas-liquid chromatography, high performance liquid chromatography, radioimmunoassay, and enzyme-linked immunosorbent assay.For example, nicotine alkaloid levels can be measured by GC-FID method based on CORESTA Recommended Method No.7, 1987 and ISO standard (ISO TC 126N 394 E.; see also Hibi et al., Plant Physiology 100:826-35(1992)) for the method using gas-liquid chromatography with capillary column and FID detector. Unless otherwise specified, all alkaloid levels described herein are measured using the method according to CORESTA Method No 62, Determination of Nicotine in Tobacco and Tobacco Products by Gas Chromatographic Analysis, February 2005, and the method defined in the Centers for Disease Control and Prevention's Protocol for Analysis of Nicotine, Total Moisture and pH in Smokeless Tobacco Products, published in the Federal Register Vol. 64, No. 55 March 23, 1999 (and amended in Vol. 74, No. 4, January 7, 2009).
[0067] Alternatively, tobacco total alkaloids can be measured using a segmented flow colorimetric method developed for the analysis of tobacco samples as employed by Skalar Instrument Co (West Chester, PA) and described by Collins et al., Tobacco Science 13:79-81 (1969). Briefly, tobacco samples are dried, crushed, extracted, and then analyzed for total alkaloids and reducing sugars. The method then uses acetic acid / methanol / water extraction and charcoal for decolorization. The determination of total alkaloids is based on the reaction of cyanogen chloride with nicotine alkaloids in the presence of aromatic amines to form colored complexes, which are measured at 460 nm. Unless otherwise specified, the total alkaloids or nicotine levels shown herein are based on dry weight (e.g., percent total alkaloids or percent nicotine).
[0068] In one aspect, the tobacco plants provided herein contain lower levels of nicotine compared to control tobacco plants that do not have either the nic1 mutation and / or the nic2 mutation when grown under similar growth conditions. In one aspect, lower nicotine levels refer to average nicotine levels that are less than 1%, less than 2%, less than 5%, less than 8%, less than 10%, less than 12%, less than 15%, less than 20%, less than 25%, less than 30%, less than 40%, less than 50%, less than 60%, less than 70%, or less than 80% of the average nicotine levels of control tobacco plants. In another aspect, the lower nicotine level is about 0.5% to 1%, about 1% to 2%, about 2% to 3%, about 3% to 4%, about 4% to 5%, about 5% to 6%, about 6% to 7%, about 7% to 8%, about 8% to 9%, about 9% to 10%, about 11% to 12%, about 12% to 13%, about 13% to 14%, about 14% to 15%, about 15% to 16%, about 16% to 17%, about 17% to 18%, about 18% to 20%, about 20% to 22%, about 20% to 24%, about 20% to 25%, about 25% to 26%, about 26% to 27%, about 27% to 28%, about 28% to 30%, about 29% to 31%, 5%, about 15%-16%, about 16%-17%, about 17%-18%, about 18%-19%, about 19%-20%, about 21%-22%, about 22%-23%, about 23%-24%, about 24%-25%, about 25%-26%, about 26%-27%, about 27%-28%, about 28%-29%, or about 29%-30% of the average nicotine level of the control tobacco plants. In further aspects, lower nicotine levels refer to average nicotine levels of about 0.5%-5%, about 5%-10%, about 10%-20%, or about 20%-30% of the average nicotine level of the control tobacco plants.
[0069] In one aspect, the tobacco plants provided herein have a dry weight ratio of about 0.01%, about 0.02%, about 0.05%, about 0.75%, about 0.1%, about 0.15%, about 0.2%, about 0.3%, about 0.35%, about 0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8%, about 0.9%, about 1%, about 1.1%, about 1.2%, about 1.3%, about 1.4%, about 1.5%, about 1.6%, about 1.7%, about 1.8%, about 1.9%, about 2.0%, about 2.1%, about 2.2%, about 2.3%, about 2.4%, about 2.5%, about 2.6%, about 2.7%, about 2.8%, about 2.9%, about 3.0%, about 3.1%, about 3.2%, about 3.3%, about 3.4%, about 3.5%, about 3.6%, about 3.7%, about 3.8%, about 3.9 ...5%, about 3.6%, about 3.7%, about 3.8%, about 3.9%, The nicotine or total alkaloid level comprises an average nicotine or total alkaloid level selected from the group consisting of about 1.9%, about 2%, about 2.1%, about 2.2%, about 2.3%, about 2.4%, about 2.5%, about 2.6%, about 2.7%, about 2.8%, about 2.9%, about 3%, about 3.1%, about 3.2%, about 3.3%, about 3.4%, about 3.5%, about 3.6%, about 3.7%, about 3.8%, about 3.9%, about 4%, about 5%, about 6%, about 7%, about 8%, and about 9%. In another aspect, the tobacco plants provided herein have a dry weight ratio of about 0.01% to 0.02%, about 0.02% to 0.05%, about 0.05% to 0.75%, about 0.75% to 0.1%, about 0.1% to 0.15%, about 0.15% to 0.2%, about 0.2% to 0.3%, about 0.3% to 0.35%, about 0.35% to 0.4%, about 0.4% to 0.5%, about 0.5% to 0.6%, about 0.6% to 0.7%, about 0.7% to 0.8%, about 0.8% to 0.9%, about 0.9% to 1%, about 1% to 1.1%, about 1.1% to 1.2%, about 1.2% to 1.3%, about 1.3% to 1.4%, about 1.4% to 1.5%, or about 1.5% to 1.6%. %, about 1.5%-1.6%, about 1.6%-1.7%, about 1.7%-1.8%, about 1.8%-1.9%, about 1.9%-2%, about 2%-2.1%, about 2.1%-2.2%, about 2.2%-2.3%, about 2.3%-2.4%, about 2.4%-2.5%, about 2.5%-2.6%, about 2.6%-2.7%, about 2.7%-2.8%, about 2.8%-2.9%, about 2.9%-3%, about 3%-3.1%, about 3.1%-3.2%, about 3.2%-3.3%, about 3.3%-3.4%, about 3.4%-3.5%, and about 3.5%-3.6%.In a further aspect, the tobacco plants provided herein comprise an average nicotine or total alkaloid level selected from the group consisting of about 0.01%-0.1%, about 0.02%-0.2%, about 0.03%-0.3%, about 0.04%-0.4%, about 0.05%-0.5%, about 0.75%-1%, about 0.1%-1.5%, about 0.15%-2%, about 0.2%-3%, and about 0.3%-3.5% on a dry weight basis.
[0070] The present disclosure also provides tobacco plants with altered nicotine levels without negatively affecting other tobacco traits, such as leaf grade index values. In one aspect, low-nicotine or no-nicotine tobacco varieties provide commercially acceptable grades of cured tobacco. Tobacco grades are evaluated based on factors including, but not limited to, leaf position on the stem, leaf size, leaf color, leaf uniformity and integrity, maturity, feel, elasticity, gloss (relating to the intensity and depth of leaf coloration as well as brilliance), hygroscopicity (the tobacco leaf's ability to absorb and retain moisture from the surroundings), and green color characteristics or shades. Leaf grades can be determined, for example, using the Official Standard Grade (7 USC § 511) published by the Agricultural Marketing Service of the US Department of Agriculture.For example, the Official Standard Grades for Burley Tobacco (US Type 31 and Foreign Type 93), effective November 5, 1990 (55 FR 40645); the Official Standard Grades for Flue-Cured Tobacco (US Types 11, 12, 13, 14 and Foreign Type 92), effective March 27, 1989 (54 FR 7925); the Official Standard Grades for Pennsylvania Seedleaf Tobacco (US Type 41), effective January 8, 1965 (29 FR 16854); the Official Standard Grades for Ohio Cigar-Leaf Tobacco (US Types 42, 43, and 44), effective December 8, 1963 (28 FR 11719 and 28 FR 11926); See, for example, the Official Standard Grades for Wisconsin Cigar-Binder Tobacco (US Types 54 and 55), effective November 20, 1969 (34 FR 17061); the Official Standard Grades for Wisconsin Cigar-Binder Tobacco (US Types 54 and 55), effective November 20, 1969 (34 FR 17061); and the Official Standard Grades for Georgia and Florida Shade-Grown Cigar-Wrapper Tobacco (US Type 62), effective April 1971. USDA grade index values may be determined in accordance with industry accepted grade index values.See, e.g., Bowman et al, Tobacco Science, 32:39-40 (1988); Legacy Tobacco Document Library (Bates Document #523267826-523267833, July 1, 1988, Memorandum on the Proposed Burley Tobacco Grade Index); and Miller et al., 1990, Tobacco Intern., 192:55-57 (all of the above references are incorporated by reference in their entirety). In one aspect, the USDA Grade Index is a numerical representation of the received Federal grade from 0 to 100, weighted average of all stem locations. A higher Grade Index indicates higher quality. Alternatively, leaf grade may be determined via hyperspectral imaging. See, e.g., WO2011 / 027315 (published March 10, 2011; incorporated by reference in its entirety). A comparable leaf grade index indicates a leaf grade index that does not change by more than 30% or less than 30% of a suitable control or comparator when leaves from a similar petiole location are compared. In one aspect, a comparable leaf grade index does not change by more than 25%, 20%, 15%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, or 1% or less than 25%, 20%, 15%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, or 1% of a suitable control or comparator when leaves from a similar petiole location are compared.
[0071] In one aspect, the tobacco plants provided herein contain similar levels of one or more tobacco aroma compounds selected from the group consisting of 3-methylvaleric acid, valeric acid, isovaleric acid, labdanoids, cembranoids, sugar esters, and reducing sugars, compared to a control tobacco plant when grown under similar growth conditions. In another aspect, the tobacco plants provided herein contain a nic1 mutation, a nic2 mutation, or a combination thereof that does not have an effect on the levels of one or more tobacco aroma compounds selected from the group consisting of 3-methylvaleric acid, valeric acid, isovaleric acid, labdanoids, cembranoids, sugar esters, and reducing sugars.
[0072] As used herein, tobacco aroma compounds are compounds that are associated with the flavor and aroma of tobacco smoke.These compounds include, but are not limited to, 3-methylvaleric acid, valeric acid, isovaleric acid, cembranoid and labdanoid diterpenes, and sugar esters.The concentration of tobacco aroma compounds can be measured by any known metabolite profiling method in the art, including, but not limited to, gas chromatography-mass spectrometry (GC-MS), nuclear magnetic resonance spectrometry, and liquid chromatography-mass spectrometry.See The Handbook of Plant Metabolomics, edited by Weckwerth and Kahl, (Wiley-Blackwell) (May 28, 2013).
[0073] As used herein, a "reducing sugar" is any sugar (monosaccharide or polysaccharide) that has a free or potentially free aldehyde or ketone group. Glucose and fructose act as nicotine buffers in cigarette smoke by reducing the pH of the smoke and effectively reducing the amount of "free" unprotonated nicotine. Reducing sugars balance the flavor of the smoke, for example, by modifying the sensory impact of nicotine and other tobacco alkaloids. An inverse relationship between sugar content and alkaloid content has been reported across tobacco varieties, within the same variety, and within the same plant line driven by growing conditions. Reducing sugar levels can be measured using a segmented flow colorimetric method developed for the analysis of tobacco samples as employed by Skalar Instrument Co (West Chester, PA) and described by Davis, Tobacco Science 20:139-144 (1976). For example, the sample is dialyzed against a sodium carbonate solution. Copper neocuproine is added to the sample and the solution is heated. The copper neocuproine chelate is reduced in the presence of sugar resulting in a colored complex which is measured at 460 nm.
[0074] In one aspect, the tobacco plant provided herein comprises one or more non-naturally occurring mutant alleles at the nic1 and / or nic2 locus that reduce or eliminate one or more gene activities from the nic1 and / or nic2 locus.In one aspect, these mutant alleles result in lower nicotine levels.Mutant nic1 and / or nic2 alleles can be introduced by any method known in the art, including random or targeted mutagenesis approaches.
[0075] Such mutagenesis methods include, but are not limited to, seed treatment with ethyl methyl sulfate (EMS) (Hildering and Verkerk, The use of induced mutations in plant breeding. Pergamon press, pp 317-320, 1965) or UV irradiation, X-rays, and fast neutron irradiation (see, e.g., Verkerk, Neth. J. Agric. Sci. 19:197-203, 1971; and Poehlman, Breeding Field Crops, Van Nostrand Reinhold, New York (3rd ed), 1987), transposon tagging (Fedoroff et al., 1984; U.S. Pat. Nos. 4,732,856 and 5,013,658), as well as T-DNA insertion methodologies (Hoekema et al., 1983; U.S. Pat. No. 5,149,645). EMS-induced mutagenesis consists of chemically inducing random point mutations throughout the length of the genome. Fast neutron mutagenesis consists of exposing seeds to neutron bombardment, which causes large deletions through double-stranded DNA breaks. Transposon tagging involves inserting a transposon into an endogenous gene to reduce or eliminate the expression of the gene. Types of mutations that can be present in tobacco genes include, for example, point mutations, deletions, insertions, duplications, and inversions. Such mutations are desirably present in the coding regions of tobacco genes, but mutations in the promoter regions and introns or non-translated regions of tobacco genes may also be desirable.
[0076] In addition, TILLING (Targeting Induced Local Lesions In Genomes), a rapid and automatable method of screening for chemically induced mutations using denaturing HPLC or selective endonuclease digestion of selected PCR products, is also applicable to the present disclosure. See McCallum et al. (2000) Nat. Biotechnol. 18:455-457. Mutations that affect gene expression or interfere with gene function can be determined using methods well known in the art. Insertion mutations in gene exons usually result in null mutants. Mutations in conserved residues can be particularly effective in inhibiting protein function. In one aspect, the tobacco plant comprises nonsense (e.g., stop codon) mutations in one or more NCG genes described in U.S. Provisional Patent Application Nos. 62 / 616,959 and 62 / 625,878, both of which are incorporated herein by reference in their entirety.
[0077] In one aspect, the present disclosure also provides tobacco strains with altered nicotine levels while maintaining commercially acceptable leaf quality. These strains can be produced by introducing mutations in one or more genes in the nic1 and / or nic2 locus via precise genome engineering techniques, such as transcription activator-like effector nucleases (TALENs), meganucleases, zinc finger nucleases, and clustered regularly-interspaced short palindromic repeats (CRISPR) / Cas9 systems, CRISPR / Cpf1 systems, CRISPR / Csm1 systems, and combinations thereof (see, for example, US Patent Application Publication No. 2017 / 0233756). See, for example, Gaj et al., Trends in Biotechnology, 31(7):397-405(2013).
[0078] Screening and selection of mutagenized tobacco plants may be via any methodology known to those skilled in the art. Examples of screening and selection methodologies include, but are not limited to, Southern analysis, PCR amplification for detection of polynucleotides, Northern blot, ribonuclease protection, primer extension, RT-PCR amplification for detection of RNA transcripts, Sanger sequencing, next generation sequencing technology (e.g., Illumina, PacBio, Ion Torrent, 454), enzyme assay for detection of enzyme or ribozyme activity of polypeptides and polynucleotides, and protein gel electrophoresis, Western blot, immunoprecipitation, and enzyme-linked immunoassay for detection of polypeptides. Other techniques such as in situ hybridization, enzyme staining, and immunostaining can also be used to detect the presence or expression of polypeptides and / or polynucleotides. Methods for carrying out all the techniques referred to are known.
[0079] In one aspect, the tobacco plant or plant genome provided herein is mutagenized or edited with a nuclease selected from the group consisting of a meganuclease, a zinc finger nuclease (ZFN), a transcription activator-like effector nuclease (TALEN), a CRISPR / Cas9 nuclease, a CRISPR / Cpf1 nuclease, or a CRISPR / Csm1 nuclease.
[0080] In one aspect, the tobacco plant provided herein comprising a nic1 mutation, a nic2 mutation, or both, further comprises a transgene or mutation that results in early senescence. In one aspect, the mutation that results in early senescence is yellow burley1 (-yb1). In one aspect, the mutation that results in early senescence is yellow burley2 (-yb2). In one aspect, the mutation that results in early senescence is pale yellow (PY).
[0081] In one aspect, the tobacco plant or portion thereof comprises a first genomic modification that provides a lower level of nicotine or total alkaloids and a second genomic modification that provides an equivalent level of one or more traits, the traits being selected from the group consisting of total leaf polyamine levels, total root polyamine levels, total leaf chlorophyll levels, mesophyll cell number per unit leaf area, and leaf epidermal cell size, compared to a control tobacco plant, the control plant not having both the first and second genomic modifications. In one aspect, the tobacco plant or portion thereof comprises a first genomic modification that provides a lower level of nicotine or total alkaloids and a second genomic modification that provides an equivalent level of total leaf polyamine levels, compared to a control tobacco plant, the control plant not having both the first and second genomic modifications. In one aspect, the tobacco plant or part thereof comprises a first genomic modification that provides a lower level of nicotine or total alkaloids and a second genomic modification that provides a comparable level of total root polyamine levels compared to a control tobacco plant, the control plant not having both the first and second genomic modifications. In one aspect, the tobacco plant or part thereof comprises a first genomic modification that provides a lower level of nicotine or total alkaloids and a second genomic modification that provides a comparable level of total leaf chlorophyll levels compared to a control tobacco plant, the control plant not having both the first and second genomic modifications. In one aspect, the tobacco plant or part thereof comprises a first genomic modification that provides a lower level of nicotine or total alkaloids and a second genomic modification that provides a comparable level of mesophyll cell number per unit leaf area compared to a control tobacco plant, the control plant not having both the first and second genomic modifications. In one aspect, the tobacco plant or portion thereof comprises a first genomic modification that provides a lower level of nicotine or total alkaloids and a second genomic modification that provides a comparable level of leaf epidermal cell size compared to a control tobacco plant, the control plant not having both the first and second genomic modifications.
[0082] In one aspect, the first genome modification, the second genome modification, or both, comprises a transgene, a mutation, or both. In one aspect, the genome modification, the second genome modification, or both, comprises a transgene. In one aspect, the first genome modification, the second genome modification, or both, comprises a mutation. In one aspect, the first genome modification, the second genome modification, or both, is not based on a transgene. In one aspect, the first genome modification, the second genome modification, or both, is not based on a mutation.
[0083] In one aspect, the tobacco plant provided herein comprises a first genome modification that provides a lower level of nicotine compared to control tobacco plant.In one aspect, the tobacco plant provided herein comprises a first genome modification that comprises nic1 mutation, nic2 mutation, or both.In one aspect, the tobacco plant provided herein comprises a transgene that targets Nic1 locus, a transgene that targets Nic2 locus, or both.
[0084] In one aspect, the tobacco plant provided herein comprises a first genomic modification comprising a mutation in a gene or locus encoding a protein selected from the group consisting of aspartate oxidase, agmatine deiminase (AIC), arginase, diamine oxidase, arginine decarboxylase (ADC), methylputrescine oxidase (MPO), NADH dehydrogenase, ornithine decarboxylase (ODC), phosphoribosylanthranilate isomerase (PRAI), putrescine N-methyltransferase (PMT), quinolate phosphoribosyltransferase (QPT), and S-adenosyl-methionine synthase (SAMS), A622, NBBl, BBL, MYC2, Nic1, Nic2, ethylene response factor (ERF) transcription factor, nicotine uptake permease (NUP), and MATE transporter. In one aspect, the tobacco plant provided herein comprises a first genomic modification comprising a transgene that targets and suppresses a gene or locus encoding a protein selected from the group consisting of aspartate oxidase, agmatine deiminase (AIC), arginase, diamine oxidase, arginine decarboxylase (ADC), methylputrescine oxidase (MPO), NADH dehydrogenase, ornithine decarboxylase (ODC), phosphoribosylanthranilate isomerase (PRAI), putrescine N-methyltransferase (PMT), quinolate phosphoribosyltransferase (QPT), and S-adenosyl-methionine synthase (SAMS), A622, NBBl, BBL, MYC2, Nic1, Nic2, ethylene response factor (ERF) transcription factor, nicotine uptake permease (NUP), and MATE transporter.
[0085] In one aspect, the tobacco plant provided herein comprises a first genomic modification comprising a mutation in a gene or locus encoding a protein selected from the group consisting of ERF32, ERF34, ERF39, ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168. In one aspect, the tobacco plant provided herein comprises a first genomic modification comprising a transgene that targets and suppresses a gene or locus encoding a protein selected from the group consisting of ERF32, ERF34, ERF39, ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168.
[0086] In one aspect, a tobacco plant or plant genome is provided that has been mutated or edited to have one or more mutations in one or more NCG genes selected from the group consisting of NCG1 to NCG35, the one or more mutations reducing or eliminating the activity or expression of the one or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that has been mutated or edited to have one or more mutations in one or more NCG genes selected from the group consisting of NCG1, NCG2, NCG11, NCG12, NCG13, NCG15, NCG16, NCG17, NCG21, NCG22, NCG24, NCG26, NCG29, NCG30, and NCG35, the one or more mutations reducing or eliminating the activity or expression of the one or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that has been mutated or edited to have one or more mutations in one or more NCG genes selected from the group consisting of NCG1 to NCG21, the one or more mutations reducing or eliminating the activity or expression of the one or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that has been mutated or edited to have one or more mutations in one or more NCG genes selected from the group consisting of NCG1, NCG2, NCG11, NCG12, NCG15, NCG16, and NCG17, the one or more mutations reducing or eliminating the activity or expression of the one or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that has been mutated or edited to have one or more mutations in one or more NCG genes selected from the group consisting of NCG2, NCG12, NCG15, NCG16, and NCG17, the one or more mutations reducing or eliminating the activity or expression of the one or more NCG genes.In one aspect, the provided tobacco plant or plant genome is mutated or edited to have one or more mutations in one or more NCG genes selected from the group consisting of NCG12, NCG15, NCG16, and NCG17, where the one or more mutations reduce or eliminate the activity or expression of the one or more NCG genes. In another aspect, the edited or mutated tobacco plant with one or more, two or more, three or more, four or more, or five or more NCG mutations further comprises one or more mutations in one or more, two or more, three or more, four or more, or five or more ERF genes selected from the group consisting of ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168, where the one or more mutations reduce or eliminate the activity or expression of the one or more ERF genes.
[0087] In one aspect, a tobacco plant or plant genome is provided that has been mutated or edited to have two or more mutations in two or more NCG genes selected from the group consisting of NCG1 to NCG35, and the two or more mutations reduce or eliminate the activity or expression of the two or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that has been mutated or edited to have two or more mutations in two or more NCG genes selected from the group consisting of NCG1, NCG2, NCG11, NCG12, NCG13, NCG15, NCG16, NCG17, NCG21, NCG22, NCG24, NCG26, NCG29, NCG30, and NCG35, and the two or more mutations reduce or eliminate the activity or expression of the two or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that is mutated or edited to have two or more mutations in two or more NCG genes selected from the group consisting of NCG1 to NCG21, the two or more mutations reducing or eliminating the activity or expression of one or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that is mutated or edited to have two or more mutations in two or more NCG genes selected from the group consisting of NCG1, NCG2, NCG11, NCG12, NCG15, NCG16, and NCG17, the two or more mutations reducing or eliminating the activity or expression of one or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that is mutated or edited to have two or more mutations in two or more NCG genes selected from the group consisting of NCG2, NCG12, NCG15, NCG16, and NCG17, the two or more mutations reducing or eliminating the activity or expression of two or more NCG genes.In one aspect, the provided tobacco plant or plant genome is mutated or edited to have two or more mutations in two or more NCG genes selected from the group consisting of NCG12, NCG15, NCG16, and NCG17, where the two or more mutations reduce or eliminate the activity or expression of the two or more NCG genes. In another aspect, the edited or mutated tobacco plant with two or more NCG mutations further comprises two or more mutations in two or more ERF genes selected from the group consisting of ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168, where the two or more mutations reduce or eliminate the activity or expression of the two or more ERF genes.
[0088] In one aspect, a tobacco plant or plant genome is provided that is mutated or edited to have three or more mutations in three or more NCG genes selected from the group consisting of NCG1 to NCG35, the three or more mutations reducing or eliminating the activity or expression of the three or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that is mutated or edited to have three or more mutations in three or more NCG genes selected from the group consisting of NCG1, NCG2, NCG11, NCG12, NCG13, NCG15, NCG16, NCG17, NCG21, NCG22, NCG24, NCG26, NCG29, NCG30, and NCG35, the three or more mutations reducing or eliminating the activity or expression of the three or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that is mutated or edited to have three or more mutations in three or more NCG genes selected from the group consisting of NCG1 to NCG21, the three or more mutations reducing or eliminating the activity or expression of the three or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that is mutated or edited to have three or more mutations in three or more NCG genes selected from the group consisting of NCG1, NCG2, NCG11, NCG12, NCG15, NCG16, and NCG17, the three or more mutations reducing or eliminating the activity or expression of the three or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that is mutated or edited to have three or more mutations in three or more NCG genes selected from the group consisting of NCG2, NCG12, NCG15, NCG16, and NCG17, the three or more mutations reducing or eliminating the activity or expression of the three or more NCG genes.In one aspect, the provided tobacco plant or plant genome is mutated or edited to have three or more mutations in three or more NCG genes selected from the group consisting of NCG12, NCG15, NCG16, and NCG17, where the three or more mutations reduce or eliminate the activity or expression of the three or more NCG genes. In another aspect, the edited or mutated tobacco plant with three or more NCG mutations further comprises three or more mutations in three or more ERF genes selected from the group consisting of ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168, where the three or more mutations reduce or eliminate the activity or expression of the three or more ERF genes.
[0089] In one aspect, a tobacco plant or plant genome is provided that is mutated or edited to have four or more mutations in four or more NCG genes selected from the group consisting of NCG1 to NCG35, the four or more mutations reducing or eliminating the activity or expression of the four or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that is mutated or edited to have four or more mutations in four or more NCG genes selected from the group consisting of NCG1, NCG2, NCG11, NCG12, NCG13, NCG15, NCG16, NCG17, NCG21, NCG22, NCG24, NCG26, NCG29, NCG30, and NCG35, the four or more mutations reducing or eliminating the activity or expression of the four or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that is mutated or edited to have four or more mutations in four or more NCG genes selected from the group consisting of NCG1 to NCG21, the four or more mutations reducing or eliminating the activity or expression of the four or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that is mutated or edited to have four or more mutations in four or more NCG genes selected from the group consisting of NCG1, NCG2, NCG11, NCG12, NCG15, NCG16, and NCG17, the four or more mutations reducing or eliminating the activity or expression of the four or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that is mutated or edited to have four or more mutations in four or more NCG genes selected from the group consisting of NCG2, NCG12, NCG15, NCG16, and NCG17, the four or more mutations reducing or eliminating the activity or expression of the four or more NCG genes.In one aspect, the provided tobacco plant or plant genome is mutated or edited to have four or more mutations in four or more NCG genes selected from the group consisting of NCG12, NCG15, NCG16, and NCG17, where the four or more mutations reduce or eliminate the activity or expression of the four or more NCG genes. In another aspect, the edited or mutated tobacco plant with four or more NCG mutations further comprises four or more mutations in four or more ERF genes selected from the group consisting of ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168, where the four or more mutations reduce or eliminate the activity or expression of the four or more ERF genes.
[0090] In one aspect, the provided tobacco plant or plant genome comprises one or more transgenes targeting one or more NCG genes selected from the group consisting of NCG1 to NCG35, wherein the one or more transgenes reduce or eliminate the activity or expression of the one or more NCG genes. In one aspect, the provided tobacco plant or plant genome comprises one or more transgenes targeting one or more NCG genes selected from the group consisting of NCG1, NCG2, NCG11, NCG12, NCG13, NCG15, NCG16, NCG17, NCG21, NCG22, NCG24, NCG26, NCG29, NCG30, and NCG35, wherein the one or more transgenes reduce or eliminate the activity or expression of the one or more NCG genes. In one aspect, the provided tobacco plant or plant genome comprises one or more transgenes targeting one or more NCG genes selected from the group consisting of NCG1-NCG21, wherein the one or more transgenes reduce or eliminate the activity or expression of the one or more NCG genes. In one aspect, the provided tobacco plant or plant genome comprises one or more transgenes targeting one or more NCG genes selected from the group consisting of NCG1, NCG2, NCG11, NCG12, NCG15, NCG16, and NCG17, wherein the one or more transgenes reduce or eliminate the activity or expression of the one or more NCG genes. In one aspect, the tobacco plant or plant genome provided comprises one or more transgenes that target one or more NCG genes selected from the group consisting of NCG2, NCG12, NCG15, NCG16, and NCG17, and the one or more transgenes reduce or eliminate the activity or expression of the one or more NCG genes.In one aspect, the provided tobacco plant or plant genome comprises one or more transgenes targeting one or more NCG genes selected from the group consisting of NCG12, NCG15, NCG16, and NCG17, wherein the one or more transgenes reduce or eliminate the activity or expression of the one or more NCG genes. In another aspect, the tobacco plant having one or more, two or more, three or more, four or more, or five or more NCG targeting transgenes further comprises one or more mutations in one or more, two or more, three or more, four or more, or five or more ERF genes selected from the group consisting of ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168, wherein the one or more mutations reduce or eliminate the activity or expression of the one or more ERF genes. In another aspect, the tobacco plant having a transgene targeting one or more, two or more, three or more, four or more, or five or more NCGs further comprises one or more transgenes targeting one or more, two or more, three or more, four or more, or five or more ERF genes selected from the group consisting of ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168, wherein the transgene targeting the one or more ERFs reduces or eliminates the activity or expression of the one or more ERF genes.
[0091] In one aspect, a tobacco plant or plant genome is provided that includes two or more transgenes targeting two or more NCG genes selected from the group consisting of NCG1 to NCG35, and the two or more transgenes reduce or eliminate the activity or expression of the two or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that includes two or more transgenes targeting two or more NCG genes selected from the group consisting of NCG1, NCG2, NCG11, NCG12, NCG13, NCG15, NCG16, NCG17, NCG21, NCG22, NCG24, NCG26, NCG29, NCG30, and NCG35, and the two or more transgenes reduce or eliminate the activity or expression of the two or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that includes two or more transgenes targeting two or more NCG genes selected from the group consisting of NCG1 to NCG21, and the two or more transgenes reduce or eliminate the activity or expression of one or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that includes two or more transgenes targeting two or more NCG genes selected from the group consisting of NCG1, NCG2, NCG11, NCG12, NCG15, NCG16, and NCG17, and the two or more transgenes reduce or eliminate the activity or expression of one or more NCG genes. In one aspect, the tobacco plant or plant genome provided comprises two or more transgenes targeting two or more NCG genes selected from the group consisting of NCG2, NCG12, NCG15, NCG16, and NCG17, wherein the two or more transgenes reduce or eliminate the activity or expression of the two or more NCG genes.In one aspect, the provided tobacco plant or plant genome comprises two or more transgenes targeting two or more NCG genes selected from the group consisting of NCG12, NCG15, NCG16, and NCG17, wherein the two or more transgenes reduce or eliminate the activity or expression of the two or more NCG genes. In another aspect, the tobacco plant having the transgenes targeting two or more NCGs further comprises two or more mutations in two or more ERF genes selected from the group consisting of ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168, wherein the two or more mutations reduce or eliminate the activity or expression of the two or more ERF genes. In another aspect, the tobacco plant having a transgene targeting two or more NCGs further comprises two or more transgenes targeting two or more ERF genes selected from the group consisting of ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168, wherein the transgenes targeting the two or more ERFs reduce or eliminate the activity or expression of the two or more ERF genes.
[0092] In one aspect, a tobacco plant or plant genome is provided that includes three or more transgenes targeting three or more NCG genes selected from the group consisting of NCG1 to NCG35, and the three or more transgenes reduce or eliminate the activity or expression of the three or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that includes three or more transgenes targeting three or more NCG genes selected from the group consisting of NCG1, NCG2, NCG11, NCG12, NCG13, NCG15, NCG16, NCG17, NCG21, NCG22, NCG24, NCG26, NCG29, NCG30, and NCG35, and the three or more transgenes reduce or eliminate the activity or expression of the three or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that includes three or more transgenes targeting three or more NCG genes selected from the group consisting of NCG1-NCG21, and the three or more transgenes reduce or eliminate the activity or expression of the three or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that includes three or more transgenes targeting three or more NCG genes selected from the group consisting of NCG1, NCG2, NCG11, NCG12, NCG15, NCG16, and NCG17, and the three or more transgenes reduce or eliminate the activity or expression of the three or more NCG genes. In one aspect, the tobacco plant or plant genome provided comprises three or more transgenes targeting three or more NCG genes selected from the group consisting of NCG2, NCG12, NCG15, NCG16, and NCG17, wherein the three or more transgenes reduce or eliminate the activity or expression of the three or more NCG genes.In one aspect, the provided tobacco plant or plant genome comprises three or more transgenes targeting three or more NCG genes selected from the group consisting of NCG12, NCG15, NCG16, and NCG17, wherein the three or more transgenes reduce or eliminate the activity or expression of the three or more NCG genes. In another aspect, the tobacco plant having the transgenes targeting three or more NCGs further comprises three or more mutations in three or more ERF genes selected from the group consisting of ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168, wherein the three or more mutations reduce or eliminate the activity or expression of the three or more ERF genes. In another aspect, the tobacco plant having transgenes targeting three or more NCGs further comprises three or more transgenes targeting three or more ERF genes selected from the group consisting of ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168, wherein the transgenes targeting the three or more ERFs reduce or eliminate the activity or expression of the three or more ERF genes.
[0093] In one aspect, a tobacco plant or plant genome is provided that includes four or more transgenes targeting four or more NCG genes selected from the group consisting of NCG1-NCG35, wherein the four or more transgenes reduce or eliminate the activity or expression of the four or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that includes four or more transgenes targeting four or more NCG genes selected from the group consisting of NCG1, NCG2, NCG11, NCG12, NCG13, NCG15, NCG16, NCG17, NCG21, NCG22, NCG24, NCG26, NCG29, NCG30, and NCG35, wherein the four or more transgenes reduce or eliminate the activity or expression of the four or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that includes four or more transgenes targeting four or more NCG genes selected from the group consisting of NCG1-NCG21, wherein the four or more transgenes reduce or eliminate the activity or expression of the four or more NCG genes. In one aspect, a tobacco plant or plant genome is provided that includes four or more transgenes targeting four or more NCG genes selected from the group consisting of NCG1, NCG2, NCG11, NCG12, NCG15, NCG16, and NCG17, wherein the four or more transgenes reduce or eliminate the activity or expression of the four or more NCG genes. In one aspect, the tobacco plant or plant genome provided comprises four or more transgenes targeting four or more NCG genes selected from the group consisting of NCG2, NCG12, NCG15, NCG16, and NCG17, wherein the four or more transgenes reduce or eliminate the activity or expression of the four or more NCG genes.In one aspect, the provided tobacco plant or plant genome comprises four or more transgenes targeting four or more NCG genes selected from the group consisting of NCG12, NCG15, NCG16, and NCG17, wherein the four or more transgenes reduce or eliminate the activity or expression of the four or more NCG genes. In another aspect, the tobacco plant having the transgenes targeting four or more NCGs further comprises four or more mutations in four or more ERF genes selected from the group consisting of ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168, wherein the four or more mutations reduce or eliminate the activity or expression of the four or more ERF genes. In another aspect, the tobacco plant having transgenes targeting four or more NCGs further comprises four or more transgenes targeting four or more ERF genes selected from the group consisting of ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168, wherein the transgenes targeting the four or more ERFs reduce or eliminate the activity or expression of the four or more ERF genes.
[0094] In one aspect, the tobacco plant provided herein comprises a second genome modification comprising an inducible promoter functionally linked to a transcriptional DNA sequence encoding a non-coding RNA for suppressing ornithine decarboxylase (ODC) gene.In another aspect, a tobacco plant is provided in which MYB8 activity is suppressed via transgene suppression, mutagenesis, or targeted genome editing.For simplicity, all cases herein that refer to ODC suppression (e.g., functionally linked to any particular type of promoter) apply equally to MYB8 suppression.
[0095] In one aspect, the tobacco plants provided herein comprise a reduced amount of total complex polyamines in the leaves compared to control tobacco plants. In one aspect, the tobacco plants provided herein comprise a reduced amount of total complex polyamines in the roots compared to control tobacco plants. As used herein, complex polyamines include, but are not limited to, soluble complex polyamines, such as phenolamides containing a backbone consisting of free polyamines (e.g., putrescine, spermine, and / or spermidine), conjugated with one or more phenylpropanoids, such as ferulic acid, caffeic acid, and courmaric acid. Complex polyamines also include, but are not limited to, insoluble complex polyamines incorporated into structural polymers such as lignin. In one aspect, the tobacco plants provided herein comprise a reduced amount of total free polyamines (e.g., putrescine, spermine, and spermidine) in the leaves compared to control tobacco plants. In one aspect, the tobacco plants provided herein comprise a reduced amount of total complex polyamines in the roots compared to control tobacco plants. In one aspect, the tobacco plant provided herein comprises a reduced amount of one or more polyamines selected from the group consisting of putrescine, spermidine, and spermine in the leaves compared to control tobacco plants.In one aspect, the tobacco plant provided herein comprises a reduced amount of one or more polyamines selected from the group consisting of putrescine, spermidine, and spermine in the roots compared to control tobacco plants.In one aspect, the tobacco plant provided herein comprises a reduced amount of one or more polyamines selected from the group consisting of putrescine, spermidine, and spermine in the leaves compared to control tobacco plants.In one aspect, the tobacco plant provided herein comprises a reduced amount of one or more polyamines selected from the group consisting of putrescine, spermidine, and spermine in the roots compared to control tobacco plants.
[0096] In one aspect, the characteristics or traits of the tobacco plant described herein are measured at a time selected from the group consisting of just before flowering, at the time of topping, 1 week after topping (WPT), 2WPT, 3WPT, 4WPT, 5WPT, 6WPT, 7WPT, 8WPT, and at harvest.In one aspect, the tobacco plant provided herein, comprising the first genome modification and the second genome modification, can produce leaves with a leaf grade equivalent to the leaf grade of the leaves from a control plant.In one aspect, the tobacco plant provided herein, comprising the first genome modification and the second genome modification, has a total leaf yield equivalent to that of a control plant.
[0097] As used herein, "editing" or "genome editing" refers to targeted mutagenesis of at least 1, at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, at least 8, at least 9, or at least 10 nucleotides of an endogenous plant genome nucleic acid sequence, or removal or replacement of an endogenous plant genome nucleic acid sequence. In one aspect, the edited nucleic acid sequence provided has at least 99.9%, at least 99.5%, at least 99%, at least 98%, at least 97%, at least 96%, at least 95%, at least 94%, at least 93%, at least 92%, at least 91%, at least 90%, at least 85%, at least 80%, or at least 75% sequence identity with the endogenous nucleic acid sequence. In one aspect, the edited nucleic acid sequences provided have at least 99.9%, at least 99.5%, at least 99%, at least 98%, at least 97%, at least 96%, at least 95%, at least 94%, at least 93%, at least 92%, at least 91%, at least 90%, at least 85%, at least 80%, or at least 75% sequence identity to SEQ ID NOs:23-28 and fragments thereof. In another aspect, the edited nucleic acid sequences provided have at least 99.9%, at least 99.5%, at least 99%, at least 98%, at least 97%, at least 96%, at least 95%, at least 94%, at least 93%, at least 92%, at least 91%, at least 90%, at least 85%, at least 80%, or at least 75% sequence identity to a polynucleotide encoding a polypeptide selected from the group consisting of SEQ ID NOs:29-34.
[0098] Meganuclease, ZFN, TALEN, CRISPR / Cas9, CRISPR / Csm1 and CRISPR / Cpf1 induce double-stranded DNA breaks at the target site of genome sequence, which are then repaired by the natural process of homologous recombination (HR) or non-homologous end joining (NHEJ). Sequence modification is then performed at the cut site, which may include deletion or insertion resulting in gene disruption in the case of NHEJ, or integration of donor nucleic acid sequence by HR. In one aspect, the method provided comprises editing the plant genome with the provided nuclease to mutate at least 1, at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, at least 8, at least 9, at least 10 nucleotides, or more than 10 nucleotides in the plant genome via HR with a donor polynucleotide. In one aspect, the mutation provided is caused by genome editing using a nuclease. In another aspect, the mutation provided is caused by non-homologous end joining or homologous recombination.
[0099] In one aspect, the mutations provided herein provide dominant mutants that activate expression or activity of a gene of interest, e.g., a gene selected from the group consisting of a biosynthetic enzyme, a regulatory transcription factor, a transporter, a catabolic enzyme, or a combination thereof, for one or more antioxidants.
[0100] Meganucleases, commonly identified in microorganisms, are unique enzymes with high activity and long recognition sequences (>14 bp) that result in site-specific digestion of target DNA. Engineered forms of naturally occurring meganucleases typically have extended DNA recognition sequences (e.g., 14-40 bp). Engineering meganucleases can be more challenging than ZFNs and TALENs because the DNA recognition and cleavage functions of meganucleases are intertwined in a single domain. Special methods of mutagenesis and high-throughput screening have been used to generate novel meganuclease variants that recognize unique sequences and have improved nuclease activity.
[0101] ZFNs are synthetic proteins that consist of engineered zinc finger DNA binding domains fused to the cleavage domain of the FokI restriction endonuclease. ZFNs can be designed to cleave stretches of almost any length of double-stranded DNA due to the modification of the zinc finger DNA binding domain. ZFNs form dimers from monomers that are composed of the non-specific DNA cleavage domain of the FokI endonuclease fused to a zinc finger array that is engineered to bind to the target DNA sequence.
[0102] The DNA binding domain of ZFNs is typically composed of an array of 3-4 zinc fingers. The amino acids at positions -1, +2, +3, and +6 relative to the start of the zinc finger ∞-helix, which contribute to site-specific binding to the target DNA, can be altered and customized to fit a specific target sequence. Other amino acids form a consensus scaffold to generate ZFNs with different sequence specificities. Rules for selecting target sequences for ZFNs are known in the art.
[0103] The FokI nuclease domain requires dimerization to cleave DNA, and thus two ZFNs with C-terminal regions are required to bind to opposing DNA strands (separated by 5-7 bp) at the cleavage site. If the two-ZF-binding site is palindromic, the ZFN monomer can cleave the target site. The term ZFN, as used herein, is broad and includes monomeric ZFNs that can cleave double-stranded DNA without assistance from another ZFN. The term ZFN is also used to refer to one or both members of a pair of ZFNs engineered to work together to cleave DNA at the same site.
[0104] Without being limited by any scientific theory, the DNA binding specificity of zinc finger domains can in principle be re-engineered using one of a variety of methods, so customized ZFNs could theoretically be constructed to target almost any gene sequence. Published methods for engineering zinc finger domains include Context-dependent Assembly (CoDA), Oligomerized Pool Engineering (OPEN), and Modular Assembly.
[0105] TALEN is an artificial restriction enzyme that is generated by fusing a transcription activator-like effector (TALE) DNA binding domain to a FokI nuclease domain. When each member of a TALEN pair binds to a DNA site adjacent to a target site, the FokI monomer dimerizes and causes double-stranded DNA breaks at the target site. The term TALEN as used herein is broad and includes monomeric TALENs that can cut double-stranded DNA without the assistance of another TALEN. The term TALEN is also used to refer to one or both members of a pair of TALENs that work together to cut DNA at the same site.
[0106] Transcription activator-like effectors (TALEs) can be engineered to bind to virtually any DNA sequence. TALE proteins are DNA-binding domains derived from various plant bacterial pathogens of the genus Xanthomonas. Xanthomonas pathogens secrete TALEs into host plant cells during infection. TALEs translocate to the nucleus, where they recognize and bind to specific DNA sequences in the promoter regions of specific genes in the host genome. TALEs have a central DNA-binding domain composed of 13-28 repeat monomers of 33-34 amino acids. The amino acids of each monomer are highly conserved except for hypervariable amino acid residues at positions 12 and 13. The two variable amino acids are called repeat variable diresidues (RVDs). The amino acid pairs NI, NG, HD, and NN of the RVDs preferentially recognize adenine, thymine, cytosine, and guanine / adenine, respectively, and modulation of the RVDs can recognize consecutive DNA bases. This simple relationship between amino acid sequence and DNA recognition made it possible to engineer specific DNA-binding domains by selecting combinations of repeat segments containing appropriate RVDs.
[0107] Besides the wild-type FokI cleavage domain, variants of the FokI cleavage domain with mutations have been designed to improve cleavage specificity and cleavage activity. The FokI domain functions as a dimer and requires two constructs with specific DNA binding domains for sites in the target genome with appropriate orientation and spatial arrangement. Both the number of amino acid residues between the TALEN DNA binding domain and the FokI cleavage domain and the number of bases between two individual TALEN binding sites are parameters to achieve high levels of activity.
[0108] The amino acid sequence of the TALE binding domain and its relationship to DNA recognition allows for a designable protein. Software programs such as DNA Works can be used to design TALE constructs. Other methods for designing TALE constructs are known to those skilled in the art. See Doyle et al., Nucleic Acids Research (2012) 40:W117-122.; Cermak et al., Nucleic Acids Research (2011). 39:e82; and tale-nt.cac.cornell.edu / about.
[0109] The CRISPR / Cas9 system, CRISPR / Csm1, or CRISPR / Cpf1 system is an alternative to the ZFN and TALEN FokI-based methods. The CRISPR system is based on RNA-guided engineered nucleases that use complementary base pairing to recognize DNA sequences at target sites.
[0110] The CRISPR / Cas9, CRISPR / Csm1, and CRISPR / Cpf1 systems are part of the adaptive immune system of bacteria and archaea, protecting them from invasive nucleic acids such as viruses by cleaving foreign DNA in a sequence-dependent manner. Immunity is acquired by the incorporation of a short piece of invasive DNA, known as a spacer, between two adjacent repeats at the proximal end of the CRISPR locus. The spacer-containing CRISPR array is transcribed during the subsequent encounter with the invasive DNA and processed into a short interfering CRISPR RNA (crRNA) of about 40 nt in length, which in combination with the trans-activating CRISPR RNA (tracrRNA) activates and guides the Cas9 nuclease, which cleaves a homologous double-stranded DNA sequence, known as a protospacer, in the invasive DNA. A prerequisite for cleavage is the presence of a conserved protospacer adjacent motif (PAM) downstream of the target DNA, which usually has the sequence 5-NGG-3, less frequently NAG. Specificity is provided by a so-called "seed sequence" approximately 12 bases upstream of the PAM, which must match between the RNA and the target DNA. Cpf1 and Csm1 act in a similar manner to Cas9, but Cpf1 and Csm1 require tracrRNA.
[0111] In yet another aspect, the tobacco plants provided further comprise one or more mutations in one or more loci encoding nicotine demethylase (e.g., CYP82E4, CYP82E5, CYP82E10) that confer a reduced amount of nornicotine compared to a control plant lacking one or more mutations in one or more loci encoding nicotine demethylase (see U.S. Patent Nos. 8,319,011, 8,124,851, 9,187,759, 9,228,194, 9,228,195, and 9,247,706). In one aspect, the modified tobacco plants described further comprise reduced nicotine demethylase activity compared to a control plant when grown and cured under equivalent conditions. In a further aspect, the tobacco plants provided further comprise one or more mutations or transgenes that result in increased levels of one or more antioxidants (see U.S. Patent Application No. 15 / 727,523 and PCT Application No. PCT / US2017 / 055618). In another aspect, the tobacco plants provided further comprise one or more mutations or transgenes that result in reduced levels of one or more TSNAs (e.g., N'-nitrosonornicotine (NNN), 4-methylnitrosamino-l-(3-pyridyl)-l-butanone (NNK), N'-nitrosoanatabine (NAT) N'-nitrosoanabasine (NAB)).
[0112] The present disclosure also provides compositions and methods for inhibiting the expression or function of one or more genes involved in polyamine biosynthesis or its regulation in plants, particularly in plants of the genus Nicotiana, including various commercial varieties of tobacco plants.
[0113] In one aspect, the disclosure provides a tobacco plant or part thereof comprising a heterologous expression cassette comprising an ODC inhibitory sequence. In another aspect, the tobacco plant or part thereof comprises a heterologous expression cassette comprising an inhibitory sequence of a gene comprising a sequence having at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 98%, at least 99%, or 100% identity to a sequence selected from the group consisting of SEQ ID NOs: 23-28, and fragments thereof, wherein the inhibitory sequence is operably linked to a promoter functional in a plant cell, and the inhibitory sequence is selected from the group consisting of SEQ ID NOs: 23-28. At least 21, at least 22, at least 23, at least 24, at least 25, at least 26, at least 27, at least 28, at least 29, at least 30, at least 31, at least 32, at least 33, at least 34, at least 35, at least 36, at least 37, at least 38, at least 39, at least 40, at least 41, at least 42, at least 43, at least 44, at least 45 of a sequence having at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 98%, at least 99%, or 100% identity to a sequence selected from the group consisting of NO:23 to 28, and fragments thereof , at least 46, at least 47, at least 48, at least 49, at least 50, at least 51, at least 52, at least 53, at least 54, at least 55, at least 56, at least 57, at least 58, at least 59, at least 60, at least 61, at least 62, at least 63, at least 64, at least 65, at least 66, at least 67, at least 68, at least 69, at least 70, at least 71, at least 72, at least 73, at least 74, at least 75, at least 76, at least 77, at least 78, at least 79, or at least 80 nucleotide fragments.
[0114] As used herein, the terms "inhibit", "inhibition" and "inhibiting" are defined as any method known in the art or described herein that reduces the expression or function of a gene product of interest (e.g., a target gene product). "Inhibition" can be in the context of a comparison between two plants, e.g., a genetically altered plant and a wild-type plant. Alternatively, inhibition of expression or function of a target gene product can be in the context of a comparison between plant cells, organelles, organs, tissues, or plant parts within the same plant or between different plants, including a comparison between developmental or temporal stages within the same plant or plant part, or between plants or plant parts. "Inhibition" includes any relative reduction in the function or production of a gene product of interest, up to and including complete elimination of the function or production of the gene product. The term "inhibition" encompasses any method or composition that downregulates the translation and / or transcription of a target gene product or the functional activity of a target gene product. In one aspect, the mRNA or protein levels of one or more genes in the modified plant are less than 95%, less than 90%, less than 80%, less than 70%, less than 60%, less than 50%, less than 40%, less than 30%, less than 20%, less than 10%, less than 5%, less than 4%, less than 3%, less than 2%, or less than 1% of the mRNA or protein levels of the same genes in a plant that is not mutant or in a plant that has not been genetically modified to inhibit expression of that gene.
[0115] The term "inhibitory sequence" encompasses any polynucleotide or polypeptide sequence capable of inhibiting the expression or function of a gene involved in regulating nicotine biosynthesis from the Nic1b locus in a plant, such as a full-length polynucleotide or polypeptide sequence, a truncated polynucleotide or polypeptide sequence, a fragment of a polynucleotide or polypeptide sequence, a variant of a polynucleotide or polypeptide sequence, a nucleotide sequence in a sense orientation, a nucleotide sequence in an antisense orientation, a complement of a nucleotide sequence in a sense or antisense orientation, an inverted region of a nucleotide sequence, a hairpin of a nucleotide sequence, a double-stranded nucleotide sequence, a single-stranded nucleotide sequence, and combinations thereof. The term "polynucleotide sequence" includes sequences such as RNA, DNA, chemically modified nucleic acids, nucleic acid analogs, and combinations thereof.
[0116] Inhibitory sequence is designated by the name of target gene product. Thus, "ODC inhibitory sequence" refers to an inhibitory sequence that can inhibit the expression of ODC gene involved in polyamine biosynthesis regulation in plants, for example, at the transcription and / or translation level, or can inhibit the function of gene product. When the phrase "can inhibit" is used in the context of polynucleotide inhibitory sequence, it is intended to mean that the inhibitory sequence itself exerts an inhibitory effect; or, when the inhibitory sequence codes for an inhibitory nucleotide molecule (e.g., hairpin RNA, miRNA, or double-stranded RNA polynucleotide) or codes for an inhibitory polypeptide (e.g., a polypeptide that inhibits the expression or function of a target gene product), after its transcription (e.g., in the case of an inhibitory sequence that codes for a hairpin RNA, miRNA, or double-stranded RNA polynucleotide) or its transcription and translation (in the case of an inhibitory sequence that codes for an inhibitory polypeptide), the product that is transcribed or translated, respectively, exerts an inhibitory effect on the target gene product (e.g., inhibits the expression or function of the target gene product).
[0117] The disclosed ODC inhibitory sequence can be a sequence that induces gene silencing through any silencing pathway or mechanism known in the art, including but not limited to sense suppression / co-suppression, antisense suppression, double-stranded RNA (dsRNA) interference, hairpin RNA interference and intron-containing hairpin RNA interference, amplicon-mediated interference, ribozyme, small interfering RNA, artificial or synthetic microRNA, and artificial trans-acting siRNA.The ODC inhibitory sequence can be in the range of at least about 20 nucleotides, about 50 nucleotides, about 70 nucleotides, about 100 nucleotides, about 150 nucleotides, about 200 nucleotides, about 250 nucleotides, about 300 nucleotides, about 350 nucleotides, about 400 nucleotides to the full-length polynucleotide encoding the protein of the present disclosure, depending on the desired outcome. In one aspect, the ODC inhibitory sequence can be a fragment of about 50 to about 400 nucleotides, about 70 to about 350 nucleotides, about 90 to about 325 nucleotides, about 90 to about 300 nucleotides, about 90 to about 275 nucleotides, about 100 to about 400 nucleotides, about 100 to about 350 nucleotides, about 100 to about 325 nucleotides, about 100 to about 300 nucleotides, about 125 to about 300 nucleotides, or about 125 to about 275 nucleotides in length.
[0118] The use of the term "polynucleotide" is not intended to limit the present disclosure to polynucleotides that are composed of DNA. Those skilled in the art will recognize that polynucleotides can include ribonucleotides and combinations of ribonucleotides and deoxyribonucleosides. Such deoxyribonucleosides and ribonucleotides include both naturally occurring molecules and synthetic analogs. The polynucleotides of the present disclosure also encompass all forms of sequences, including, but not limited to, single-stranded forms, double-stranded forms, hairpins, and stem-and-loop structures.
[0119] In one aspect, the disclosure provides a recombinant DNA construct comprising a promoter operably linked to a polynucleotide encoding an RNA molecule capable of binding to an RNA encoding a polypeptide having an amino acid sequence at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 98%, at least 99% identical to an amino acid sequence selected from the group consisting of SEQ ID NOs:23-28 and fragments thereof, and the RNA molecule represses expression of the polypeptide. In one aspect, the RNA molecule is selected from the group consisting of microRNA, siRNA, and trans-acting siRNA. In another aspect, the recombinant DNA construct encodes a double-stranded RNA. Also provided are transgenic tobacco plants or parts thereof, cured tobacco materials, or tobacco products comprising these recombinant DNA constructs. In one aspect, these transgenic plants, cured tobacco materials, or tobacco products comprise lower levels of nicotine compared to a control tobacco plant not having the recombinant DNA construct. Further provided is a method of reducing nicotine levels in a tobacco plant, comprising transforming the tobacco plant with any of these recombinant DNA constructs.
[0120] As used herein, "operably linked" refers to a functional link between two or more elements. For example, the functional link between a polynucleotide of interest and a regulatory sequence (e.g., a promoter) is a functional link that allows the expression of the polynucleotide of interest. Functionally linked elements may be contiguous or non-contiguous.
[0121] As used herein and in reference to a sequence, "heterologous" refers to a sequence that originates from a foreign species or, if from the same species, has been substantially modified in composition and / or genomic location from its natural form by deliberate human intervention. This term also applies to nucleic acid constructs, which may be referred to herein as "polynucleotide constructs" or "nucleotide constructs." Thus, a "heterologous" nucleic acid construct is intended to mean a construct that originates from a foreign species or, if from the same species, has been substantially modified in composition and / or location from its natural form by deliberate human intervention. Heterologous nucleic acid constructs include, but are not limited to, recombinant nucleotide constructs that have been introduced into a plant or plant part thereof, for example, via transformation methods or subsequent breeding of a transgenic plant with another plant of interest. In one aspect, the promoter used is heterologous to the sequence driven by the promoter. In another aspect, the promoter used is heterologous to tobacco. In a further aspect, the promoter used is native to tobacco.
[0122] In one aspect, the modified tobacco plant described is a cisgenic plant. As used herein, "cisgenesis" or "cisgenic" refers to a genetic modification of a plant, plant cell, or plant genome in which all components (e.g., promoter, donor nucleic acid, selection gene) originate exclusively from the plant (i.e., no components of non-plant origin are used). In one aspect, the modified plant, plant cell, or plant genome provided is cisgenic. The cisgenic plants, plant cells, and plant genomes provided can lead to ready-to-use tobacco lines. In another aspect, the modified tobacco plant provided does not contain any non-tobacco genetic material and sequences.
[0123] As used herein, "gene expression" refers to the biosynthesis or production of a gene product, including transcription and / or translation of the gene product.
[0124] In one aspect, the recombinant DNA construct or expression cassette may also contain a selection marker gene for the selection of transgenic cells. Selection marker genes include, but are not limited to, genes that confer resistance to antibiotics, such as genes that code for neomycin phosphotransferase II (NEO) and hygromycin phosphotransferase (HPT), as well as genes that confer resistance to herbicidal compounds, such as glufosinate ammonium, bromoxynil, imidazolinone, and 2,4-dichlorophenoxyacetate (2,4-D). Additional selection markers include phenotypic markers, such as β-galactosidase, and fluorescent proteins, such as green fluorescent protein (GFP).
[0125] In one aspect, the recombinant DNA construct or expression cassette comprises a promoter selected from the group consisting of a constitutive promoter, an inducible promoter, and a tissue-preferred promoter (eg, a leaf-specific or root-specific promoter). Exemplary constitutive promoters include the core promoter of the Rsyn7 promoter and other constitutive promoters disclosed in U.S. Pat. No. 6,072,050; the core CaMV 35S promoter (Odell et al. (1985) Nature 313:810-812); ubiquitin (Christensen et al. (1989) Plant Mol. Biol. 12:619-632 and Christensen et al. (1992) Plant Mol. Biol. 18:675-689); pEMU (Last et al. (1991) Theor. Appl. Genet. 81:581-588); MAS (Velten et al. (1984) EMBO J 3:2723-2730); and the ALS promoter (U.S. Pat. No. 5,659,026). Exemplary chemical inducible promoters include tobacco PR-1a promoter that is activated by salicylic acid.Other chemical inducible promoters of interest include steroid-responsive promoters (see, for example, Schena et al. (1991) Proc.Natl.Acad.Sci.USA 88:10421-10425 and McNellis et al. (1998) Plant J.14(2):247-257 glucocorticoid-inducible promoters) and tetracycline-inducible promoters (see, for example, Gatz et al. (1991) Mol.Gen.Genet.227:229-237 and U.S. Patent Nos. 5,814,618 and 5,789,156).Additional exemplary promoters that may be used include promoters that regulate thermo-regulated gene expression, light-regulated gene expression (e.g., the pea rbcS-3A; the maize rbcS promoter; the chlorophyll alb-binding protein gene found in pea; or the Arabssu promoter), hormone-regulated gene expression (e.g., the abscisic acid (ABA) responsive sequence from the Em gene in wheat; the ABA-inducible HVA1 and HVA22, and rd29A promoters in barley and Arabidopsis; etc. and those involved in wound-inducible gene expression (e.g., wunl), organ-specific gene expression (e.g., the tuber-specific storage protein gene; the 23 kDa zein gene from maize described by; or in common bean (β-phaseolin gene), or pathogen-inducible promoters (e.g., PR-1, prp-1, or β-1,3 glucanase promoter, the fungus-inducible wirla promoter in wheat, and nematode-inducible promoters TobRB7-5A and Hmg-1 in tobacco cured parsley, respectively).
[0126] In one aspect, the provided tobacco plant further comprises an increase or decrease in the expression of the activity of genes involved in nicotine biosynthesis or transport.The genes involved in nicotine biosynthesis include, but are not limited to, arginine decarboxylase (ADC), methylputrescine oxidase (MPO), NADH dehydrogenase, ornithine decarboxylase (ODC), phosphoribosylanthranilic acid isomerase (PRAI), putrescine N-methyltransferase (PMT), quinolinic acid phosphoribosyltransferase (QPT), and S-adenosyl-methionine synthetase (SAMS).The nicotine synthase that catalyzes the condensation step between nicotinic acid derivatives and methylpyrrolinium cations has not been elucidated, but two candidate genes (A622 and NBB1) have been proposed.See US2007 / 0240728A1 and US2008 / 0120737A1.A622 codes for an isoflavone reductase-like protein. In addition, several transporters may be involved in the transfer of nicotine. A transporter gene designated MATE has been cloned and characterized (Morita et al., PNAS 106:2447-52 (2009)).
[0127] In one aspect, the provided tobacco plants further comprise increased or decreased levels of mRNA, protein, or both of one or more genes encoding a product selected from the group consisting of PMT, MPO, QPT, ADC, ODC, PRAI, SAMS, BBL, MATE, A622, and NBBl, compared to a control tobacco plant. In another aspect, the provided tobacco plants further comprise a transgene that directly suppresses the expression of one or more genes encoding a product selected from the group consisting of PMT, MPO, QPT, ADC, ODC, PRAI, SAMS, BBL, MATE, A622, and NBBl. In another aspect, the provided tobacco plants further comprise a transgene or mutation that suppresses the expression or activity of one or more genes encoding a product selected from the group consisting of PMT, MPO, QPT, ADC, ODC, PRAI, SAMS, BBL, MATE, A622, and NBBl. In another aspect, the tobacco plant provided further comprises a transgene that overexpresses one or more genes encoding a product selected from the group consisting of PMT, MPO, QPT, ADC, ODC, PRAI, SAMS, BBL, MATE, A622, and NBBl.
[0128] Also disclosed is the transformation of tobacco plants with the described recombinant construct or expression cassette using any suitable transformation method known in the art.Methods for introducing polynucleotide sequences into tobacco plants are known in the art, including but not limited to stable transformation method, transient transformation method, and virus-mediated method."Stable transformation" refers to the transformation in which the nucleotide construct of interest introduced into the plant is integrated into the genome of the plant and can be inherited by its progeny."Transient transformation" is intended to mean that the sequence is introduced into the plant and is only expressed or only transiently present in the plant.
[0129] Suitable methods for introducing polynucleotides into plant cells of the present disclosure include microinjection (Crossway et al. (1986) Biotechniques 4:320-334), electroporation (Shillito et al. (1987) Meth. Enzymol. 153:313-336; Riggs et al. (1986) Proc. Natl. Acad. Sci. USA 83:5602-5606), Agrobacterium-mediated transformation (U.S. Pat. Nos. 5,104,310, 5,149,645, 5,177,010, 5,231,019, 5,463,174, 5,464,763, 5,469,976, 4,762,785, 5,004,863, 5,159,135, 5,563,055, and 5,981,840), direct gene transfer (Paszkowski et al. (1984) EMBO J. 3:2717-2722), and ballistic particle acceleration. acceleration) (see, e.g., U.S. Pat. Nos. 4,945,050, 5,141,131, 5,886,244, 5,879,918, and 5,932,782; Tomes et al. (1995) in Plant Cell, Tissue, and Organ Culture Fundamental Methods, edited by Gamborg and Phillips (Springer-Verlag, Berlin); McCabe et al. (1988) Biotechnology 6:923-926).Weissinger et al. (1988) Ann. Rev. Genet. 22:421-477; Christou et al. (1988) Plant Physiol. 87:671-674 (soybean); McCabe et al. (1988) Bio / Technology 6:923-926 (soybean); Finer and McMullen (1991) In Vitro Cell Dev. Biol. 27P:175-182 (soybean); Singh et al. (1998) Theor. Appl. Genet. 96:319-324 (soybean); De Wet et al. (1985), The Experimental Manipulation of Ovule Tissues, eds. Chapman et al. (Longman, NY), pp. 197-209 (pollen); Kaeppler et al. (1990) Plant Cell Reports 9:415-418 and Kaeppler et al. (1992) Theor. Appl. Genet. 84:560-566 (whisker-mediated transformation); D'Halluin et al. (1992) Plant Cell 4:1495-1505 (electroporation).
[0130] In another aspect, recombinant constructs or expression cassettes may be introduced into plants by contacting the plant with a virus or viral nucleic acid. In general, such methods include incorporating the expression cassette of the present disclosure into a viral DNA or RNA molecule. It is recognized that promoters for use in expression cassettes also include promoters used for transcription by viral RNA polymerase. Methods for introducing polynucleotides into plants and expressing proteins encoded therein involving viral DNA or RNA molecules are known in the art. See, for example, U.S. Patent Nos. 5,889,191, 5,889,190, 5,866,785, 5,589,367, 5,316,931, and Porta et al. (1996) Molecular Biotechnology 5:209-221.
[0131] Any plant tissue that can be subsequently propagated using clonal methods, whether by organogenesis or embryogenesis, may be transformed with a recombinant construct or expression cassette. By "organogenesis" is intended the process by which shoots and roots develop sequentially from the center of the growing point. By "embryogenesis" is intended the process by which shoots and roots develop together in a coordinated (not sequential) manner, whether from somatic cells or from gametes. Exemplary tissues suitable for the various transformation protocols described include, but are not limited to, callus tissue, existing meristematic tissues (e.g., apical meristem, axillary bud, and root apical meristem) and induced meristems (e.g., cotyledonary meristem and hypocotyl meristem), hypocotyl, cotyledon, leaf disk, pollen, and embryo, etc.
[0132] In one aspect, the tobacco plant provided is from a tobacco species selected from the group consisting of flue-cured, air-cured, dark air-cured, dark flue-cured, Galpao, and Oriental tobacco. In another aspect, the tobacco plant provided is from a tobacco species selected from the group consisting of Burley, Maryland, and dark tobacco.
[0133] In one aspect, the provided tobacco plant is of flue-cured tobacco background or exhibits one or more flue-cured tobacco characteristics described herein. Flue-cured tobacco (also called Virginia or bright tobacco) accounts for approximately 40% of the world's tobacco production. Flue-cured tobacco is often also referred to as "bright tobacco" due to the golden yellow to deep orange color it attains during curing. Flue-cured tobacco has a light, vibrant aroma and taste. Flue-cured tobacco is generally high in sugar and low in oil. The major flue-cured tobacco growing countries are Argentina, Brazil, China, India, Tanzania and the United States. In one aspect, the low alkaloid or low nicotine tobacco plants or seeds provided are selected from the group consisting of CC 13, CC 27, CC 33, CC 37, CC 65, CC 67, CC 700, GF 318, GL 338, GL 368, GL 939, K 346, K 399, K326, NC 102, NC 196, NC 291, NC 297, NC 299, NC 471, NC 55, NC 606, NC 71, NC 72, NC 92, PVH 1118, PVH 1452, PVH 2110, SPEIGHT 168, SPEIGHT 220, SPEIGHT 225, SPEIGHT 227, SPEIGHT 168 ... 236, and any variety essentially derived from any one of the foregoing varieties.In another aspect, the low alkaloid or low nicotine tobacco plants or seeds provided are selected from the group consisting of Coker 48, Coker 176, Coker 371-Gold, Coker 319, Coker 347, GL 939, K 149, K326, K 340, K 346, K 358, K 394, K 399, K 730, NC 27NF, NC 37NF, NC 55, NC 60, NC 71, NC 72, NC 82, NC 95, NC 297, NC 606, NC 729, NC 2326, McNair 373, McNair 944, Ox 207, Ox 414. NF, Reams 126, Reams 713, Reams 744, RG 8, RG 11, RG 13, RG 17, RG 22, RG 81, RG H4, RG H51, Speight H-20, Speight G-28, Speight G-58, Speight G-70, Speight G-108, Speight G-111, Speight G-117, Speight 168, Speight 179, Speight NF-3, Va 116, Va 182, and any variety essentially derived from any one of the foregoing varieties. See WO2004 / 041006A1. In a further aspect, the low alkaloid or low nicotine tobacco plant, seed, hybrid, variety, or strain is any flue-cured background selected from the group consisting of K326, K346, and NC196.
[0134] In one aspect, the provided tobacco plant is of air-cured tobacco background or exhibits one or more of the characteristics of air-cured tobacco described herein. Air-cured tobacco includes Burley, Maryland, and dark tobacco. The common factor is that the curing is mainly without artificial sources of heat and humidity. Burley tobacco is light brown to dark brown in color, high in oil, and low in sugar. Burley tobacco is air-cured in barns. The main Burley growing countries are Argentina, Brazil, Italy, Malawi, and the United States. Maryland tobacco is very plump, has good burning characteristics, low nicotine, and a neutral aroma. The main Maryland growing countries include the United States and Italy. In one aspect, the low alkaloid or low nicotine tobacco plants or seeds provided are of a burley tobacco background selected from the group consisting of Clay 402, Clay 403, Clay 502, Ky 14, Ky 907, Ky 910, Ky 8959, NC 2, NC 3, NC 4, NC 5, NC 2000, TN 86, TN 90, TN 97, R 610, R 630, R 711, R 712, NCBH 129, Bu 21 x Ky 10, HB04P, Ky 14 x L 8, Kt 200, Newton 98, Pedigo 561, Pf561, and Va 509. In a further aspect, the low alkaloid or low nicotine tobacco plant, seed, hybrid, variety, or strain is of any burley background selected from the group consisting of TN 90, KT 209, KT 206, KT212, and HB 4488. In another aspect, the low alkaloid or low nicotine tobacco plant or seed provided is of a Maryland tobacco background selected from the group consisting of Md 10, Md 40, Md 201, Md 609, Md 872, and Md 341.
[0135] In one aspect, the provided tobacco plant is a background of dark air-cured tobacco or exhibits one or more characteristics of dark air-cured tobacco as described herein. Dark air-cured tobacco is primarily distinguished from other varieties by its curing process, which gives dark air-cured tobacco its medium to dark brown color and unique aroma. Dark air-cured tobacco is primarily used in the production of chewing tobacco and snuff. In one aspect, the provided low alkaloid or low nicotine tobacco plant or seed is a background of dark air-cured tobacco selected from the group consisting of Sumatra, Jatim, Dominican Cubano, Besuki, One sucker, Green River, Virginia sun-cured, and Paraguan Passado.
[0136] In one aspect, the provided tobacco plant is a background of dark flue-cured tobacco or exhibits one or more characteristics of dark flue-cured tobacco described herein. Dark flue-cured tobacco is generally dried on the floor of a closed drying barn with a low-burning wood fire. Their leaves have a low sugar content but a high nicotine content. Dark flue-cured tobacco is used to make pipe blends, cigarettes, chewing tobacco, snuff and strong-tasting cigars. The main growing areas of dark flue-cured tobacco are Tennessee, Kentucky and Virginia in the United States. In one aspect, the low alkaloid or low nicotine tobacco plant or seed provided is of a dark flue-cured tobacco background selected from the group consisting of Narrow Leaf Madole, Improved Madole, Tom Rosson Madole, Newton's VH Madole, Little Crittenden, Green Wood, Little Wood, Small Stalk Black Mammoth, DT 508, DT 518, DT 592, KY 171, DF 911, DF 485, TN D94, TN D950, VA 309, and VA 359.
[0137] In one aspect, the provided tobacco plant is of oriental tobacco background or exhibits one or more of the oriental tobacco characteristics described herein.Oriental tobacco is also called Greek, aromatic, and Turkish tobacco due to the fact that it is typically grown in the eastern Mediterranean region, such as Turkey, Greece, Bulgaria, Macedonia, Syria, Lebanon, Italy, and Romania.In addition to the small plant and leaf size inherent to today's oriental varieties, its unique aromatic characteristics are the result of the plant's adaptation to the poor soil and harsh climatic conditions in which it develops over the past centuries. In one aspect, the low alkaloid or low nicotine tobacco plants or seeds provided are from Izmir, Katerini, Samsun, Basma, and Krumovgrad, Trabzon, Thesalian, Tasova, Sinop, Izmit, Hendek, Edirne, Semdinli, Azyanman, and / or other tobacco plants. and an oriental tobacco background selected from the group consisting of Adiyanman, Yayladag, Iskenderun, Duzce, Macedonian, Mavra, Prilep, Bafra, Bursa, Bucak, Bitlis, Balikesir, and any variety essentially derived from any one of the foregoing varieties.
[0138] In one aspect, the low alkaloid or low nicotine tobacco plant, seed, hybrid, variety, or strain is selected from the group consisting of BU 64, CC 101, CC 200, CC 27, CC 301, CC 400, CC 500, CC 600, CC 700, CC 800, CC 900, Cocker 176, Cocker 319, Cocker 371 Gold, Cocker 48, CU 263, DF911, Galpao tobacco, GL 26H, GL 350, GL 600, GL 737, GL 939, GL 973, HB 04P, K 149, K 326, K 346, K 358, K394, K 399, K 730, KDH 959, KT 200, KT204LC, KY 10, KY 14, KY 160, KY 17, KY 171, KY 907, KY907LC, KTY14xL8 LC, Little Crittenden, McNair 373, McNair 944, msKY 14xL8, Narrow Leaf Madole, NC 100, NC 102, NC 2000, NC 291, NC 297, NC 299, NC 3, NC 4, NC 5, NC 6, NC7, NC 606, NC 71, NC 72, NC 810, NC BH 129, NC 2002, Neal Smith Madole, OXFORD 207, "Perique" Tobacco, PVH03, PVH09, PVH19, PVH50, PVH51, R 610, R 630, R 7-11, R 7-12, RG 17, RG 81, RG H51, RGH 4, RGH 51, RS 1410, Speight 168, Speight 172, Speight 179, Speight 210, Speight 220, Speight 225, Speight 227, Speight 234, Speight G-28, Speight G-70, Speight H-6, Speight H20, Speight NF3, TI 1406, TI 1269, TN 86, TN86LC, TN 90, TN 97, TN97LC, TN D94, TN D950, TR (Tom Rosson) Madore, VA309, or VA359, Maryland 609, HB3307PLC, HB4488PLC, KT206LC, KT209LC, KT210LC, KT212LC, R610LC, PVH2310, NC196, KTD14LC, KTD6LC, KTD8LC, PD7302LC, PD7305LC, PD7309LC, PD7318LC, PD7319LC, PD7312LC, Shirey LC, or any commercial tobacco variety by standard tobacco breeding techniques known in the art, or in its genetic background.
[0139] Any of the above specific varieties of dark air-cured, burley, Maryland, dark fire-cured, or Oriental are listed for illustrative purposes only. Any additional dark air-cured, burley, Maryland, dark fire-cured, or Oriental varieties are also contemplated in this application.
[0140] Populations of the described tobacco plants are also provided. In one aspect, the population of tobacco plants has a planting density of about 5,000 to about 8,000, about 5,000 to about 7,600, about 5,000 to about 7,200, about 5,000 to about 6,800, about 5,000 to about 6,400, about 5,000 to about 6,000, about 5,000 to about 5,600, about 5,000 to about 5,200, about 5,200 to about 8,000, about 5,600 to about 8,000, about 6,000 to about 8,000, about 6,400 to about 8,000, about 6,800 to about 8,000, about 7,200 to about 8,000, or about 7,600 to about 8,000 plants per acre. In another aspect, the population of tobacco plants is grown in a soil type having low to moderate fertility. exists within.
[0141] Also provided is a container of seeds from the described tobacco plant.The container of tobacco seeds of the present disclosure can contain any number, weight, or volume of seeds.For example, the container can contain at least about 100, at least about 200, at least about 300, at least about 400, at least about 500, at least about 600, at least about 700, at least about 800, at least about 900, at least about 1000, at least about 1500, at least about 2000, at least about 2500, at least about 3000, at least about 3500, at least about 4000, or more, or more than about 100, about 200, about 300, about 400, about 500, about 600, about 700, about 800, about 900, about 1000, about 1500, about 2000, about 2500, about 3000, about 3500, about 4000, or more seeds. Alternatively, the container may contain at least about 1 ounce, at least about 5 ounces, at least about 10 ounces, at least about 1 pound, at least about 2 pounds, at least about 3 pounds, at least about 4 pounds, at least about 5 pounds, or more, or more than about 1 ounce, about 5 ounces, about 10 ounces, about 1 pound, about 2 pounds, about 3 pounds, about 4 pounds, about 5 pounds, or more of seeds. The tobacco seed container may be any container available in the art. As non-limiting examples, the container may be a box, bag, packet, pouch, tape roll, tube, or bottle.
[0142] Cured tobacco materials made from the described low alkaloid or low nicotine tobacco plants are also provided. Cured tobacco materials made from the described tobacco plants having higher levels of total alkaloids or nicotine are further provided.
[0143] "Curing" is a ripening process that reduces moisture and results in the breakdown of chlorophyll, which gives the tobacco leaf its golden color and converts starch to sugars. Cured tobacco thus has a higher reducing sugar content and a lower starch content compared to the harvested green leaf. In one aspect, the provided green leaf tobacco can be dried using conventional means, such as hot air curing, barn drying, fire curing, air drying, or sun drying. See, for example, Tso (1999, Chapter 1, Tobacco, Production, Chemistry and Technology, edited by Davis & Nielsen, Blackwell Publishing, Oxford) for a description of different types of curing methods. Cured tobacco is typically aged in wooden drums (e.g., vats) or cardboard boxes in compressed conditions for several years (e.g., 2-5 years) at a moisture content in the range of 10% to about 25%. See U.S. Patent Nos. 4,516,590 and 5,372,149. The cured and aged tobacco can then be further processed. Further processing includes conditioning the tobacco under vacuum with or without the introduction of steam at various temperatures, pasteurization, and fermentation. Fermentation is typically characterized by high initial moisture content, heat production, and a loss of 10-20% of the dry weight. See, e.g., U.S. Pat. Nos. 4,528,993, 4,660,577, 4,848,373, 5,372,149; U.S. Patent Application Publication No. 2005 / 0178398; and Tso (1999, Chapter 1, Tobacco, Production, Chemistry and Technology, edited by Davis & Nielsen, Blackwell Publishing, Oxford). The cured, aged, and fermented tobacco may be further processed (e.g., cut, shredded, puffed, or blended). See, e.g., U.S. Patent Nos. 4,528,993, 4,660,577, and 4,987,907. In one aspect, the cured tobacco materials of the present disclosure are sun-dried. In another aspect, the cured tobacco materials of the present disclosure are air-dried, hot-air-dried, or flame-dried.
[0144] Tobacco materials obtained from the tobacco strains, varieties, or hybrids of the present disclosure can be used to make tobacco products. As used herein, "tobacco product" is defined as any product made or derived from tobacco that is intended for human use or consumption.
[0145] Tobacco products provided include, but are not limited to, cigarette products (e.g., cigarettes and bidi cigarettes), cigar products (e.g., cigar wrapping tobacco and cigarillos), pipe tobacco products, tobacco-derived products, tobacco-derived nicotine products, smokeless tobacco products (e.g., moist snuff, dry snuff, and chewing tobacco), films, chewables, tabs, shaped portions, gels, consumable units, insoluble matrices, hollow shapes, reconstituted tobacco, and expanded tobacco. See, e.g., U.S. Patent Application Publication No. US2006 / 0191548.
[0146] As used herein, a "cigarette" refers to a tobacco product having a "rod" and a "filler". The cigarette "rod" includes the cigarette paper, the filter, the plug wrap (used to contain the filter material), the tipping paper that holds the cigarette paper (including the filler) to the filter, and any adhesives that hold these components together. The "filler" includes (1) all tobacco, including but not limited to reconstituted tobacco and expanded tobacco, (2) non-tobacco substitutes (including but not limited to herbs, non-tobacco plant materials, and other spices that may accompany the tobacco wrapped in the cigarette paper), (3) casings, (4) flavoring materials, and (5) all other additives (mixed with the tobacco and substitutes and wrapped into the cigarette).
[0147] As used herein, "reconstituted tobacco" refers to that portion of tobacco filler made from tobacco dust and other tobacco waste materials that have been processed into sheet form and cut into strips to resemble tobacco. In addition to cost savings, reconstituted tobacco is of great importance due to its contribution to the taste of a cigarette from the flavor development process using the reaction of ammonia with sugars.
[0148] As used herein, "expanded tobacco" refers to a portion of tobacco filler that has been processed through the expansion of a suitable gas to "expand" the tobacco, resulting in a reduced density and greater filling capacity, which reduces the weight of the tobacco used in the cigarette.
[0149] The tobacco products derived from the plants of the present disclosure also include cigarettes and other smoking articles, particularly including filter elements, in which rods of smokable material contain dry tobacco in tobacco blends.In one aspect, the tobacco products of the present disclosure are selected from the group consisting of cigarillos, non-ventilated recess filter cigarettes, ventilated recess filter cigarettes, cigars, snuff, pipe tobacco, cigar tobacco, cigarette tobacco, chewing tobacco, leaf tobacco, hookah, shredded tobacco, and cut tobacco.In another aspect, the tobacco products of the present disclosure are smokeless tobacco products.Smokeless tobacco products are not combusted and include, but are not limited to, chewing tobacco, moist smokeless tobacco, snus, and dry snuff.Chewing tobacco is coarsely divided tobacco leaves that are typically packaged in large pouch-like packages and used in plugs or twists. Moist smokeless tobacco is moist, more finely divided tobacco provided in loose or pouch form, typically packaged in round cans and used as pinches or in pouches placed between the cheek and gums of adult tobacco consumers. Snus is heat-treated smokeless tobacco. Dry snuff is finely ground tobacco placed in the mouth or used nasally. In a further aspect, the tobacco product of the present disclosure is selected from the group consisting of loose-leaf chewing tobacco, plug chewing tobacco, moist snuff, and nasal snuff. In yet another aspect, the tobacco product of the present disclosure is selected from the group consisting of electronically heated cigarettes, e-cigarettes, and electronic vaporization devices.
[0150] In one aspect, the tobacco product of the present disclosure can be a blended tobacco product. In one aspect, the blended tobacco product includes dried tobacco material. In one aspect, the dried tobacco material constitutes approximately at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, or at least 95% of the dried tobacco in the tobacco blend by weight. In one aspect, the dried tobacco material constitutes approximately at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, or at least 95% of the dried tobacco in the tobacco blend by volume.
[0151] In one aspect, the tobacco product of the present disclosure can be a blended tobacco product. In another aspect, the tobacco product of the present disclosure can be a low-nicotine tobacco product. In a further aspect, the tobacco product of the present disclosure can include a level of nornicotine less than about 3 mg / g. For example, the nornicotine content in such products can be about 3.0 mg / g, about 2.5 mg / g, about 2.0 mg / g, about 1.5 mg / g, about 1.0 mg / g, about 750 μg / g, about 500 pg / g, about 250 pg / g, about 100 pg / g, about 75 pg / g, about 50 pg / g, about 25 pg / g, about 10 pg / g, about 7.0 pg / g, about 5.0 pg / g, about 4.0 pg / g, about 2.0 pg / g, about 1.0 pg / g, about 0.5 pg / g, about 0.4 pg / g, about 0.2 pg / g, about 0.1 pg / g, about 0.05 pg / g, about 0.01 pg / g, or undetectable.
[0152] In one aspect, the provided dried tobacco material or tobacco product has about 0.01%, about 0.02%, about 0.05%, about 0.75%, about 0.1%, about 0.15%, about 0.2%, about 0.3%, about 0.35%, about 0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8%, about 0.9%, about 1%, about 1.1%, about 1.2%, about 1.3%, about 1.4%, about 1.5%, about 1.6%, about 1.7%, about 1.8%, about 1.9%, about 2.0%, about 2.1%, about 2.2%, about 2.3%, about 2.4%, about 2.5%, about 2.6%, about 2.7%, about 2.8%, about 2.9%, about 3.0%, about 3.1%, about 3.2%, about 3.3%, about 3.4%, about 3.5%, about 3.6%, about 3.7%, about 3.8%, about 3.9 ...5%, about 3.6%, about 3.7%, about 3.8%, about 3.9%, about , about 1.9%, about 2%, about 2.1%, about 2.2%, about 2.3%, about 2.4%, about 2.5%, about 2.6%, about 2.7%, about 2.8%, about 2.9%, about 3%, about 3.1%, about 3.2%, about 3.3%, about 3.4%, about 3.5%, about 3.6%, about 3.7%, about 3.8%, about 3.9%, about 4%, about 5%, about 6%, about 7%, about 8%, and about 9%. In another aspect, the provided dried tobacco material or tobacco product has about 0.01% to 0.02%, about 0.02% to 0.05%, about 0.05% to 0.75%, about 0.75% to 0.1%, about 0.1% to 0.15%, about 0.15% to 0.2%, about 0.2% to 0.3%, about 0.3% to 0.35%, about 0.35% to 0.4%, about 0.4% to 0.5%, about 0.5% to 0.6%, about 0.6% to 0.7%, about 0.7% to 0.8%, about 0.8% to 0.9%, about 0.9% to 1%, about 1% to 1.1%, about 1.1% to 1.2%, about 1.2% to 1.3%, about 1.3% to 1.4%, about 1.4% to 1. 5%, about 1.5%-1.6%, about 1.6%-1.7%, about 1.7%-1.8%, about 1.8%-1.9%, about 1.9%-2%, about 2%-2.1%, about 2.1%-2.2%, about 2.2%-2.3%, about 2.3%-2.4%, about 2.4%-2.5%, about 2.5%-2.6%, about 2.6%-2.7%, about 2.7%-2.8%, about 2.8%-2.9%, about 2.9%-3%, about 3%-3.1%, about 3.1%-3.2%, about 3.2%-3.3%, about 3.3%-3.4%, about 3.4%-3.5%, and about 3.5%-3.6%.In a further aspect, the provided dried tobacco material or tobacco product comprises an average nicotine or total alkaloid level selected from the group consisting of about 0.01%-0.1%, about 0.02%-0.2%, about 0.03%-0.3%, about 0.04%-0.4%, about 0.05%-0.5%, about 0.75%-1%, about 0.1%-1.5%, about 0.15%-2%, about 0.2%-3%, and about 0.3%-3.5% on a dry weight basis.
[0153] The present disclosure also provides a method for breeding tobacco strains, cultivars, or varieties that contain a desired level of total alkaloids or nicotine, e.g., low nicotine or no nicotine. Breeding can be carried out via any known technique. DNA fingerprinting, SNP mapping, haplotype mapping, or similar techniques may be used in marker-assisted selection (MAS) breeding programs to transfer or breed desired traits or alleles into tobacco plants. For example, breeders can use F1 hybrid plants or further cross F1 hybrid plants with other donor plants that have agronomically desirable genotypes to create segregating populations in the F2 or backcross generation. Plants in the F2 or backcross generation can be screened for desired agronomic traits or desired chemical profiles using one of the techniques known in the art or listed herein. Depending on the expected inheritance pattern or MAS technique used, self-pollination of selected plants can be performed before each cycle of backcrossing to help identify the desired individual plants. Backcrossing or other breeding procedures can be repeated until the desired phenotype of the recurrent parent is recovered. The recurrent parent in this disclosure can be a flue-cured variety, a burley variety, a dark air-cured variety, a dark fire-cured variety, or an oriental variety. Other breeding techniques can be found, for example, in Wernsman, EA and Rufty, RC 1987. Chapter Seventeen. Tobacco. Pages 669-698 In: Cultivar Development. Crop Species. WH Fehr (ed.), MacMillan Publishing Go., Inc., New York, NY (incorporated herein in its entirety by reference).
[0154] The results of plant breeding programs using the described tobacco plants include useful strains, cultivars, varieties, progeny, inbreds, and hybrids of the present disclosure. As used herein, the term "variety" refers to a group of plants that share certain characteristics that separate them from other plants of the same species. Varieties are often, but not always, sold commercially. Although they have one or more characteristic traits, varieties are further characterized by very little overall variation between individuals within the variety. "Pure-stock" varieties may be created by self-pollination and selection from a single parent using tissue or cell culture techniques, or by several generations of vegetative propagation. A variety may be essentially derived from another strain or variety. As defined by the International Convention for the Protection of New Varieties of Plants (December 2, 1961; revised at Geneva on November 10, 1972, October 23, 1978, and March 19, 1991), a variety is "essentially derived" from an early variety if it a) is derived primarily from the early variety, or a variety derived primarily from the early variety while retaining the expression of essential characteristics resulting from the genotype or combination of genotypes of the early variety, b) is clearly distinguishable from the early variety, and c) matches the early variety in the expression of essential characteristics resulting from the genotype or combination of genotypes of the early variety, except for differences resulting from the act of derivation. Essentially derived varieties can be obtained, for example, by natural or induced mutants, somatic breeding line variants, selection of variant individuals from plants of the early variety, backcrossing, or transformation. It is considered that the first tobacco variety and the second tobacco variety from which the first variety is essentially derived have essentially the same genetic background. A "strain", as distinguished from a variety, most often refers to a group of plants used non-commercially, for example in botanical research. Strains typically exhibit little overall variation among individuals for one or more traits of interest, although there may be some variation among individuals for other traits.
[0155] As used herein, a "locus" is a chromosomal region where a polymorphic nucleic acid, a trait determinant, a gene, or a marker is located. The locus of the present disclosure includes one or more polymorphisms in a population, e.g., alternative alleles exist in some individuals. As used herein, an "allele" refers to alternative nucleic acid sequences at a particular locus. The length of an allele can be as short as one nucleotide base, but is typically longer. For example, a first allele can exist on one chromosome and a second allele exists on a second homologous chromosome, e.g., for different chromosomes of a heterozygous individual, or between different homozygous or heterozygous individuals in a population. As used herein, the term "chromosomal interval" refers to a continuous linear span of genomic DNA on a single chromosome.
[0156] As used herein, "introgression" or "introject" refers to the transfer of a desired allele of a genetic locus from one genetic background to another.
[0157] As used herein, "crossed" or "crossing" means to produce offspring through fertilization (e.g., a cell, seed, or plant), and includes crossing between plants (sexual) and self-fertilization (self-pollination).
[0158] As used herein, "backcrossing" and "backcrossing" refer to a method in which a progeny plant is repeatedly crossed back to one of its parents. In a backcrossing scheme, the "donor" parent refers to the parent plant that has the desired gene or locus to be transferred. The "recipient" parent (used one or more times) or "recurrent" parent (used two or more times) refers to the parent plant to which the gene or locus is being transferred. The initial cross produces the F1 generation. The term "BC1" refers to the second use of the recurrent parent, "BC2" refers to the third use of the recurrent parent, and so on. In one aspect, backcrossing is performed repeatedly, with the progeny individuals of each successive backcross generation being themselves backcrossed to the same parent genotype.
[0159] As used herein, "single-gene converted" or "single-gene conversion" refers to a plant developed using the plant breeding technique known as backcrossing or through genetic engineering, where essentially all of the desired morphological and physiological characteristics of the variety are restored in addition to a single gene that is transferred into the variety via the backcrossing technique or through genetic engineering.
[0160] As used herein, "elite variety" means any variety that has resulted from breeding and selection for superior agronomic performance.
[0161] As used herein, "selecting" or "selection" in the context of marker-assisted selection or breeding refers to the act of collecting or choosing desired individuals, usually from a population, based on certain predetermined criteria.
[0162] As used herein, the term "trait" refers to one or more detectable characteristics of a cell or organism that can be influenced by genotype. A phenotype can be observable by the naked eye or by any other means of evaluation known in the art, such as microscopy, biochemical analysis, genomic analysis, assays for specific disease resistance, etc. In some cases, a phenotype is directly controlled by a single gene or locus, e.g., a "single gene trait." In other cases, a phenotype is the result of several genes.
[0163] It is understood that any tobacco plant of the present disclosure may further comprise additional agronomically desirable traits, for example, by transformation with a genetic construct or transgene using techniques known in the art. Non-limiting examples of desirable traits are herbicide resistance, pest resistance, disease resistance; high yield; high grade index value; curability; drying quality; mechanical harvestability; holding ability; leaf quality; height, plant maturity (e.g., early maturity, early to medium maturity, medium maturity, medium to late maturity, or late maturity); stem size (e.g., small, medium, or large stem); or number of leaves per plant (e.g., few (e.g., 5-10 leaves), medium (e.g., 11-15 leaves), or many (e.g., 16-21 leaves) leaves), or any combination. In one aspect, the disclosed low-nicotine or nicotine-free tobacco plants or seeds contain one or more transgenes expressing one or more insecticidal proteins, such as the crystal protein of Bacillus thuringiensis or a nutritional insecticidal protein from Bacillus cereus, such as VIP3 (see, e.g., Estruch et al. (1997) Nat. Biotechnol. 15:137). In another aspect, the tobacco plants further contain transferred traits that confer resistance to leaf spot disease (U.S. Pat. No. 5,689,035) or resistance to cyst nematodes (U.S. Pat. No. 5,491,081).
[0164] The present disclosure also provides tobacco plants having yields equivalent to the yields of corresponding initial tobacco plants containing altered nicotine or total alkaloid levels but without such altered nicotine levels. In one aspect, the low-nicotine or no-nicotine tobacco varieties provide yields selected from the group consisting of about 1200-3500, about 1300-3400, about 1400-3300, about 1500-3200, about 1600-3100, about 1700-3000, about 1800-2900, about 1900-2800, about 2000-2700, about 2100-2600, about 2200-2500, and about 2300-2400 lb / acre. In another aspect, the low nicotine or nicotine free tobacco varieties are selected from the group consisting of tobacco varieties having a molecular weight of about 1200-3500, about 1300-3500, about 1400-3500, about 1500-3500, about 1600-3500, about 1700-3500, about 1800-3500, about 1900-3500, about 2000-3500, about 2100-3500 , about 2200-3500, about 2300-3500, about 2400-3500, about 2500-3500, about 2600-3500, about 2700-3500, about 2800-3500, about 2900-3500, about 3000-3500, and about 3100-3500 lb / acre. In a further aspect, the low-nicotine or nicotine-free tobacco plant provides a yield that is 65%-130%, 70%-130%, 75%-130%, 80%-130%, 85%-130%, 90%-130%, 95%-130%, 100%-130%, 105%-130%, 110%-130%, 115%-130%, or 120%-130% of the yield of a control plant having an essentially identical genetic background except for the nic1b mutation, the nic2 mutation, the Nic1b transgene, the Nic2 transgene, or combinations thereof. In further aspects, the low-nicotine or nicotine-free tobacco plant provides a yield that is 70%-125%, 75%-120%, 80%-115%, 85%-110%, or 90%-100% of the yield of a control plant having essentially the same genetic background except for the nic1 mutation, the nic2 mutation, the Nic1 transgene, the Nic2 transgene, or a combination thereof.
[0165] In one aspect, the tobacco plant (e.g., a low-nicotine, nicotine-free, or low-alkaloid tobacco variety) does not exhibit one or more, two or more, three or more, or all of the LA BU21 traits selected from the group consisting of lower yield, delayed maturation and senescence, higher susceptibility to insect herbivory, increased polyamine content after topping, higher chlorophyll, more mesophyll cells per unit leaf area, and poor end-product quality after drying. In one aspect, the disclosed tobacco plant (e.g., a low-nicotine, nicotine-free, or low-alkaloid tobacco variety) does not exhibit two or more of the LA BU21 traits selected from the group consisting of lower yield, delayed maturation and senescence, higher susceptibility to insect herbivory, increased polyamine content after topping, higher chlorophyll, more mesophyll cells per unit leaf area, and poor end-product quality after drying. In one aspect, the disclosed tobacco plants (e.g., low-nicotine, nicotine-free, or low-alkaloid tobacco varieties) do not exhibit three or more of the LA BU21 traits selected from the group consisting of lower yield, delayed maturation and senescence, higher susceptibility to insect herbivory, increased polyamine content after topping, higher chlorophyll, more mesophyll cells per unit leaf area, and poor end-product quality after curing. In one aspect, the disclosed tobacco plants (e.g., low-nicotine, nicotine-free, or low-alkaloid tobacco varieties) exhibit one or more, two or more, three or more, or all of the LA BU21 traits selected from the group consisting of lower yield, delayed maturation and senescence, higher susceptibility to insect herbivory, increased polyamine content after topping, higher chlorophyll, more mesophyll cells per unit leaf area, and poor end-product quality after curing at a lower level compared to LA BU21, LAFC53, or LN KY171.In one aspect, the disclosed tobacco plants (e.g., low-nicotine, nicotine-free, or low-alkaloid tobacco varieties) exhibit two or more of the LA BU21 traits selected from the group consisting of lower yield, delayed maturation and senescence, higher susceptibility to insect herbivory, increased polyamine content after topping, higher chlorophyll, more mesophyll cells per unit leaf area, and poor end-product quality after curing, at lower levels compared to LA BU21, LAFC53, or LN KY171. In one aspect, the disclosed tobacco plants (e.g., low-nicotine, nicotine-free, or low-alkaloid tobacco varieties) exhibit three or more, or all of the LA BU21 traits selected from the group consisting of lower yield, delayed maturation and senescence, higher susceptibility to insect herbivory, increased polyamine content after topping, higher chlorophyll, more mesophyll cells per unit leaf area, and poor end-product quality after curing, at lower levels compared to LA BU21, LAFC53, or LN KY171.
[0166] In one aspect, the modified tobacco plants (e.g., low-nicotine, nicotine-free, or low-alkaloid tobacco varieties) include modifications that impart a desired trait (e.g., low-nicotine, nicotine-free, or low-alkaloid) without substantially affecting a trait selected from the group consisting of yield, maturity and senescence, susceptibility to insect herbivory, polyamine content after topping, chlorophyll levels, mesophyll cell number per unit leaf area, and end-product quality after curing.
[0167] In one aspect, the modified tobacco plant comprises a modification that confers a desired trait (e.g., low nicotine, no nicotine, or low alkaloids) and further comprises traits substantially equivalent to an unmodified control plant, the traits being selected from the group consisting of yield, maturity and senescence, susceptibility to insect herbivory, polyamine content after topping, chlorophyll levels, mesophyll cell number per unit leaf area, and end-product quality after drying.
[0168] In one aspect, the modified tobacco plant includes a modification that confers a desired trait (e.g., low nicotine, no nicotine, or low alkaloids) and further includes a yield of greater than 80%, greater than 85%, greater than 90%, greater than 95%, greater than 100%, greater than 105%, greater than 110%, greater than 115%, greater than 120%, greater than 125%, greater than 130%, greater than 135%, or greater than 140% relative to the yield of an unmodified control plant. In one aspect, the disclosed modified tobacco plant includes a modification that confers a desired trait (e.g., low nicotine, no nicotine, or low alkaloids) and further includes a yield of between 70% and 140%, between 75% and 135%, between 80% and 130%, between 85% and 125%, between 90% and 120%, between 95% and 115%, or between 100% and 110% relative to the yield of an unmodified control plant. In one aspect, the disclosed modified tobacco plants include modifications that confer a desired trait (e.g., low nicotine, no nicotine, or low alkaloids) and further include a yield of 70% to 80%, 75% to 85%, 80% to 90%, 85% to 95%, 90% to 100%, 95% to 105%, 105% to 115%, 110% to 120%, 115% to 125%, 120% to 130%, 125 to 135%, or 130% to 140% relative to the yield of an unmodified control plant.
[0169] In one aspect, the modified tobacco plant includes modifications that confer a desired trait (e.g., low nicotine, no nicotine, or low alkaloids) and further includes a post-topping polyamine content that is greater than 80%, greater than 85%, greater than 90%, greater than 95%, greater than 100%, greater than 105%, greater than 110%, greater than 115%, greater than 120%, greater than 125%, greater than 130%, greater than 135%, or greater than 140% relative to the post-topping polyamine content of an unmodified control plant. In one aspect, the disclosed modified tobacco plants include modifications that confer a desired trait (e.g., low nicotine, no nicotine, or low alkaloids) and further include a post-topping polyamine content of between 70% and 140%, between 75% and 135%, between 80% and 130%, between 85% and 125%, between 90% and 120%, between 95% and 115%, or between 100% and 110% relative to the post-topping polyamine content of an unmodified control plant. In one aspect, the disclosed modified tobacco plants include modifications that confer a desired trait (e.g., low nicotine, no nicotine, or low alkaloids) and further include a post-topping polyamine content of 70% to 80%, 75% to 85%, 80% to 90%, 85% to 95%, 90% to 100%, 95% to 105%, 105% to 115%, 110% to 120%, 115% to 125%, 120% to 130%, 125 to 135%, or 130% to 140% relative to the post-topping polyamine content of an unmodified control plant.
[0170] In one aspect, the modified tobacco plant includes modifications that confer a desired trait (e.g., low nicotine, no nicotine, or low alkaloids) and further includes a chlorophyll level that is greater than 80%, greater than 85%, greater than 90%, greater than 95%, greater than 100%, greater than 105%, greater than 110%, greater than 115%, greater than 120%, greater than 125%, greater than 130%, greater than 135%, or greater than 140% relative to the chlorophyll level of an unmodified control plant. In one aspect, the disclosed modified tobacco plants contain modifications that confer a desired trait (e.g., low nicotine, no nicotine, or low alkaloids) and further contain a chlorophyll level that is between 70% and 140%, between 75% and 135%, between 80% and 130%, between 85% and 125%, between 90% and 120%, between 95% and 115%, or between 100% and 110% relative to the chlorophyll level of an unmodified control plant. In one aspect, the disclosed modified tobacco plants include modifications that confer a desired trait (e.g., low nicotine, no nicotine, or low alkaloids) and further include a chlorophyll level that is 70%-80%, 75%-85%, 80%-90%, 85%-95%, 90%-100%, 95%-105%, 105%-115%, 110%-120%, 115%-125%, 120%-130%, 125-135%, or 130%-140% relative to the chlorophyll level of an unmodified control plant.
[0171] In one aspect, the modified tobacco plant comprises a modification that confers a desired trait (e.g., low nicotine, no nicotine, or low alkaloids) and further comprises a number of mesophyll cells per unit leaf area that is 80% greater, 85% greater, 90% greater, 95% greater, 100% greater, 105% greater, 110% greater, 115% greater, 120% greater, 125% greater, 130% greater, 135% greater, or 140% greater than the number of mesophyll cells per unit leaf area of an unmodified control plant. In one aspect, the disclosed modified tobacco plants include modifications that confer a desired trait (e.g., low nicotine, no nicotine, or low alkaloids) and further include a mesophyll cell number per unit leaf area that is between 70% and 140%, between 75% and 135%, between 80% and 130%, between 85% and 125%, between 90% and 120%, between 95% and 115%, or between 100% and 110% relative to the number of mesophyll cells per unit leaf area of an unmodified control plant. In one aspect, the disclosed modified tobacco plants include modifications that confer a desired trait (e.g., low nicotine, no nicotine, or low alkaloids) and further include a mesophyll cell number per unit leaf area that is 70% to 80%, 75% to 85%, 80% to 90%, 85% to 95%, 90% to 100%, 95% to 105%, 105% to 115%, 110% to 120%, 115% to 125%, 120% to 130%, 125 to 135%, or 130% to 140% of the mesophyll cell number per unit leaf area of an unmodified control plant.
[0172] In one aspect, the low-nicotine or no-nicotine tobacco varieties are adapted for mechanical harvesting. In another aspect, the disclosed low-nicotine or no-nicotine tobacco varieties are mechanically harvested.
[0173] In one aspect, a method for improving leaf quality in a reduced alkaloid tobacco plant is provided, the method comprising growing a tobacco plant; reducing putrescine levels in the tobacco plant, and harvesting leaves from the tobacco plant.
[0174] In one aspect, a method for improving leaf quality in reduced alkaloid tobacco plants is provided, the method comprising growing the tobacco plant; suppressing expression or activity of the ornithine decarboxylase (ODC) gene in the tobacco plant, and harvesting leaves from the tobacco plant. In one aspect, the suppressing is within 2 WPT, within 4 WPT, within 6 WPT, or within 8 WPT. In one aspect, the suppressing includes suppressing the ODC gene both before and after topping the tobacco plant. In one aspect, the suppressing does not include the use of a chemical inhibitor. In one aspect, the suppressing is accomplished by inducing expression of a non-coding RNA for suppressing the ornithine decarboxylase (ODC) gene. In one aspect, the suppressing includes applying an ODC inhibitor to the tobacco plant. In one aspect, the suppressing is accomplished by applying an ODC inhibitor to the tobacco plant. In one aspect, the ODC inhibitor is DFMO.
[0175] In one aspect, the tobacco plant provided is a hybrid plant. Hybrids can be produced by preventing self-pollination of a first variety of female parent plant (e.g., seed parent) to allow pollen from a second variety of male parent plant to fertilize the female parent plant, and F1 hybrid seeds can be formed in the female plant. Self-pollination of female plants can be prevented by emasculating flowers at an early flower development stage. Alternatively, pollen formation can be prevented in female parent plants using a form of male sterility. For example, male sterility can be caused by male sterility (MS), where a transgene inhibits microsporogenesis and / or pollen formation, or transgenic male sterility, or self-incompatibility. Female parent plants containing MS are particularly useful. In aspects where the female parent plant is MS, pollen may be harvested from the male fertile plant and manually applied to the stigma of the MS female parent plant and the resulting F1 seeds are harvested.
[0176] The plant can be used to form a single-cross tobacco F1 hybrid. The pollen from the male parent plant is manually transferred to the emasculated or male-sterile female parent plant to form F1 seeds. Alternatively, a three-way cross can be carried out in which the single-cross F1 hybrid is used as the female parent to cross with a different male parent. As another alternative, a double-cross hybrid can be produced in which the F1 progeny of two different single crosses are crossed with themselves. Self-incompatibility can be used for certain advantages to prevent self-pollination of the female parent when forming a double-cross hybrid.
[0177] In one aspect, the low-nicotine or nicotine-free tobacco variety is male sterile. In another aspect, the low-nicotine or nicotine-free tobacco variety is cytoplasmic male sterile. Male-sterile tobacco plants may be produced by any method known in the art. Methods for producing male-sterile tobacco are described in Wernsman, EA and Rufty, RC 1987. Chapter Seventeen. Tobacco. Pages 669-698 In: Cultivar Development. Crop Species. WH Fehr (ed.), MacMillan Publishing Go., Inc., New York, NY 761 pp.
[0178] In further aspects, the tobacco parts provided include, but are not limited to, leaves, stems, roots, seeds, flowers, pollen, anthers, ovules, pedicels, fruits, meristems, cotyledons, hypocotyls, pods, embryos, endosperms, explants, calli, tissue cultures, shoots, cells, and protoplasts. In one aspect, the tobacco parts provided do not include seeds. In one aspect, the present disclosure provides tobacco plant cells, tissues, and organs that are not reproductive materials and do not mediate the natural reproduction of plants. In another aspect, the present disclosure also provides tobacco plant cells, tissues, and organs that are reproductive materials and mediate the natural reproduction of plants. In another aspect, the present disclosure provides tobacco plant cells, tissues, and organs that cannot be maintained through photosynthesis. In another aspect, the present disclosure provides somatic tobacco plant cells. Somatic cells are different from germ line cells and do not mediate plant reproduction.
[0179] The provided cells, tissues, and organs may be from seeds, fruits, leaves, cotyledons, hypocotyls, meristems, embryos, endosperms, roots, shoots, stems, pods, flowers, inflorescences, stems, pedicels, styles, stigmas, receptacles, petals, sepals, pollen, anthers, filaments, ovaries, ovules, pericarp, phloem, and vascular tissues. In another aspect, the present disclosure provides tobacco plant chloroplasts. In a further aspect, the present disclosure provides epidermal cells, stomatal cells, leaf or root hairs, storage roots, or tubers. In another aspect, the present disclosure provides tobacco protoplasts.
[0180] Those skilled in the art will appreciate that tobacco plants naturally reproduce through seeds, not through asexual or vegetative propagation. In one aspect, the present disclosure provides tobacco endosperm. In another aspect, the present disclosure provides tobacco endosperm cells. In a further aspect, the present disclosure provides male or female sterile tobacco plants that cannot reproduce without human intervention.
[0181] In one aspect, the disclosure provides nucleic acid molecules comprising at least about 40%, at least about 45%, at least about 50%, at least about 55%, at least about 60%, at least about 65%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 91%, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, at least about 99%, or at least about 100% identity to a sequence selected from the group consisting of SEQ ID NOs:23-28 and fragments thereof. In one aspect, the disclosure provides a polypeptide or protein that comprises at least about 40%, at least about 45%, at least about 50%, at least about 55%, at least about 60%, at least about 65%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 91%, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, at least about 99%, or at least about 100% identity to an amino acid sequence selected from the group consisting of SEQ ID NOs: 29-34. In another aspect, the disclosure provides a biologically active variant of a protein having an amino acid sequence selected from the group consisting of SEQ ID NOs: 29-34. Biologically active variants of the proteins of the disclosure may differ from the protein by as few as 1-15 amino acid residues, as few as 10, as few as 9, as few as 8, as few as 7, as few as 6, as few as 5, as few as 4, as few as 3, as few as 2, or as few as 1 amino acid residue. Orthologous genes or proteins of genes or proteins from the ODC pathway are also provided. "Orthologs" are genes that are derived from a common ancestral gene and are found in different species as a result of speciation.Orthologs may share at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or more sequence identity or similarity at the nucleotide and / or protein sequence level. The function of orthologs is often highly conserved between species.
[0182] As used herein, the term "sequence identity" or "identity" in the context of two polynucleotide or polypeptide sequences refers to the residues in the two sequences that are the same when aligned for maximum correspondence over a specified comparison window. When the percentage of sequence identity is used in the context of proteins, it is recognized that non-identical residue positions often differ by conservative amino acid substitutions, where amino acid residues are replaced with other amino acid residues that have similar chemical properties (e.g., charge or hydrophobicity), and thus do not change the functional properties of the molecule. When sequences differ in conservative substitutions, the percent sequence identity may be adjusted upwards to correct for the conservative nature of the substitution. Sequences that differ by such conservative substitutions are considered to have "sequence similarity" or "similarity".
[0183] The provided nucleic acid molecules, polypeptides, or proteins can be isolated or substantially purified. An "isolated" or "purified" nucleic acid molecule, polypeptide, protein, or biologically active portion thereof is substantially or essentially free from components that normally associate with or interact with the polynucleotide or protein as found in its naturally occurring environment. For example, an isolated or purified polynucleotide or protein is substantially free from other cellular materials or culture medium when produced by recombinant technology, and is substantially free from chemical precursors or other chemicals when chemically synthesized.
[0184] The present disclosure further provides a method of producing a tobacco product comprising tobacco material from the disclosed tobacco plant. In one aspect, the method includes conditioning aged tobacco material made from the tobacco plant to increase its moisture content from about 12.5% to about 13.5% to about 21%, and blending the conditioned tobacco material to produce a desired blend. In one aspect, the method of producing a tobacco product further includes casing or flavoring the blend. Generally, during the casing process, casing or source materials are added to the blends to enhance their quality by balancing the chemical composition and to develop certain desired flavor characteristics. Further details on casing processing can be found in Tobacco Production, Chemistry and Technology, edited by L. Davis and M. Nielsen, Blackwell Science, 1999.
[0185] The provided tobacco material may also be processed using methods including, but not limited to, heat treatment (e.g., cooking, toasting), flavoring, enzymatic treatment, expansion, and / or curing. Both fermented and non-fermented tobaccos may be processed using these techniques. Examples of suitable processed tobaccos include dark air-cured, dark fire-cured, burley, hot-air-cured, and products from whole leaf stemming operations, as well as cigar fillers or wrappers. In one aspect, the tobacco fiber comprises up to 70% dark tobacco on a fresh weight basis. For example, the tobacco may be conditioned by a heating, steaming, and / or pasteurization step as described in U.S. Patent Application Publication No. 2004 / 0118422 or U.S. Patent Application Publication No. 2005 / 0178398.
[0186] The provided tobacco material may be subjected to fermentation. Fermentation is typically characterized by high initial moisture content, heat production, and a loss of 10-20% of dry weight. See, e.g., U.S. Pat. Nos. 4,528,993, 4,660,577, 4,848,373, and 5,372,149. In addition to improving leaf aroma, fermentation may change either or both of the leaf's color and feel. Also, during the fermentation process, evolved gases may be produced, oxygen may be taken up, pH may be altered, and the amount of water retained may be altered. See, e.g., U.S. Pat. App. Pub. No. 2005 / 0178398 and Tso (1999, Chapter 1, Tobacco, Production, Chemistry and Technology, edited by Davis & Nielsen, Blackwell Publishing, Oxford). The cured, or cured and fermented tobacco may be further processed (e.g., cut, expanded, blended, milled, or ground) prior to incorporation into an oral product. The tobacco is, in some cases, long-cut, fermented, cured, moist tobacco having an oven volatiles content of 48 to 50 percent by weight prior to mixing with the copolymer and, optionally, flavorings and other additives.
[0187] In one aspect, the provided tobacco material can be processed to a desired size. In one aspect, the tobacco fiber can be processed to have an average fiber size of less than 200 micrometers. In one aspect, the tobacco fiber is 75-125 micrometers. In another aspect, the tobacco fiber is processed to have a size of 75 micrometers or less. In one aspect, the tobacco fiber comprises long cut tobacco, which can be cut or chopped to a width of about 10 cuts / inch to about 110 cuts / inch and a length of about 0.1 inch to about 1 inch. The double cut tobacco fiber can have a particle size range such that about 70% of the double cut tobacco fiber falls between a mesh size of -20 mesh and 80 mesh.
[0188] The provided tobacco material may be processed to have a total oven volatile content of about 10% or more, about 20% or more, about 40% or more, about 15% to about 25%, about 20% to about 30%, about 30% to about 50%, about 45% to about 65%, or about 50% to about 60% by weight. Those skilled in the art will appreciate that "moist" tobacco typically refers to tobacco having an oven volatile content of about 40% to about 60% by weight (e.g., about 45% to about 55%, or about 50% by weight). As used herein, "oven volatile content" is determined by calculating the percentage weight loss of a sample after drying the sample for 3.25 hours in a forced air oven preheated to 110°C. Oral products may have an overall oven volatile content that is different from the oven volatile content of the tobacco fiber used to make the oral product. The processing steps described may reduce or increase the oven volatile content.
[0189] Having now broadly described the present disclosure, the same will be more readily understood by reference to the following examples, which are provided by way of illustration and are not intended to limit the disclosure, unless otherwise specified.
[0190] The following are exemplary aspects of the present disclosure. Embodiment 1. A tobacco plant comprising an inducible promoter operably linked to a transcribable DNA sequence encoding a non-coding RNA for repressing an ornithine decarboxylase (ODC) gene. Embodiment 2. The tobacco plant of embodiment 1, comprising a mutation or transgene that confers reduced levels of nicotine. Embodiment 3. The tobacco plant of embodiment 1 or 2, which is a low-alkaloid tobacco plant. Aspect 4. A tobacco plant according to any one of aspects 1 to 3, comprising a nic1 mutation, a nic2 mutation, or both. Embodiment 5. The tobacco plant of any of embodiments 1-4, comprising a mutation in a gene or locus encoding a protein selected from the group consisting of aspartate oxidase, agmatine deiminase (AIC), arginase, diamine oxidase, arginine decarboxylase (ADC), methylputrescine oxidase (MPO), NADH dehydrogenase, ornithine decarboxylase (ODC), phosphoribosylanthranilate isomerase (PRAI), putrescine N-methyltransferase (PMT), quinolate phosphoribosyltransferase (QPT), S-adenosyl-methionine synthase (SAMS), A622, NBB1, BBL, MYC2, Nic1, Nic2, ethylene response factor (ERF) transcription factors, nicotine uptake permease (NUP), and MATE transporters. Embodiment 6. The tobacco plant of any of embodiments 1-5, comprising a mutation in a gene or locus encoding a protein selected from the group consisting of ERF32, ERF34, ERF39, ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168. Embodiment 7. The tobacco plant according to any of embodiments 1-6, comprising a transgene that targets and represses a gene encoding a protein selected from the group consisting of aspartate oxidase, agmatine deiminase (AIC), arginase, diamine oxidase, arginine decarboxylase (ADC), methylputrescine oxidase (MPO), NADH dehydrogenase, ornithine decarboxylase (ODC), phosphoribosylanthranilate isomerase (PRAI), putrescine N-methyltransferase (PMT), quinolate phosphoribosyltransferase (QPT), S-adenosyl-methionine synthase (SAMS), A622, NBB1, BBL, MYC2, Nic1, Nic2, ethylene response factor (ERF) transcription factors, nicotine uptake permease (NUP), and MATE transporters. Embodiment 8. The tobacco plant of any of embodiments 1-7, comprising a transgene that targets and suppresses a gene encoding a protein selected from the group consisting of ERF32, ERF34, ERF39, ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168. Embodiment 9. The tobacco plant of any of embodiments 1 to 8, which is capable of producing leaves containing a comparable level of one or more polyamines compared to a comparable leaf of a control plant not comprising said mutation or said transgene. Aspect 10. The tobacco plant of any of aspects 1 to 9, wherein the equivalent level is within 20%, within 17.5%, within 15%, within 12.5%, within 10%, within 7.5%, within 5%, within 2.5%, or within 1% of the level in the control. Embodiment 11. The tobacco plant of any one of claims 1 to 10, which is capable of producing leaves containing equivalent chlorophyll levels compared to equivalent leaves of a control plant not comprising said mutation or said transgene. Aspect 12. The tobacco plant of any one of aspects 1 to 11, wherein the equivalent chlorophyll level is within 20%, within 17.5%, within 15%, within 12.5%, within 10%, within 7.5%, within 5%, within 2.5%, or within 1% of the level in the control. Aspect 13. The tobacco plant of any of aspects 1 to 12, which is capable of producing leaves that contain a comparable number of mesophyll cells per unit leaf area as compared to a comparable leaf of a control plant that does not contain the mutation or the transgene. Aspect 14. The tobacco plant of any of aspects 1-13, wherein said mesophyll cells per equivalent unit leaf area is within 20%, within 17.5%, within 15%, within 12.5%, within 10%, within 7.5%, within 5%, within 2.5%, or within 1% of the level in said control. Embodiment 15. The tobacco plant of any of embodiments 1 to 14, which is capable of producing leaves that comprise a comparable epidermal cell size compared to a comparable leaf of a control plant that does not comprise the mutation or the transgene. Aspect 16. The tobacco plant of any of aspects 1 to 15, wherein the equivalent epidermal cell size is within 20%, within 17.5%, within 15%, within 12.5%, within 10%, within 7.5%, within 5%, within 2.5%, or within 1% of the level in the control. Embodiment 17. The tobacco plant of any of embodiments 1-16, comprising a comparable leaf yield compared to a comparable leaf of a control plant not comprising said mutation or said transgene. Aspect 18. The tobacco plant of any of aspects 1-17, wherein said equivalent leaf yield is within 20%, within 17.5%, within 15%, within 12.5%, within 10%, within 7.5%, within 5%, within 2.5%, or within 1% of the level in said control. Aspect 19. The tobacco plant of any one of aspects 1 to 18, which exhibits a comparable susceptibility to insect feeding damage as compared to a comparable leaf of a control plant that does not contain the mutation or the transgene. Aspect 20. The tobacco plant of any of aspects 1-19, wherein the ornithine decarboxylase (ODC) gene encodes a polypeptide sequence having at least 80%, at least 85%, at least 90%, at least 95%, at least 97%, at least 99%, or 100% identity to a sequence selected from the group consisting of SEQ ID NOs: 29-34. Embodiment 21. The tobacco plant of any of embodiments 1 to 20, wherein the ODC gene comprises a nucleotide sequence having at least 90%, at least 95%, at least 97%, at least 99%, or 100% identity to a sequence selected from the group consisting of SEQ ID NOs: 23 to 28. Aspect 22. The tobacco plant according to any one of Aspects 1 to 21, wherein the inducible promoter is a pinching-inducible promoter. Aspect 23. The tobacco plant of any of aspects 1 to 22, wherein the inducible promoter is also a tissue-specific or tissue-preferred promoter. Embodiment 24. The tobacco plant according to any of embodiments 1 to 23, wherein the tissue-specific or tissue-preferred promoter is specific or preferred for one or more tissues or organs selected from the group consisting of shoots, roots, leaves, stems, flowers, haustorium, root tips, mesophyll cells, epidermal cells, and vasculature. Aspect 25. The tobacco plant of any one of aspects 1 to 24, wherein the inducible promoter controls root-specific or root-preferred expression. Aspect 26. The tobacco plant of any one of aspects 1 to 25, wherein the inducible promoter comprises a sequence selected from the group consisting of SEQ ID NOs: 1 to 11. Aspect 27. The tobacco plant of any one of aspects 1 to 26, wherein the inducible promoter controls leaf-specific or leaf-preferred expression. Aspect 28. The tobacco plant of any one of aspects 1 to 27, wherein the inducible promoter comprises a sequence selected from the group consisting of SEQ ID NOs: 12 to 21. Embodiment 29. The tobacco plant of any of embodiments 1 to 28, wherein the inducible promoter is heterologous to the transcribable DNA sequence. Aspect 30. The tobacco plant according to any one of aspects 1 to 29, wherein the non-coding RNA is selected from the group consisting of microRNA (miRNA), antisense RNA, small interfering RNA (siRNA), trans-acting siRNA (ta-siRNA), and hairpin RNA (hpRNA). Embodiment 31. The tobacco plant according to any one of embodiments 1 to 30, wherein the non-coding RNA comprises a nucleotide sequence having at least 90%, at least 95%, at least 97%, at least 99%, or 100% identity to a sequence selected from the group consisting of SEQ ID NOs: 35 and 36. Embodiment 32. The tobacco plant according to any of embodiments 1 to 31, wherein the non-coding RNA is provided in an ODC RNAi construct comprising a nucleotide sequence having at least 90% identity to SEQ ID NO:22. Embodiment 33. A tobacco plant or part thereof comprising a nic1 mutation, a nic2 mutation, or both, and further comprising a transgene or mutation that confers an early senescence trait. Embodiment 34. The tobacco plant of embodiment 33, wherein the mutation that confers the early senescence trait is yellow burley1 (-yb1). Embodiment 35. The tobacco plant of embodiment 33 or 34, wherein the mutation that confers the early senescence trait is yellow burley2 (-yb2). Aspect 36. The tobacco plant according to any one of aspects 33 to 35, wherein the mutation that confers the early senescence trait is pale yellow (PY). Aspect 37. Compared to a control tobacco plant, a. a first genomic modification that provides a low level of nicotine or total alkaloids; b. Providing equivalent levels of one or more traits, the traits being: i. whole leaf polyamine levels, ii. whole root polyamine levels; iii. total leaf chlorophyll levels; iv. number of mesophyll cells per unit leaf area, and v. Leaf epidermal cell size A second genome modification selected from the group consisting of: 1. A tobacco plant or part thereof comprising: The tobacco plant or part thereof, wherein the control plant does not have both the first genomic modification and the second genomic modification. Aspect 38. Compared to a control tobacco plant, a. a first genomic modification that provides a low level of nicotine or total alkaloids; b. A second genome modification that provides equivalent levels of whole leaf polyamine levels. 1. A tobacco plant or part thereof comprising: The tobacco plant or part thereof, wherein the control plant does not have both the first genomic modification and the second genomic modification. Aspect 39. Compared to a control tobacco plant, a. a first genomic modification that provides a low level of nicotine or total alkaloids; b. A second genome modification that provides equivalent levels of whole root polyamine levels. 1. A tobacco plant or part thereof comprising: The tobacco plant or part thereof, wherein the control plant does not have both the first genomic modification and the second genomic modification. 40. Compared to a control tobacco plant, a. a first genomic modification that provides a low level of nicotine or total alkaloids; b. A second genome modification that provides equivalent levels of whole leaf chlorophyll levels. 1. A tobacco plant or part thereof comprising: The tobacco plant or part thereof, wherein the control plant does not have both the first genomic modification and the second genomic modification. Aspect 41. Compared to a control tobacco plant, a. a first genomic modification that provides a low level of nicotine or total alkaloids; b. A second genome modification that provides a comparable level of mesophyll cell number per unit leaf area. 1. A tobacco plant or part thereof comprising: The tobacco plant or part thereof, wherein the control plant does not have both the first genomic modification and the second genomic modification. 42. Compared to a control tobacco plant, a. a first genomic modification that provides a low level of nicotine or total alkaloids; b. A second genome modification that provides a comparable level of leaf epidermal cell size. 1. A tobacco plant or part thereof comprising: The tobacco plant or part thereof, wherein the control plant does not have both the first genomic modification and the second genomic modification. Aspect 43. The tobacco plant or part thereof according to any one of Aspects 37-42, wherein the tobacco plant comprises a reduced amount of total complexed polyamines in the leaves relative to the control tobacco plant. Aspect 44. The tobacco plant or part thereof according to any one of Aspects 37-43, wherein the tobacco plant comprises a reduced amount of total complexed polyamines in the roots relative to the control tobacco plant. Aspect 45. The tobacco plant or part thereof according to any one of Aspects 37 to 44, wherein the tobacco plant comprises a reduced amount of total free polyamines in the leaves relative to the control tobacco plant. Aspect 46. The tobacco plant or part thereof according to any one of Aspects 37-45, wherein the tobacco plant comprises a reduced amount of total complexed polyamines in roots relative to the control tobacco plant. Aspect 47. The tobacco plant or part thereof according to any of aspects 37 to 46, wherein the tobacco plant comprises a reduced amount of all complexes of one or more polyamines selected from the group consisting of putrescine, spermidine, and spermine in the leaves compared to the control tobacco plant. Aspect 48. The tobacco plant or part thereof according to any of aspects 37 to 47, wherein the tobacco plant comprises a reduced amount of one or more polyamines selected from the group consisting of putrescine, spermidine, and spermine in the roots compared to the control tobacco plant. Aspect 49. The tobacco plant or part thereof according to any one of aspects 37 to 48, wherein the tobacco plant comprises a reduced amount of total free forms of one or more polyamines selected from the group consisting of putrescine, spermidine, and spermine in the leaves compared to the control tobacco plant. Aspect 50. The tobacco plant or part thereof according to any of aspects 37 to 49, wherein the tobacco plant comprises a reduced amount of one or more polyamines selected from the group consisting of putrescine, spermidine, and spermine in the roots compared to the control tobacco plant. Embodiment 51. The tobacco plant or part thereof according to any of embodiments 37 to 50, wherein the first genomic modification provides a reduced level of nicotine relative to the control tobacco plant. Embodiment 52. The tobacco plant or part thereof according to any one of embodiments 37 to 51, wherein the first genomic modification, the second genomic modification, or both, comprises a transgene, a mutation, or both. Embodiment 53. The tobacco plant or part thereof according to any one of embodiments 37 to 52, wherein the first genomic modification, the second genomic modification, or both, comprise a transgene. Embodiment 54. The tobacco plant or part thereof according to any one of embodiments 37 to 53, wherein the first genomic modification, the second genomic modification, or both, comprise a mutation. Embodiment 55. A tobacco plant or part thereof according to any of embodiments 37 to 54, wherein neither the first genomic modification nor the second genomic modification or both are based on a transgene. Embodiment 56. A tobacco plant or part thereof according to any of embodiments 37 to 55, wherein neither the first genomic modification nor the second genomic modification or both are based on a mutation. Aspect 57. The tobacco plant or part thereof according to any one of aspects 37 to 56, wherein the first genomic modification comprises a nic1 mutation, a nic2 mutation, or both. Embodiment 58. A tobacco plant or part thereof according to any one of embodiments 37 to 57, wherein the first genomic modification comprises a transgene targeted to the Nic1 locus, a transgene targeted to the Nic2 locus, or both. Aspect 59. The tobacco plant or part thereof according to any of aspects 37 to 58, wherein the second genomic modification comprises a transcribable DNA sequence encoding a non-coding RNA for suppressing the ornithine decarboxylase (ODC) gene, the MYB8 gene, or both. Embodiment 60. The tobacco plant or part thereof according to any of embodiments 37 to 59, wherein the transcribable DNA sequence is operably linked to a heterologous promoter selected from the group consisting of a constitutive promoter, a developmental promoter, a tissue-specific promoter, a tissue-preferred promoter, an inducible promoter, and any combination thereof. Aspect 61. The tobacco plant or part thereof according to any one of aspects 37 to 60, wherein the second genomic modification comprises overexpression of diamine oxidase, repression of arginine decarboxylase, or both. Embodiment 62. The tobacco plant or part thereof according to any of embodiments 37 to 61, wherein the first genomic modification comprises a mutation in a gene or locus encoding a protein selected from the group consisting of aspartate oxidase, agmatine deiminase (AIC), arginase, diamine oxidase, arginine decarboxylase (ADC), methylputrescine oxidase (MPO), NADH dehydrogenase, ornithine decarboxylase (ODC), phosphoribosylanthranilate isomerase (PRAI), putrescine N-methyltransferase (PMT), quinolate phosphoribosyltransferase (QPT), and S-adenosyl-methionine synthase (SAMS), A622, NBB1, BBL, MYC2, Nic1, Nic2, ethylene response factor (ERF) transcription factors, nicotine uptake permease (NUP), and MATE transporters. Embodiment 63. The tobacco plant or part thereof according to any one of embodiments 37 to 62, wherein the first genomic modification comprises a mutation in a gene or locus encoding a protein selected from the group consisting of ERF32, ERF34, ERF39, ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168. Aspect 64. The tobacco plant or part thereof according to any of aspects 37 to 63, wherein the first genomic modification comprises a transgene that targets and suppresses a gene or locus encoding a protein selected from the group consisting of aspartate oxidase, agmatine deiminase (AIC), arginase, diamine oxidase, arginine decarboxylase (ADC), methylputrescine oxidase (MPO), NADH dehydrogenase, ornithine decarboxylase (ODC), phosphoribosylanthranilate isomerase (PRAI), putrescine N-methyltransferase (PMT), quinolate phosphoribosyltransferase (QPT), and S-adenosyl-methionine synthase (SAMS), A622, NBBl, BBL, MYC2, Nic1, Nic2, ethylene response factor (ERF) transcription factors, nicotine uptake permease (NUP), and MATE transporters. Embodiment 65. The tobacco plant or part thereof according to any one of embodiments 37 to 64, wherein the first genomic modification comprises a transgene that targets and suppresses a gene or locus encoding a protein selected from the group consisting of ERF32, ERF34, ERF39, ERF189, ERF115, ERF221, ERF104, ERF179, ERF17, and ERF168. Aspect 66. The tobacco plant or part thereof described in any of aspects 37 to 65, wherein the low level is measured at a time selected from the group consisting of just before flowering, at the time of topping, 1 week after topping (WPT), 2 WPT, 3 WPT, 4 WPT, 5 WPT, 6 WPT, 7 WPT, 8 WPT, and at harvest. Aspect 67. A tobacco plant or part thereof according to any of aspects 37 to 66, wherein the equivalent level is measured at a time selected from the group consisting of just before flowering, at the time of topping, 1 week after topping (WPT), 2 WPT, 3 WPT, 4 WPT, 5 WPT, 6 WPT, 7 WPT, 8 WPT, and at harvest. Aspect 68. The tobacco plant or part thereof according to any one of aspects 37 to 67, wherein the tobacco plant is capable of producing leaves having a leaf grade equivalent to a leaf grade of leaves derived from the control plant. Aspect 69. The tobacco plant or part thereof according to any one of aspects 37 to 68, wherein the tobacco plant has a total leaf yield equivalent to that of the control plant. Embodiment 70. The tobacco plant or part thereof of any preceding embodiment, wherein said tobacco plant comprises a nicotine level selected from the group consisting of less than 3%, less than 2.75%, less than 2.5%, less than 2.25%, less than 2.0%, less than 1.75%, less than 1.5%, less than 1.25%, less than 1%, less than 0.9%, less than 0.8%, less than 0.7%, less than 0.6%, less than 0.5%, less than 0.4%, less than 0.3%, less than 0.2%, less than 0.1%, and less than 0.05%. Embodiment 71. The tobacco plant or part thereof of any of embodiments 37-70, wherein said tobacco plant comprises a level of nicotine that is less than 1%, 2%, 5%, 8%, 10%, 12%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, or 80% of the nicotine level of said control plant when grown under comparable growth conditions. Embodiment 72. A population of tobacco plants according to any preceding embodiment. Aspect 73. A dried tobacco material derived from the tobacco plant of any of the preceding aspects. Embodiment 74. The dried tobacco material of embodiment 73, produced by a drying process selected from the group consisting of hot air drying, air drying, flame drying, and sun drying. Aspect 75. A tobacco blend comprising the dry tobacco material according to aspect 73 or 74. Aspect 76. A tobacco blend according to any of aspects 73-75, wherein the dried tobacco material constitutes approximately at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, or at least 95% of the dried tobacco in the tobacco blend by weight. Aspect 77. A tobacco blend according to any of aspects 73-76, wherein the dried tobacco material constitutes approximately at least 10%, at least 15%, at least 20%, at least 25%, at least 30%, at least 35%, at least 40%, at least 45%, at least 50%, at least 55%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, or at least 95% of the dried tobacco in the tobacco blend by volume. Aspect 78. A tobacco product comprising the dried tobacco material according to any one of aspects 73 to 77. Aspect 79. The tobacco product according to aspect 78, which is selected from the group consisting of cigarettes, cigarillos, non-ventilated recess filter cigarettes, ventilated recess filter cigarettes, cigars, snuff, pipe tobacco, cigar tobacco, cigarette tobacco, chewing tobacco, leaf tobacco, shredded tobacco, and cut tobacco. Embodiment 80. The tobacco product according to embodiment 78 or 79, which is selected from the group consisting of loose-leaf chewing tobacco, plug chewing tobacco, moist snuff, and nasal snuff. 81. A method for improving leaf quality in a reduced alkaloid tobacco plant, comprising: a. growing a tobacco plant; b. reducing putrescine levels in said tobacco plant; c. harvesting leaves from said tobacco plants. The method comprises: 82. A method for improving leaf quality in a reduced alkaloid tobacco plant, comprising: a. growing a tobacco plant; b. suppressing the expression or activity of the ornithine decarboxylase (ODC) gene in said tobacco plant; c. harvesting leaves from said tobacco plants. The method comprises: Aspect 83. The method of aspect 81 or 82, wherein the inhibiting step is within 2 WPT, within 4 WPT, within 6 WPT, or within 8 WPT. Embodiment 84 The method according to any one of embodiments 81 to 83, wherein said suppressing step comprises suppressing said ODC gene before or after topping a tobacco plant. Embodiment 85. The method of any one of embodiments 82 to 84, wherein the inhibiting step does not include the use of a chemical inhibitor. Embodiment 86 The method according to any one of embodiments 82 to 85, wherein the inhibiting step comprises applying an ODC inhibitor to the tobacco plant. Aspect 87. The method of any one of aspects 82 to 86, wherein the inhibiting step is by applying an ODC inhibitor to the tobacco plant. Aspect 88. The method of any one of aspects 82 to 87, wherein the ODC inhibitor is DFMO. Aspect 89. A method according to any one of aspects 82 to 88, wherein the suppressing step is by inducing expression of a non-coding RNA for suppressing the ornithine decarboxylase (ODC) gene. Embodiment 90. The method of any one of embodiments 82 to 89, further comprising reducing nitrogen fertilization or reducing nitrates. EXAMPLES
[0191] Example 1: Plant material and general growing conditions Seeds of Nicotiana tabacum L. cv. Burley 21 wild type NA and HI (nic2), LI (nic1), and LA (nic1nic2) near-isogenic cultivars were obtained from the US Nicotiana Germplasm Collection at North Carolina State University and used in all greenhouse experiments. Seeds were grown at 27 / 23°C day / night temperature with a 16-h photoperiod (approximately 200 mmol / s -1 m -2Plants were germinated in pots under greenhouse conditions at 100 nm (λ = 400–700 nm) and 70% relative humidity. Five-week-old tobacco plantlets were transferred to 13 L pots with standard substrate (Einheitserde, Frondenberg, Germany). Plants were attached to a continuous drip irrigation system operating for approximately 5 min every 4 h and irrigated for 5 min per hour during a 16-h photoperiod with 0.7% (w / v) Ferty 2 Mega containing 16% nitrogen, (Planta Dungemittel, Regenstauf, Germany) for a further 4 weeks. Greenhouse plants were topped when 50% of the plants had at least one open flower. After topping, plants were grown for a further 4–7 weeks until harvest, 30 days after topping. Tobacco leaves used for polyamine analysis were collected from greenhouse-grown plants at three time points: before flowering (6.5-week-old plants), just before topping, i.e., floral apex removal (9-week-old plants), and at harvest (13-week-old plants, 4 weeks after topping). Root samples were collected at topping and harvest. LA and NA tobacco plants were grown in the field at 135 units of nitrogen per acre and sampled 1 week after topping for polyamine analysis.
[0192] For treatment with polyamine biosynthesis inhibitors, instead of a drip irrigation system, 5 mM D-arginine (AKos, Steinen, Germany), 2 mM DFMO (Synchem Ug & Co. KG, Felsberg, Germany) alone or in combination with 0.5 mM Ethephon®, or 0.5 mM Ethephon® alone (Merck KGaA, Darmstadt, Germany) were diluted in an equal volume of water used for daily irrigation and applied to LA plants three times a week, every 4 hours, at 9 am, 12 am, 3 pm, and 6 pm. Treatment with D-arginine and DFMO started before flowering (approximately 2.5 weeks before topping, when the plants were still in the vegetative stage) and continued for 6 weeks until harvest. In contrast, Ethephon® was applied from topping until harvest (4 weeks in total) to avoid premature senescence in LA plants. 12 plants were treated per inhibitor. NA plants were used as controls and were treated the same as LA plants. Further description of the experimental procedures and data is described in Nolke G, et al. Polyamines delay leaf maturation in low-alkaloid tobacco varieties. Plant Direct. 2018;2:1-12.
[0193] Example 2: Chlorophyll measurement Chlorophyll content was determined by measuring leaf absorbance in the red and infrared regions using a SPAD-502 Plus instrument (Minolta Camera Co., Osaka, Japan). Chlorophyll was measured twice on the same day in all fully expanded (>15 cm long) leaves (leaves 6-26) at different positions from six randomly selected plants from each line at five growth stages: preflowering (6.5-week-old plants and 2.5 weeks before topping), at topping, 1WPT and 2.5WPT, and at harvest (30 days after topping) before flowering. Total chlorophyll content was calculated as the average of all leaf chlorophyll measurements per plant to minimize the effect of leaf position.
[0194] Example 3: Leaf cell microscopy Four leaf discs (1 cm) cut from 15 leaves of six biological replicates at different developmental stages (preflowering, at pinching, 1WPT, and at harvest). 2 ) were mounted on slides and imaged using a Leica DM R microscope (Leica, Wetzlar, Germany) with a 10× air objective. Images were imported into ImageJ and Adobe Photoshop CS5.1 software, and cells per unit area were counted using the Count Tool in Photoshop CS5. Standard areas were designated for use in counting cells in triplicate across all images, and care was taken to avoid counting any cells twice.
[0195] Example 4: Confirmation of ODC and ADC activities To measure enzyme activity, 500 mg of tobacco leaf tissue collected from leaves of three biological replicates was ground in 1 ml HEPES extraction buffer (100 mM HEPES, 2 mM dithiothreitol (DTT), 1 mM EDTA, pH 7.5) to which 100 mg of polyvinylpyrrolidone was added during grinding. After centrifugation (13,000 g, 10 min, 4 °C), the enzyme activity was analyzed using the isotopic method as described by Capell et al. (1998). 14 The enzyme activity was measured by measuring the release of CO2. 14 C]Arg and L-[1- 14 C]Orn was used as the radioactive substrate.
[0196] Example 5: Polyamine extraction and analysis For polyamine analysis, 150 μg leaf or root material was collected from greenhouse-grown plants at different developmental stages: before flowering (leaves 6 and 12, numbered from the base), at topping (leaves 19 and 23 and roots), and at harvest (leaves 23 and 24 and roots). From three biological replicates, samples were collected after 4 h of light exposure and flash frozen in liquid nitrogen. For field-grown plants, leaf material was collected from the top five well-expanded leaves of three biological replicates. Plant material was ground in 1.6 ml pre-chilled 10% (v / v) perchloric acid and incubated at 4°C for 1 h. Extracts were vortexed for 10 s and 800 μl of supernatant was mixed with 100 μl of 1 mM hexamethylenediamine after centrifugation (16,000 g, 15 min, 4°C). 10 μl of the clear supernatant was then transferred to a fresh 2 ml tube and polyamines were extracted with 200 μl of cyclohexane for dansilation of free polyamines. To extract complexed polyamines, the pellet was resuspended in 1600 μl of 1 M NaOH and 200 μl of 1 mM hexamethylenediamine and centrifuged as above. The clear supernatant (200 μl) was transferred to a 2 ml glass ampoule containing 12 M HCl, mixed, and incubated overnight at 110° C. for 16 h to hydrolyze complexed polyamines. Dansylation of free and complexed polyamines was performed with dansyl chloride as described by Flores and Galston (1982).
[0197] Dansylated polyamines were measured by LC-MS / MS. All experiments were performed by a 3200 QTRAP™ mass spectrometer (Sciex, Darmstadt, Germany) coupled to an HPLC Agilent 1200 system (Waldbronn, Germany). The mass spectrometer was equipped with an electrospray ionization source. Samples were separated by a reversed-phase Synergi Fusion (Phenomenex, Aschaffenburg, Germany) with a pore size of 80 Å, particle size of 4 μm, and dimensions of 50 mm×2.0 mm inner diameter with a corresponding guard column at a flow rate of 800 μl / min. The column oven was heated to 30° C. For elution, solvent A contained 94.9% (v / v) water, 5% (v / v) acetonitrile, 0.1% (v / v) formic acid, and solvent B contained 94.9% (v / v) acetonitrile, 5% (v / v) water, 0.1% (v / v) formic acid. The following elution profile was used: 1 min, hold at 60% solvent A / 40% solvent B; 3 min, linearly increase to 100% solvent B, hold at 100% solvent B for 3 min; rapidly linearly decrease to 60% solvent A / 40% solvent B in 0.1 min; hold for 1 min. Total run time was 8 min and sample volume injected in each run was 10 μl.
[0198] The mass spectrometer was set to unit resolution in Q1 and Q3. All measurements were acquired in multiple reaction monitoring mode. For compound optimization, standards were prepared according to the dansylation protocol, diluted with 50:50 (v / v) methanol / water, and injected at a flow rate of 10 μl / min using a syringe pump directly connected to the ion source. The declustering potential, collision energy, collision cell entrance potential, collision cell exit potential, and entrance potential of all compounds were optimized using automatic compound optimization (Table 3). The ion source parameters were set as follows: capillary voltage = 5.5 kV, heater gas temperature = 500 °C, curtain gas = 30 psi, nebulizing gas = 70 psi, drying gas = 70 psi, and collision gas = medium. For each analyte, one transition was used for quantification and another transition was used as a qualifier. Acquired data was processed using Analyst v1.6 (Sciex). Mass calibration of the 3200 QTRAP was performed using polypropylene glycol standards (Standards Chemical Kit with Low / High Concentration PPGs, Sciex) according to the manufacturer's instructions.
[0199] Table 3. Compound parameters for polyamine quantification. DP = declustering potential, CE = collision energy, CEP = collision cell entrance potential, CXP = collision cell exit potential, EP = entrance potential. TIFF2024156794000004.tif20376
[0200] Example 6: Statistical Analysis Differences between genotypes were determined by one-way analysis of variance (ANOVA) followed by post-hoc Bonferroni test using Excel software (Microsoft, Redmond, Washington, USA). Two-tailed t-tests were applied. A p-value <0.05 was considered statistically significant.
[0201] Example 7: Biochemical and morphological differences among four cultivars during leaf maturation Senescence progression in Burley 21 NA, HI, LI, and LA lines was monitored by measuring the loss of chlorophyll a and b in leaves. Chlorophyll levels were significantly decreased (p<0.01) in all genotypes at 1 week after topping (WPT) (Fig. 1A). However, leaves of LI and LA plants contained significantly (p<0.001) higher levels of chlorophyll than NA controls at 2.5 WPT (22% more for both genotypes) and at harvest (36% and 44% more for LI and LA leaves, respectively), indicating slower chlorophyll degradation compared to NA controls. Chlorophyll loss correlated with morphological changes in the leaves of NA plants; i.e., NA leaves were wrinkled, leathery, and yellow-speckled; in contrast, LA leaves remained smooth, shiny, and green (Fig. 1B).
[0202] Given the different leaf morphology of LA and NA lines, the size and shape of mesophyll cells were examined at different time points. Before anthesis, mesophyll cells were smaller and more abundant (more cells per unit leaf area) in leaf 15 (numbered from the base) of LA plants compared to NA plants (Fig. 1C / D). From that time point until harvest, the number of leaf mesophyll cells per unit area decreased at approximately the same rate in both NA and LA lines, but the number of mesophyll cells in LA plants remained significantly (p<0.05) higher throughout maturation. The greatest difference in mesophyll cell number per unit area (54% more cells in LA plants compared to NA controls) was observed at the early leaf development stage (before anthesis). LI plants also contained more mesophyll cells than NA plants, but not to the extent observed in LA plants, and there was no significant difference in mesophyll cell number between HI and NA lines (data not shown).
[0203] Example 8: LA plants accumulate higher levels of polyamines than NA plants To investigate the effect of the nic1nic2 double mutation on polyamine biosynthesis, the levels of free and conjugated putrescine, spermidine, and spermine in NA and LA plants were compared by liquid chromatography tandem mass spectrometry (LC-MS / MS). First, the polyamine content in leaves 16–18 of field-grown plants was analyzed. At 1 WPT, the total polyamine content was significantly higher in LA plants compared to NA plants (1.9-fold, p < 0.001) (Figure 2A). Compositional analysis revealed that leaves of LA plants had significantly higher levels of free putrescine (1.4-fold, p<0.05), conjugated putrescine (2.3-fold, p<0.005), and conjugated spermidine (1.9-fold, p<0.005). This indicates that these materials accumulate because the polyamine biosynthetic pathway is strongly induced by the nic1nic2 double mutant or because the substrate cannot be further processed to nicotine. In contrast, free spermidine levels in LA plants were less than in NA plants, but this difference was not statistically significant (p>0.05).
[0204] To minimize the effects of variable environmental factors on polyamine biosynthesis, further experiments were performed under controlled greenhouse conditions mimicking standard field conditions in terms of temperature, light, and humidity (data not shown). The phenotypes of NA and LA plants in the greenhouse at harvest (30 days after topping) were similar to their field-grown counterparts in terms of plant height, number of leaves, and leaf morphology (data not shown). The effect of wounding on polyamine biosynthesis was minimized by designing the experiment such that each leaf / root sample was collected only once per plant and per time point. Time course monitoring of total polyamine content in leaves at the same developmental stages, i.e., leaf 12 before flowering, leaf 19 at topping, and leaf 24 at harvest, revealed significantly (p<0.05) higher levels of polyamines before flowering (1.5-fold) and at harvest (2.1-fold) in LA plants compared to NA controls (Figure 2B). LA plants also accumulated significantly (p<0.05) higher levels of total polyamines in roots at topping (2.4-fold) and harvest (1.4-fold) compared to NA controls (Figure 2B).
[0205] Example 9: Effect of the nic1nic2 double mutation on polyamine biosynthesis Comparative analysis of polyamine composition in selected leaves of the four cultivars (leaves 6 before anthesis, young leaves 23 at topping, and mature leaves 23 at harvest) revealed that before anthesis, lines LI and LA contained significantly (p<0.05) higher levels of free putrescine (1.6-fold and 4.2-fold, respectively) and even higher levels of conjugated putrescine (2.1-fold and 5-fold, respectively) than the NA control (Figure 3A). The conjugated putrescine and spermidine fractions increased continuously during maturation in all four cultivars, but remained significantly higher in LI and LA plants compared to the NA control (Figure 3A). The largest difference in polyamine content was observed in LA leaves at harvest, which showed a 2.1-fold increase in total polyamine levels, including a 1.8-fold increase in free putrescine, a 2.9-fold increase in conjugated putrescine, and a 2.9-fold increase in conjugated spermidine compared to the NA control. However, there were no significant differences between the NA and HI cultivars. This indicates that the effect of the nic2 single mutation on polyamine accumulation was small.
[0206] At the time of topping, roots of LA plants contained significantly (p < 0.05) higher levels of free putrescine, conjugated putrescine, and conjugated spermidine than did NA plants (2.6-, 2.9-, and 2.5-fold increases, respectively), and such differences were also observed at harvest (1.6-, 1.4-, and 2.5-fold increases, respectively) (Figure 3B).
[0207] Example 10: The polyamine biosynthetic pathway is more active in LA plants The relative contribution of ADC and ODC to putrescine biosynthesis was assessed by measuring the activity of each enzyme in the leaves (leaf 23) and roots of NA and LA plants at topping and harvesting. ADC and ODC activities changed in an organ-specific and developmental stage-specific manner in both lines (Fig. 4). ADC activity was high in leaves but minimal in roots of both lines, whereas ODC activity was high in young leaves and roots. This indicates that ODC is mainly responsible for putrescine biosynthesis in roots. ADC activity was significantly higher (1.4-fold, p<0.05) in leaves of LA plants compared to NA controls at topping and harvesting (Fig. 4A). Similarly, ODC activity was significantly (p<0.05) higher in roots at topping (1.8-fold) and harvesting (1.7-fold), and in young leaves at topping (1.5-fold) of LA plants compared to NA controls (Fig. 4B).
[0208] Example 11: Inhibition of polyamine biosynthesis in LA cultivars Assuming that there is a correlation between high polyamine levels and undesirable leaf morphology in LA varieties, the effect of treating plants with chemicals that inhibit ADC and ODC was evaluated. Preliminary experiments determined the appropriate inhibitor concentration, application time, treatment intensity, and duration (data not shown). Free and conjugated putrescine levels were significantly higher in LA plants than in NA controls before flowering and at harvest (Figure 3). Therefore, the ADC inhibitor D-arginine and the ODC inhibitor difluoromethylornithine (DFMO) were applied 2.5 weeks before top pinching and treatments continued until harvest. In addition, the plant growth regulator Ethephon® was used alone or in combination with DFMO to accelerate ripening via ethylene release. To avoid early induction of senescence, Ethephon® was applied from top pinching until harvest.
[0209] DFMO and DFMO / Ethephon® treatments partially improved the morphological phenotype of LA plants such that the leaves acquired some of the characteristics of NA leaves (wrinkling, chlorophyll degradation). In contrast, treatment with Ethephon® alone reduced chlorophyll content but did not affect leaf morphology (Figure 5). DFMO treatments initiated before flowering caused growth arrest, which was not observed when treatments were initiated at the time of topping (data not shown). D-arginine treatment did not affect chlorophyll levels or morphology of LA plants.
[0210] Analysis of polyamine levels revealed that DFMO treatment 2.5 weeks prior to topping increased total polyamine levels in LA leaves by 2.1-fold, reflecting mainly high levels of conjugated putrescine and conjugated spermidine (Figure 6A). This high proportion of conjugated polyamines persisted until harvest in DFMO- and DFMO / Ethephon®-treated plants. In contrast, treatment with Ethephon® alone significantly reduced total polyamine levels at harvest, reflecting mainly a reduction in free and conjugated putrescine. In roots, DFMO treatment significantly reduced (p<0.05) the total polyamine content of LA plants at topping (1.5-fold) and harvest (1.4-fold), mainly due to a reduction in free and conjugated putrescine as well as conjugated spermidine (Figure 6B). This reduction was not reversed by the addition of Ethephon®. In contrast to the effect in leaves, application of Ethephon® alone did not affect the polyamine content in roots. D-arginine treatment did not affect the polyamine content of LA plants. Thus, the decrease in polyamines in roots may reflect inhibition of ODC activity, the main enzyme responsible for putrescine biosynthesis in roots.
[0211] Example 12: Altering polyamine levels through genetic manipulation Modified tobacco plants are generated to suppress ODC activity in a nic1nic2 mutant background. A pinching-responsive promoter (e.g., SEQ ID NO:1-21) is used to drive an ODC RNAi cassette (e.g., SEQ ID NO:22) to suppress one or more ODC genes (e.g., coding or protein sequences shown in SEQ ID NO:23-34). Transgenic plants are generated and evaluated for leaf phenotype including, for example, total leaf polyamine levels, total root polyamine levels, total leaf chlorophyll levels, mesophyll cell number per unit leaf area, leaf epidermal cell size, and dry leaf grade.
[0212] Modified tobacco plants are also generated to modulate the expression and activity of the MYB8 gene in the nic1nic2 mutant burley background. MYB8 was reported to control inducible phenolamide levels by activating three hydroxycinnamoyl-coenzyme A:polyamine transferases in Nicotiana attenuata. See Onkokesung et al., Plant Physiology 158 (1) 389-407 (2012). Constitutive or pinching-responsive promoters (e.g., SED ID NO:1-21) are used to drive the MYB8 RNAi cassette or MYB8 cDNA sequence to repress or overexpress, respectively. Transgenic plants are generated and evaluated for leaf phenotypes, including, for example, total leaf polyamine levels, total root polyamine levels, total leaf chlorophyll levels, mesophyll cell number per unit leaf area, leaf epidermal cell size, and dry leaf grade.
[0213] Example 13: Breeding populations The low alkaloid tobacco hybrid, variety, or strain may be produced as a Burley, Dark, Flue-cured, Maryland, or Oriental tobacco, or may be selected from the group consisting of BU64, CC101, CC200, CC27, CC301, CC400, CC500, CC600, CC700, CC800, CC900, Cocker 176, Cocker 319, Cocker 371 Gold, Cocker 48, CU263, DF911, Galpao tobacco, GL26H, GL350, GL600, GL737, GL939, GL973, HB04, HB50, HB60, HB70, HB80, HB90, HB100, HB110, HB120, HB130, HB140, HB150, HB160, HB170, HB180, HB190, HB200, HB210, HB220, HB230, HB240, HB250, HB260, HB270, HB301, HB400, HB500, HB301, HB400, HB500, HB600, HB600, HB700, HB800, HB900, HB100, HB110, HB120, HB250, HB260, HB270, HB301, HB400, HB500, HB600, HB600, HB700, HB800, HB900, HB100, HB100, HB110, HB120, HB130, HB140, HB150, P, K149, K326, K346, K358, K394, K399, K730, KDH959, KT200, KT204LC, KY10, KY14, KY160, KY17, KY171, KY907, KY907LC, KTY14xL8LC, Little Crittenden, McNair 373, McNair 944, msKY14xL8, Narrow Leaf Madore, NC100, NC102, NC2000, NC291, NC297, NC299, NC3, NC4, NC5, NC6, NC7, NC606, NC71, NC72, NC810, NCBH12 9, NC2002, Neil Smith Madore, OXFORD207, "Perique" Tobacco, PVH03, PVH09, PVH19, PVH50, PVH51, R610, R630, R7-11, R7-12, RG17, RG81, RGH51, RGH4, RGH51, RS1410, Speight 168, Speight 172, Speight 179, Speight 210, Speight 220, Speight 225, Speight 227, Speight 234, Speight G-28, Speight G-70, Speight H-6, Speight H20, Speight NF3, TI1406, TI1 269, TN86, TN86LC, TN90, TN97, TN97LC, TND94, TND950, TR (Tom Rosson) Madore, VA309 or VA359, Maryland 609, HB3307PLC, HB4488PLC, KT206LC, KT209LC, KT210LC, KT212LC, R610LC, PVH2310, NC196, KTD14LC, KTD6LC, KTD8LC, PD7302LC, PD7305LC, PD7309LC, PD7318LC, PD7319LC, PD7312LC, Shirley LC,Or it can be derived essentially from any commercial tobacco variety by standard tobacco breeding techniques known in the art.
[0214] Sequence information SEQUENCE LISTING <110> ALTRIA CLIENT SERVICES LLC <120> COMPOSITIONS AND METHODS FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING ALTERED ALKALOID LEVELS WITH DESIRABLE LEAF QUALITY <150> US 62 / 638,928 <151> 2018-03-05 <160> 36 <170> PatentIn version 3.5 <210> 1 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 1 cttttaccta aacttaaata ttggccttat gcacgggcat caactcgcgt attactaaga 60 agaaagaaga acggctcctc gtctcccatg tcggcctctg gaactcttaa tataaccgcc 120 gacagacaaa accggctggt ctctcactgt ttcttatcct cagaattatt atgaacataa 180 actaaagtac ctatctcttg ttttctcatt tcacaccatt tttttcttca cttcacactt 240 ggtctcaatc aaataaaaaa cagcaaccgc cttagcttgt tgtcttcttc actactccac 300 ttgtccctag agttccccaa aaatcaag ctaagaaaaa gttaactaaa gagagaata 360 tatgggagct gaggttctt tcataagctg accgactctt tattttggcgg cgcttatttt 420 attack tcaaagaaa agttctttt gttttcctttt ttataattt tcaactccca 480 acttgtgtgt gttgtctaaa tgtctatata taaatatgta tataacggtt tgtttaagaa 540 acttgcattg gtactggttt gttcttgtca accttcttga ctagtatata tattgtaaac 600 ttttgtgtct ctgtattgga gatttttgtt tgagttctct tttgaatat tgcatgtgta 660 ttcacaggt ggcgaatttca agagacaaaa tattcacag gagagacat gagataggg 720 atagagatga tattatat gtgttggaat cgatgttttc gggtaatatt atagggaac 780 aggagatgtc tgtaatggtt tctgcactaa aacatgttgt tgctggtgaa gatagattga 840 atcaccaaat cttgactgat gaaaatggtg cagctgagaa taatctttggt tcaggttttt 900 cttcagtttc ttggggtt ggtgagaaaa gaggacgtga acaacggcaa agtagtcagc 960 aattcttaca tattggagt tctgatga gatcatcagg tattttatt ttactttact 1020 tttttttg aaaaaaatga caccgccgta aaaataataa ccgaaaaag tgtataaaat 1080 ttgtataattt tttgcgttat atatatacat tctgtatgtt atatacaaaa atatacaaa 1140 tagttaacaa atttgtatat aaaaattata caattttat acattttcg gctaccacat 1200 aataatagtt tctggcgccg gctaaaagtg ataatacccc ttttcctt aaagttttgg 1260 atttctttt agtttatgtt gtgttttcag tgggttattt gaaaactaa ttaactagtg 1320 gccaatgtag cattatacgg attcaattga atccatagct ttcgaggcat aaaataaatt 1380 tatgtgtaaa atttcattaa agttataaga tagtagaa tttgaaccca tataacagat 1440 atgaacccat aactttaaaa atacaatg ttcaatgcta gatctttaa tgttcaaccc 1500 acaaaattta aattttggat ccgcctctga ttattaaag tatattttct ctaacggttt 1560 attackwindow gatacat window attackg gggttagt gggtatagt 1620 tccggggctga agcttaata tttagatgaa acagacac aattcaatag ttgatgtg 1680 ttgcaggaat cattattgct aataacagc taaatgtaga tgagataaa tggattaaaa 1740 gatttggttg atcttctatg tgagttgtat tcattctgca ttttatttag aagtaaattg 1800 ctgcagatgc ctttgttttt agttttgatt cttgccattt tctccattaa aaaaatgcac 1860 ttgaaacata caatataaat caagtgtgtg acttttcact atattgattt ttagtacatt 1920 attaatgaaa gatacaatta ggtggatgtg tacgtgcttc attatcacat tttcattatt 1980 ttgaatagca gattttacac a 2001 <210> 2 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 2 ttgtttatgt tgtatgtatt ggtttagtga gttatgatat aatgttttca ttgaaagtgt 60 gacatgatac gagtattttc aaatggacgt gagttagcat ttcagatttt cacttcattt 120 gtcctattta tattaaaccc acaaaatgaa aatacccgta tttatgttta tacactttca 180 taaatttcaa gaatttagac aaaaagattt agctttaaaa ttttgatatg gtaattttgt 240 acgctatttt aaaactatta tgttaatatt tatcctcttt tttaaatttc acaaaaataa 300 atacataaaa tatttatttg taatttttgt ttttctttta ataattacat tttaaaatac 360 ttagttatgg atatacctca tagggggtat aattaagtgt atgattttta tatataggg 420 ggtgtcagtg tttgatctta aaatacaaaa gggtgtatcc gaaactgaat cgtattatat 480 gggtgtttag tataattaac actattatat ataagtaata ttgatattta aatctccgca 540 cttaattaaa tactgtctcg taaattaac gtctatgtgt actgacaata atgtaatatt 600 ttttaacct tgttataata ggtaatttgt attatttttg aattgatatc tctttttaa 660 tgaaaggtta catataatta tcatttagat gataagagcg tgcataaatt cattaacaat 720 atctaacata tagagggatg aagtagtact attaattttc taaaaaatga gaagcaaaaa 780 aggaatattc ttctatgtcg gcctctagct tagctaagaa ctcaacgccg actgacaaac 840 aactcctaaa gcggctctaa ttttttctct ctaaaatatt cttatccaca tataatagat 900 ctcccttcac acttactaat actgctgtcc tttattctct tcacattttg tccaaaagaa 960 ataatgacaa gtcaacaata aaaaacaatg ttttcatcaa caagattaat ctctccttct 1020 tacacgcaag caaagatgga tctagaattt gcggagatac atgaacaaac tgttcaacta 1080 gtgccaccca ggggcgaatt tataggtaaa tatatggggc acttgaacct attatttttc 1140 catcaaacta agtatttt gtatatattt tttagaattg gtctagtatt atctgctgac 1200 actcatgctc caaaaggct aaatgtgca cttggttgaa tattgatta tttacctaaa 1260 ggactacgaa tcgaatctca cttaatactt ttttctct ccttttttaa tagtgcactc 1320 atattataa aatcctatat ccgcctatga tgtcaccatc aaacttttga tttaacggt 1380 tatataaa tattatcatc gttttaata tatatagaca atattttaa aaaaattgc 1440 cgatgtgtga cctctatctc ctagcatagg tccgccaact tggagag atacaaatt 1500 aaggaagctc atgagctgac tagccgactc tattcttg tctttat tttacaaaaa 1560 agtttgactt tactttttg ttttttgtt ttaagtaat ttcaactcc caacttaggt 1620 tagtctaagt ctctatatat ataacggttg gttcaagaaa gcctaaaaa gaggggtta 1680 gctggttggt atattagtt tgttcatctt gtcaacttc ttgaaagca aaagtttta 1740 atattttgtt ttcctcttt tgaatcttga agttgattc aaacttctca tttatagaa 1800 tactctgtta agacttttta gttagtatag tatactagct atatactaga ttaacttttt 1860 ttttttatt tataaagtcc cttaatttag tgaagttttg ttacatgtgt atactcaagg 1920 tggcaaattt tagaaacaaa gccatttata agccaataag agatgatgtg atgttttctg 1980 ggattaatag agaagaggag a 2001 <210> 3 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 3 aggagcgttc aaagtttaga tgatttatta tggtatatgt gcatttttca ccacttgttg 60 ccaatataat actacatttt cctctcgaga cgacaaagaa tgataatgaa gatacctttt 120 cttgctgaag atttgtcag tatactgcaa ctgattttag caactttgct cttcatatta 180 taagtcaatt atatactgtc gaatctttct attgtttaat cagtcgcccc tcatgcatgt 240 aaattaaagt ataatatata taaagtataa cttgaatgtg gatttttccc ccacatatat 300 aataaaacaa tgaaaggaaa agatctatat atgtgtcttt gatttttagt gggccaaaca 360 aaaaaaaag aagcagcaat atgtcagtat tcaggagaaa ttcaaaaata gtcagattta 420 cactgatca ttcaaaata gttcagtttc aaagtaatc aaaatttagc cactttcat 480 gtaagataa aaagagcga aaatattgtt caaacccga aaatacgcc agtatattat 540 actggagttc aagtataagt atgcttgaac tccacatat tattggag ttccaggata 600 agtatgttgg aactccagca taatatgatg gagttccaac ataagtacac tagactcta 660 gcataatata ctggagtttc agcaagtata attgtccagt atatatact ggagttttgga 720 gcacaagtgc tccagtctcc agtatattaa taatggagtc agcaagtat accggtccag 780 cataatatgc tggagttcat acacaggtgc accgaatcc agtatat gctggaccgg 840 tctctgttgc agcaaatag tggctatttt tcattgactt tgtaacact gactatttt 900 gatgaccag tccgaaaact agctataccg tgctatttt acatgaaaaa cggaatacaat 960 actataatat atcatgttgt tatataat tgaaagacg aaactcga aaaaattc 1020 aaatagtca aatcgatcaa gtgtgtacca tattttggaac gtgtaaatag caatctcta 1080 tgtcggtggg gcaccctctc tgttatata cagctccaga taagtacagt ctaaattgaa 1140 gtttcaactt gtgttaaaat atttaatctg atattatctg catgctacat aattattgta 1200 cgagcttgga ctttggggct catgcttttg tccttcgttt cgagaacgca aataagttcg 1260 gtgcactaag ctttcgctgt gcgcgggtcc ggataagggt ggaccacaag agtctattgt 1320 atatagtttt accctacatt tctgcaagag gctgtttcta tggcttgaac cggtgacctc 1380 ctggtcacat gacagcaact tttcagtta ctccaagact cccttttaca aacttcactt 1440 attattacgc aaaaagaaaa gaaaattgtt gtggcttagt tggataggac actttatttg 1500 acgcaattct tgaaatggta aaatacactt aaaaatcaag catttttat attctctgaa 1560 tcaggtcaac tattcagaag tgtttccaag ttgtcataca aatacttttt ccccccaagt 1620 tgcagaggtc ataacttaac ttacttgacg tcaaaaattt catttaaggt gttcaaactt 1680 aaaataagta aaaaaaatct ccgataaagg gtgtttaata tatcttatat atcattaaaa 1740 tttatatattt tacctatata tataataa ttttcagaca aagggtggtc agttgaccaa 1800 acttagggct atgtaccttc gcccatcatg actatatata tatatata tatatata 1860 tatattgtta gtagcccttc aaagttgcat aattattaga gagaatacac atttaaatat 1920 tgaccaaact tgtctataaa tttggatatt tttgctactt taattttctg aagcaaataa 1980 gaaagaagat catttgagaa a 2001 <210> 4 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 4 tgtcgcagga gcttatccac caccttttgt atgatatttt cttttagttg gttatttgat 60 ttgtccttt ctctatccaa tcgaacaatt ataagaaatg caccaatatt acttttatct 120 atcccaattt atgtgatatt tttattttct gagattcaaa ttttttaatt ttgattatat 180 acttagacat aaaatctttt aacttttccg aaataaaaaat tacatatttg aaaattacgt 240 aaaaagtact ataactcaca aaaaatatta attttaaact atttaaaaaat atatataaaaa 300 agattacagt caaataataa ctcgtttgac tctcaagata cggataccgt cacataaatg 360 ggacgaaggt ggtatattga gtgtcctttc ataaacatag tactagtatt ttttgggaag 420 ctccatgaaa atgatatttt ttaattttta ttagtttat ttaattttt attttatcca 480 taatgatatt tttataatga cataaatatt ttcgaactta gtaactgttg ctcaaagttt 540 gcatatttat taaaattcaa taagcaagtg caaaacgttt attgcaaact caaaaaatta 600 660 tatattttaa attaattttt aatatgtacc cgtgggagtt gggtcggagg aagtataatg 720 gagacagaac cagctaagat aatcaataat tatactaaaa ggaatttagt actttctttt 780 tggtgttctc tctgtttcag tttatgtgaa cctattcttt tttagtccgt taaaaaaaat 840 gatctttttc taaatttagt aataatttag cctaaactta taattctacc cttaatgaga 900 aacttttata accatacaaa tattctgagt cttcttttta acttgtttag tataccaaat 960 ttcaaaaatc tttatttttt ttttaaattt tatgctcaat caaatatgtt cacgtaaatt 1020 agaacggatg aattatcacg taactaatct aagtaatcac agttgtctta catcaagctg 1080 gtcataggta aggggaaaca ctaattccaa gaagtcgtaa cgtgacctaa attaaaactg 1140 ccaccctttg gacaaaaaca aagggaaccc attttgcccc attgtgacaa ccaaatgaca 1200 ccaatggca tatattgtga catacaccac ccaatcacca aatccaacta ataaatgtct 1260 tactttttgc atctaggtt gtacctaac taaataat gataaaatt tgtgaagat 1320 taggattca attatataat agctaaatt atagatttct tttttcta tttaaatagc 1380 ttatttggtc acatttctaa aattagctta tttttttta aaaaaattat ttttctcaa 1440 agttatta aaaaaatact tttgagaagc agtttgtatt tgagtaatca atttgaaag 1500 cattttgag tagcaattaa tctttggtca aacttttaa aattattgt aaatatatat 1560 fatherfather father father father attgacaaa agtataat atttgtgtc 1620 gandactgcg aaatagat gggtcacatt caatccaa tctcattagc tttactacg 1680 tgtttggatt actccccaa cttgatggct gattgatcat cgaattttg ccacactatc 1740 acttcttatg gtccaaatac ttccatact ttctataca taaaattctt caaacccctc 1800 gaaaggtca ttcaactt tcacgtgatc tggaactt gcaacttct tgccatct 1860 tgtcacttgc ttgaccact tgcactcacct tattattag tataaaattt ttttactt 1920 ccaatctcaa gatctataaa tagaaagttt tctttcctta gttcttgttt cactatcaaa 1980 tgaagaggca aagaggaaaag a 2001 <210> 5 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 5 ttttataccc atactcgtga tcatattagc gatcccccta atcgtagtga cggccactcc 60 tgcaatttcg gacctttgta cggtacaata gcgaataggg ctcctaaaaa acgtaaacct 120 gtaaatgata aagataacag ctaaaaaaaat gcaaccatcc tttgaaacaa tatttttttt 180 aaaaaaaaaa aaaagttctt gcatgcaaat ttaacttctgt atactaatct ccaatgcgat 240 ttagaactta aaaattacta ttcctaaaca attagaaaaa ctgcatttct taatctaagg 300 atgttttgtg tctgtcctat tgaaacaact ttagactaca gatcgttaaa ttgtaatcaa 360 ccttctttta gtgtaaactg acgcggcttt accctttggt cagttaaata atccttacat 420 ttggtaaatg cttatatta ctcacgcgat taagagtaat gacctcgcaa aggtagagtt 480 caactgcacc tcactttgta ttctttgaaa tagccctcaa acattacgtc aatgaaataa 540 cgatatgatc tcgattttga atttctgagt cccaggttag tatatatata attacattcc 600 tattatcatg gcagatttt aaaaaaag aaaaaagaaaaaaaactg 660 acctagaaat atctccagtc cgctctctag aaatataatg catgaacact agagatagg 720 acattaaga gagtcacatg gttgtttatg gcgagaaata ttgctaaaaa taaaaaaaat 780 atgatattat atgtcacata aagttggata atgtaatgt tggataa aacacttcaa 840 gcccaatcat aggccgactg gtgaatggct gcttaaattt caattgatt tacacctac 900 CAatacaaa atattaact ctttggtatt gttactattt ggcaatcaat catattcata 960 attggcatgt gagttgaagc taattgatga agcgaattt gatgcgtgag tagtctcttt 1020 attgcaccac actaactgtt gagatatttt gctcaactta ttgagaaa aaaaaata 1080 aaaatgaact ctttggacac ttcaatctt tcattgccat ttatcagat aatctgatgt 1140 aactaaaaaa ataataggac cagtacccaa atccagatc ttttcccagc aacaggaaac 1200 ctttatcaa tttagtccc catttagact acctaatca agagatact ctgcattcga 1260 cttaattcac gcacattgtc aagacaa agaccttagc gaagccacc aactctttc 1320 tttactttt tcatattgct ccatcagtttt taatttat cacacagtttt attcggtat 1380 gggatttaaa aaaaacttt taaatcttgt ggtctttaaa gtataaaaga taaaagtttt 1440 gtggagccat atattgtg tgacttaaaatttctaaaaaatatt tatattata 1500 ttattttca atatagaata tataattttt ttggaacgga ctaataaag attgtatta 1560 tatactatat cattgaaac gggaggta gatggttatc cgcacgcatc tttagtagtg 1620 acagttattc gatcttataa taggttggcc tatgcatgct gatgtattgt cttttagtag 1680 ctacatattg agttgaatta ccttttacca tgcctgcgac cccatgcaa caagctta 1740 ggtcctacga ggaatgtcct tctcagcacg ccagatgcac atacatgaac caggcaaaa 1800 aagcaagga atttaacct tttgccatt aattacattt aaactggact agctcattcc 1860 cccagctc cccaccaca gctccttcta taaattcaga aaccaactgc acccccaca 1920 ttcatcataa ctcgatctaa ctttagttat tgagagacaa accattaca gaagcttaat 1980 ccttagagaa attaagagag a 2001 <210> 6 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 6 gaatttggt atttttcgaa aatttgaaaa actccaaaag gttattttc aaaattttcc 60 cttcaaatca ctcacaaaat ttcaaaaaca gctccaattt atattcatat ccaaacacaa 120 ctataatttt caaatactat tttgaaaaat aatttactt ttttccgaaa ttttacaatt 180 tttatgtcca aacacccacg tagttctttc aataaaattt ctaacatgtt atggcaagac 240 atgtaggacg agagttgatg ttttttttc tttgggctt ttcaaatcga gttctgcaat 300 gaattggatt taacaataat agccatctat gactagttat taaaagaatt tgataccaga 360 cagatttaac cagatttgtc atttgtagga atttgggctt ttgtatttat acccgatttt 420 ggggtcacaa ttgaagctat aactacttcg caaaaaaact tgcaaaccta cccactttac 480 aattaacttc aggcttatcg ggtctgaagt taaaaaaaa tagtctgaag tgcaacgcac 540 ttaaggccaa ttaagtctaa agtgtaaaaa ctaaggccaa atatgtctga agtacaacca 600 atggttttat accattaaga ccaatagat gtgaagtgta accaatagtt tcacacactt 660 aaggtcaaa agtctaagt gaaaaatttg cacttcagac ttaggacaa atggtcaga 720 agtgcaacca atagttcat atactttagg ccaataagtc tgaagtgaaa aaattgcact 780 ttagatgcac ttaggccaa ataggtctga agtgcacca acatttcat gtacttaaga 840 ccaaagaggc ctgaagtctt tggacttaag tgcaaattgc ccaaaata aaatttgttc 900 ttcgaatttt tacaattca tacacgattt aacacctaaa tctactccaa atgagaaaaa 960 taaagcttcg aacagctta ccactgtaaa acatcataaa ctaccttaaa atgttcac 1020 aaaacaccat aaaatcac tatatagaa gagagaag atgaggagg aggaggcctg 1080 aagttgttta aactttggat actacttaa aaaaattaa aagtggtat aggttaatg 1140 aggaggacca atagggcac tccgtaaaat ttttacatag taattaccgg tcaagaagt 1200 taagtaagag ggatgccaca ctctattgag attaccccaa taatcaccg aactccactg 1260 cttcatcaaa ctacagaaca tggttctt ctctctct ccctccctcc ctccctccct 1320 ctccaactct atctccctca atacgcacaa gcagtacttt ttcattttac tttatattg 1380 tgaggggaa ccttgaaca attataaact tattctatg tgacatgtca cggattcgag 1440 ctgtggaatc agccactaag actagcatta gggtagactt tctacac actccttagg 1500 gtgcggccat tatcgcacct gcatgagccc ggaatatctt gggcgccgag cttccctttt 1560 ttatatttgt ctgtattttt gataaaaag aaaaaggt aggagtgtt taggaattt 1620 atttcttatg gataatgtat aaaatcctcc ccggcctatt accatattac cactacaca 1680 ctttttttt ccggaatttc tattacccca tgaactattt taaagtataa taacaccac 1740 cctaagtgat gatgtggcat agagagtatg cacactctct taagggcag tggagttac 1800 aaaaatatt ttaaaattga ttacatgta caagtgtcat cttttgattg gacattacac 1860 aattaattat atctaattta ttagtctcct tcgtctcta aatctctct tgcacgaaca 1920 agggacacat cgtttcagcg gcgaaatgcc tgagcgaaaa tccaatacaa cgcaatcaa 1980 CCGAATc AAAAGCATT A 2001 <210> 7 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 7 gttttagaga gtactttggc aagaaaaaca agtgtgagag atcacccaaa acatcatatt 60 ttcttcttct ctttattttt ctggcaattt tgatcatgaa tattttcata gtttatttac 120 ccattgtcat gagtagctaa atcctttgtc tagggttttg atggaaccta ttgaagaatg 180 aacttcttga ttatgttaat atagtttgcc agtttaatct ctatttgttc aactacgtgt 240 ttgttgtagt tatttgacag gatcctcaat tagctgtgcc tatttggtat gcatactcg 300 ggagagagtg catatttagg taattgttga acaacatcac tcccaaagta taagagggat 360 ctataactgc gggtttaaag gcggaattag ggataacgaa gtcttgggtg caatctaaag 420 tgaactgtaa taaacaaagc caggtagcgt atctcgggag agtgcgtcta gtaaattatc 480 gtgattactc gggagagatt cacggtaaaa atagtgttca tggttgatag agatgtgttg 540 gtaaatctat atgaaacata aacagaaggg attccatcaa tatgggaaat cactacctta 600 gaacctttc attattgttc acaacttaag catatttagt ttacaactat ttattgactt 660 tcaatcttag ttattaata taccatcgac tgttattcac aacattggg gaagttgatt 720 ctaaagaattt tagtaagtcc aacgaaagta attgataggt taattctctg tggattcgac 780 tctcgacata atattcaga ttatattgc aacgtgtgca ttgtcctttt ataaggtata 840 gttgggcatg atcactaata cttacattat ttttctaat acttgccaaa tgacccaac 900 aaatttcag tctaaatggc cggctagtcg taatagttta acgtatttta aacgtgcgaa 960 aggggcttct tgactttatc atttatggt ttcagccggt agatggggac aacctacaaa 1020 ttatgtggcc aaggggacaa cccaatgtg aaaaactaat tattattcg ttcattcaa 1080 tttatgtgtc ttattttatt caatttttt tatcttttta atagtagta aatttttaat 1140 accaatgttt gtattttact cttaatgaca cccgttataa ggaatcatat ggcaatat 1200 atatatat atatattgac tgagagta cttttatag cttatacaca cctttaattt 1260 aaggtaaca atattaaaat tcattttaca tttagtcca tttaagctat accaccttt 1320 cattttaaggt atattaaaa ttctttttac attttagtcc agttaatcta gaacatatca 1380 gatgaaactg atcagagagt aacgatttaa attttctctg aagcagcttc agtcatatga 1440 ggcgcaatat caaatttctc ctttttggct aacgaaataa aaataaatgc gttagaagtc 1500 tctggtccga atagtagttg ttcgtttaaa acgtttataa atttaaagtt ctactgtagc 1560 cgaacacgtt tgtgtataac tatatatata gacaaaatta atagtcagcc accaaatcag 1620 taggttaatc ttctaaaatg aggctattta actaaagcta tagtctatgt acaatttcag 1680 gcaaccctat gctacttcaa caaccttggt ccccttgaag atctcaatat cccaccttat 1740 caccttatct tgttgatgct acaacgtatt gtatttgatt cttttacttt tatcctgagt 1800 agtggattta tcggaaacag tctctctacc atcacaaggt aggagtaagg tgtgtgtaca 1860 ctctaccact cccaaacccc actttgtggg attacattgt ctttgttatt gttgttgttg 1920 tcgtcgtcgt cggcggcttg aagttctcat tatattagca gccttaagtt cttgttcatt 1980 cttgtttctt atactgccag a 2001 <210> 8 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 8 tttaataagc agcggtttat ttccggcga aaagggtaag tcggccccta gcagtgagaa 60 accaaaaga aattgttcct tatattgtgc gcatgtcaac ttttttgct tggcttgtag 120 acgtatacac gtggaattaa tgagagaga tataggagt attatagtag ctaggtacat 180 agtatttagc aaatctttca tggcttgac ttcccacgaa attaaagcag taatcttcat 240 aagctgcata ttatctccat tcttatcacc tttgtacct acccacataa agcccgactg 300 tttggttggt caaggtcga atatctatg caacttggcc atatgctt ctatatatata 360 aaatatgcat ggcctaccat ttaatttgta tagcacaa atgtggcaaa taaaaaccct 420 accagtataa tttctgagct ttcacctaa attaagaag tctatatcat gctcagccta 480 tatatttga ccatcgagag caaagcatg acgatgattc cttgtattta agagtaccgt 540 ggctttattg ttaatgaagt gagtgataat tatcggagat taggtttta attattagca 600 gtagttatat tttatctgtc tatgttatgg tggcaagtt accaaattca ttgctggtt 660 gaagtaatt accgatgttt aatttgatga ataatcgag gtgcacgcta acagtaggtc 720 attagcctcc tataatgctg aaaggatgc cctaaacgta ttctaaattt ctatgtcata 780 accatacgtc aagggttata ctattatact actacagtcc aacactcgag aaaaattagg 840 acattgagtt tttattttt atttttaatt ggcgaatact gttaagttgg ttgcaaatta 900 tatactatct tttcttgtt aaaaaaatac acaatag agacaaattg actaaatgca 960 atcaaccaa acgctatatc aaacagaatc tgctgtattt aagacttatt caagttgag 1020 atctcacat ctcagcctta aaagttgag atgggtaata ttggtttttta ataattata 1080 tgacaaaaaa gaggtaggtt gttattatta taagatgga tggtgattct ccagatatct 1140 tttggcaac ataatttaa ccaaattca acgccttaaa ggattaacta aggctccaaa 1200 tgtgaattgc gtaacgctgc atgtccccaa aaagtgaggt cggcattagc tgaaatatct 1260 tttcaggatt atcccaaag aaataccta gtcaccccg gtacttatac caaatcgagc 1320 aatttaaatc taaaaattt attaaaattt gaaatacat atcacttaat cttaatcaag 1380 tgataaaaat tacacgtca tatattctt gatttgtgg tacactatt aaaaaaaac 1440 tccgcctaaa tgatctaaag tcaaatttga ccccaaaaaa aatctaaact aaagtcaatg 1500 ctccaactca aaccggcgtc ggatacgggg cgtcactggt cagtcctatc aggactcgtg 1560 agacttgtaa ttcttatcca ctaattctca taaattcaat catattacgt tatattttta 1620 gaaaacccat ataaagatga agtagaatta gaatttaata tgttttctat atatagatcc 1680 gaaattagaa aagaagaaag ggcagagatc tgggttcttt tatcattgat cttctgtttt 1740 ccaattgtct taattcagta gctgtcatgc atgcactaga taaaagttat cactaatttt 1800 cagtgggttc cacaagtgca tgtaagtctt aggattttac tactgctact tgtttggtga 1860 cttttatata tattgtttca tagatatcaa gcattgggtg attataacaa caaagatttc 1920 agattcgact aattcaaatt cgtgtcggat aagattatat aaggaattga gaacataaaa 1980 taaggatctt tcattgaaaa a 2001 <210> 9 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 9 tggtatgaaa tttgaattgc attgagtatt cttcgtgttg ctgttgtgtg tttactttga 60 gactatgaga cggtatcccg agagatcccc ctgcatgttt actttgggac tacggatttg 120 tattccggga gatccccgtg cacttttata ttggaactac gggattgcac ccggtagatt 180 cccccaatat tgggtattta tatttgggac tacggatcgg tattctggga gatccccgcg 240 cactatgagt tggactacga gacagcaccc gggagatcca ctggatattt atatttggga 300 ctacatgatg gtatcctggg agatccctgg ttgttatctc tgtgttaagt tgtattcctt 360 ctgtgattat ttggctctgt tatagttgtt gttattttta ctatcctgtg ttacttctta 420 ttgtttgcac ttaattatat tgtcttattc tatattgtta taccttgttt ttcatctaaa 480 ctcagtaggg ccatgacttt cctcgtcact acccgaccga ggttaggctt ggcacttact 540 gagtactgct gtggtgtact catgcccttt ctgcgcatgt ttttcatgt acagatccag 600 gtacttcgac tcagccttac tatccttaag gcgaggcgat tctccagaga cttcaaagta 660 tatcttccga gtccgcaaac cgagaagtcc cttcttattc tcccatatag tattagccct 720 tctgtattta cttttgttta aacattctgg agttagacac ttgtagttat ccaacagctt 780 gtgatttcat tagattccgg gttttgggaa atttgtttc agttcgagag tttgtattgt 840 atatgtcgag cggcatctaa acgcttcatt atgttattc tgtagttttt gactagtttt 900 attctgttat ttctgttc cgtaatttgt taagcttacc tagtcgtaga gattaggtgc 960 tgtcacgata gttcacgaag gacgaactgg ggtcgtgaca agtttactta gattatagga 1020 gtttatggga tatctacagt attttttt tatatacatt ttattgatta atatgataga 1080 cagttcaaga aaaagtta caccgctagt acgtaagaa tttattctta acaaatttaa 1140 tgaacccaag tgtggttga aaaaaaaagt tgtttga aaaaaaacat tgtgtcaag 1200 ttggggttga aaaaaaaaa ttgaccaag ttgaagatga aaagagagga gagttcaaaa 1260 aaaaaaaaaaaaaaaaaaaaaaggg agaattcag ttgagaga actctttaac 1320 cactgtcttc ctctttctct ctcctggtat aaccgacat tctttaagga gttcgaagg 1380 tcgaaagcag atgcatgtaa cttcatcatt ttcagcaatcaa gtgcaattaa cggtgggaac 1440 atatctctct gagtcggccg ctgtattgtt gttttttgg caggcatcaa atctttcttt 1500 tttatttact attaaagaa attaataaa aatacaaagc tgagtatatt taactattct 1560 ttgtacaata tagagattga caccaaactt cgtgcatgat ctattagcag aaagtagcac 1620 gaagattcaa ctattctctt cacggctgtt caagtttgaa ttttcctcct tatattatat 1680 agccgtttgt aagggaattt tttcagtta tctgtaaaaa gaatcagttg tctactttgt 1740 gcatgtgctc caaatcaagt aaaataccat aagggagccc atcaattcag aatatacga 1800 tttgggttgg tcttattttt gtgctacgaa aagtgttcga cgaaattgat tttgtcagag 1860 ttcaaagtcg gtggcttcag attctgcaga aacggtgttg tgttgaagaa aagctgaaaa 1920 gggtatttat aattcaccaa aaaagcatct gggttggtgt tattttgtcg taattttgtc 1980 tagttgaag tgggtcgtac a 2001 <210> 10 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 10 acaacaacaa cattattatt aaaaacaact gcggaggcat gattgttgtt gttgttatta 60 ttgttttacg tatattgtt aaaaaacaac ttcagatgca tgattaatta agctaggatc 120 gcagtaaaat ttcataagtg ggatctggag aggatagtc agcgtacgca aatcttatcc ctacattata ggttatttc ggttatttcc cggctcaaag aaagcgattc 240 300. 300. 300. 300. 300. 300. 300. 300. 300. 300. 300 aatactaata aaagaataga aaaaaaaac aatacggaac aatattacat tttaaaactc agtccatatc aaacaacatc acaaaaatag ataaggacaa tgtgacaaac taatcacccc tgccctacat tttaatattt gcagtgtaca attaacggca tgcgtcacgc ccttagactt 480 ttgtgtgaat ttacaagtat tttattcctc aattatatcc atcaatttat atggttaaca tttatttatt tattttgggt gcaaattcac atggtttact taatggcaca gtttcttgaa ttataaacaa attcatgtta cccctgttcc aatatcgtct gcactaaaac agacaaaaaa aaatgtttac tcgcatatat taggcgcggc ccttccttga atctttacac agatactttg 720 tgtatcagac tgtcttttac ttgcacacgt tattttcgtc aaatcaatga gtgtaatgca 840. tgcgtattca atataaactt tgtactccct tccgtcctat ttagttatac tttggctaaa atatagttgtt ttaaaataat catggtttaa aaaaaaaaca agaaagagtt acttatattt 900 tttgcaattt taccctttct actctaataa atgttcctca aagaagtaaa agagattaag 960 gggagaaatt aaaaatagc cagatttata agtggtcatt ctaaaatagt cacagtttca 1020 aaagtaattg aaatttagtc acttttcatg taaagataaa tttgaacgaa aacattgttc 1080 aaaatccgaa aaaatacttc aatataatat actggaattc cagtataata taccggtcca 1140 gtatatta ctggaacttt ccgtgtgttg gagttctaac ataatatgtt ggaagttcat 1200 acacaggtgc accgatctcc agtacattat gctggaactt ttcgtgttgc agcaaaataa 1260 tgattatttt tcaatgactt tgcaaacgct ggctattttt gaatgactag tccgaaaact 1320 ggctagccgg tgctattttt atgagattga gagatctaag aataaataag ggcaattcaa 1380 tcaaataact catattagta atgttttctt aaagtatgcg tgcaaaaggc taagtaggag 1440 agagtattga ttaatcgtga ttaagtgtat atgctatcac ttaaatttga gactcttaaa 1500 cttgaactta ttaatttaat gtaaacatca ggtgcgagta agtattttca tgttaacaga 1560 cacagtctcc caaacacaaa aaaatggaat gacctgtgac aagctgctag caaaacatag 1620 gccctgctaa caccaaaaga ctgttaaagt taaacttatt aatttaatat aaatatcagg 1680 tacgaataag tattttccta actacagccg tcgactagtc ttcaaattgc tagcaaaaca 1740 taggccctaa taacaccaaa gttcctatat taagtgctat atattgtcac tttattttga 1800 gacggttaaa attaaactta ttaatttaat ataaacatca ggtacgagta agtattttca 1860 taactacagt cgtcgactag tcttcaaatt gctagcaaaa cataggccct aaaaacacca 1920 aaattcctat ctctctgtgt atatatatgt aaagcacata tctaattttg aaataaaaca 1980 ttcatagatt agcttttca a 2001 <210> 11 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 11 taaaaactga gtatgtcaac atgaggatca actggcagat atacttacaa aggattgtg 60 aagagctcaa catgtacatt tgctgaacaa gctagggttg aagaatctgt atcaaccatc 120 agcttgagag ggagtgttaa tcaacatggt taccactagt ttatttataa agtgtaaatg 180 ctaaaccata gctagtgagt tagttaatag ttagttgagt ttgttataaa tattagtcag 240 ctgtacagtt taacatagct tctctttcag aaatgaaaat tgctcttctc tcatttcctc 300 tcttctagat tcttcttc cctccttctc ttagctcaga tctctcttat gacagctaac 360 aataaatacg aatatttctt gtaacggttg ctcattgaat gttgtctttc tcaaccgata 420 tctttctttc aagttttccc cccgattcga gtatttttga aactcactca gcaccggtca 480 catattcgta atcggtgcca gctatttgct tactcatatc ttatttgact tcattgtcac 540 gtgtcagaca gaagtatgtg cgcatatacc atcaagtctc aatttgaaat aaaatcaact 600 tagcagtta aaagtcaaat ctcttttagt tcggtcttta aaataataat ttaaataatg 660 aacctataaa acacgcaact cacactgaat ataggggcag acataaaagc cgaaagactg 720 aattccgaac cggaccgaat tatttcggta tttcgatatc ggtttattca gtatttcggt 780 actatttcgg tataggattt ttagttattc ggtatttcgg tacgatcctc ggtattgaaa 840 tttcgatatt tcggtatacc gaaataccga ataatttaag tacaccttcc ttcactgccc 900 agcccgttat cattttcag cccaagtttc taacttgtta tttctcccc ttagccagta 960 gcctactaag attaagcccca acgccccaac ctaacattag aattattat attagaaaa 1020 gtataaagaa agtactcaca ttctactgct atgctcatgt agtgatttct attagaaatt 1080 attagaagtg aaggtactgc ccacattttc ttgttgctat actcattatc acccattag 1140 aaattttcta atgaattaga attcagtagt tcagcacaga gcggatgta gcgtattacc 1200 tacggggttca actgaaccta taactttcga cacagagtaa aaatttatat gtaaaaattc 1260 tttaaaattg taaaaatcgt agatgaac ccataacttt aaaaataata tgggtaacat 1320 taaaattgaa cccatagaat ttaaatcctg gattcgccctc tggttcagca ttgtttagtt 1380 cacaaaaata tgtacgatg ccgaaccgta tcgaaccac accgaaccaa acaaagat 1440 atcgaacaat accgaactac ttgtacag tattggtat gcacacttga tatatcgaat 1500 accgaaatac cgaaccgtaa ttttcgaata ccgtaccgaa ataccgaaca ctcacccata 1560 actaaacatt aaaagctag aactcaggtg tttaatgact aaacggaagt aagatctaga 1620 taatccgtca ctctgttgat ttgtaaggct atcgacatgc aaaagtggaa gcaaaatgga 1680 gccgaaattt taacaaaaat gctgaaccaa taccatgaaa ttgatgaatg gtgggaccct 1740 atttcactct tttagaattt gcgtaagacc agaaaataac ttcaatcgaa atcaaaataa 1800 ataccaaccc ttttaggccc caaatcacta cgtgtgattt gcaaacgtca ttagccttat 1860 gtaaacagtg acctcatgcc aacatattat cgcagcctat aaatcttagt ttacatttca 1920 ttttctttca aacacacaca cctcacaata gaactaagtt gtaagagttt cattttcttt 1980 gttctttctc acaaaccaaa a 2001 <210> 12 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 12 ttaactacca gaaatcacat aaatacataa aatcaaaagt ctatcacgga atatcaataa 60 aaagagaaac ataaaatgac aataagtaac aatttcaatt tgaaacttat caaataaatc 120 ttacttgtta cttttcaaat gagtgaaaaa atcgaatcat gccagattaa tatatgttaa 180 gacaaaactt aaagtaggaa gattttgaat ttttatagtt taactttaaa tattttgcac 240 caatgcaagc ttaacgcaag atactgctca tactattttc ttttctgttt ttgtaatgaa 300 gaatgattt tcttgcataa agattcttat cttttcgtg catttgacgg gatttttat 360 ttctttttc ttttctgtc aacaagaaat ttatttgtgt tgtttcgtaa cattttttcg 420 atggcttgaa accgaaaaac taaatcgatt aaccgaacc gaacatgaat aaatcgaatt 480 gaaccgaaat tattatggtt cgattttgat tattaaaatc acaaaccaaa aatcgaataa 540 accgaaccta acttctacaa aatcgaacag aaccgaccga cgcttacctg ccatttgtc 600 aggtgagaca aatattaagt agccatcaga agatcattat atatatatat atggaatctc 660 tattgtgact ccacctgtct cattttttaa gtaggatttt tattcaactt ggtagaaaaa 720 gttaaatcgt tactaattga cctatgtgtt catataaaaa attctaatat gtggtcgaaa 780 tttcaaagac cggcgcaagc gtcaagataa attaccaatg gcaataagtt gagtcttgaa 840 atttgcaaac aatcacaact tgtattagct tcgactgaga aaaaaaatgg aagaccaagt 900 gaaactgcta ggagctttc caagtccctt tagttatagg gtaatttggg ctctgaaaca 960 caagggtatc aactatgaat acatagagga agatctttca ataagagcc atgatctttt 1020 gatacac cctatctata agatgatcc tgttcttgta catgctggaa aaccaatagc 1080 agagtccaca gtcatccttg atacatcga agagacatgg cctcagaatc ctttgctacc 1140 aaaggatcct catgaaggg ctcaggctag attctggatc aagttcggag agataggt 1200 aagttaatca tgttagtag tttactttag gtccagtgtt tgccaaggt ttttaaatct 1260 aaatatcaga aggaattta tgtagagtac ttctagctag cattaaata ttttactga 1320 ggattcatat aattggcccc aacttggtag tacatgctag ttattgtca gtgttaaatc 1380 gagtaatta cctcatctaa atttttaagc gctaaatgaa ggatactata ctttattat 1440 ataggtctg cgacacacca tcacttgcag gcttaattca ttttcttga gccaaaaaca 1500 tgaaaatttt gttcatatgt cacaacata taatgagact tgagaactc agctcttata 1560 ttattagaca tggatcaat ttacttagtt attataggcc tgtacaaca agtaacatgt 1620 tatactttt tatatagag cccagaattt ttcgcaat ttcacagat agggaag 1680 caagtcaagg caactgaaaa agcaaaggaa gtgttgaaaa ttatagaaga gcaaggtctt 1740 ggagagaaga agttttttag cggggacaca attggattaa gtgacatagt ctttggatgg 1800 atagcgttat ggctggaagt catacaagaa gctgctgaag taaaggtctt cgactcagtt 1860 agtactttc ctcgtttaca tgcttggata cataacttta agcaactccc tgtaatcaaa 1920 caaaataccc cacatcggga tgcaatgcta gcttatttca aacgtcgtcg agaaatggtt 1980 gtagcagcgg cacaaggttg in 2001 <210> 13 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 13 atcagtccta gcctcgaacg acttcgaaga acgtttgtcag acaatcgagc atagccaaca 60 aaaagccgaa atatccgtga ccaaccgaat attacggctg gaatctcggc atgtatcgat 120 aaggaaccaa caatcagcga atcagaagat ttttacctt tttatagagt tgtaccaaaa 180 ataggactct tctactatat aaagggggtc taatcattca ttgacatat tgtaacacgc 240 actcataagc aatacattat tatttttatc cgtcttttaa gttcttgttc tttttcatcc 300 ataccggtct ttgtgagttc ggttcgagag tgactttc acttaggctg aaactatcca 360 actctgtgg tttaaattta ttggtcttt gtttattca tagaaactta atttattgct 420 ttgtatcaag ttaatccgcg tatccttaaa accacttata aatttaattg ttatccgatt 480 ttgaggtaa acacctatat ctatcattct attgtaatag ttgatagggt attatcha 540 taaaacctcc tagtttaatt tagctgttcc ttctctct ccaatattt cactgttcca 600 ttgcagctgc atcagataac taggagac aatttggatg gtaggcccag agaagatat 660 gatctaagac tagagagaaa ttcaccaga aaatcgtact ccttattaaa attttgtttta 720 aacggtcaa gtagtacttc tcgtcatcct aaatcctagt actatttaat ggcggctttt 780 atgttttctgg aaaaagtag ttgcaggag aaattaattt atggatgctg cgtttaacta 840 tagattggtg ttaacaata tcaaaactca aaaggttag cttcaaacta ataatattt 900 agacattaat tattatcctg taatattaa aatttcatc agatacttt ccaatttgct 960 atattatta ttattcta tatatatgct tttttttttt gagaataga gaatattatta 1020 tttctacga aagatgactt tcgtctctt ccgccaaaat ataggtgaaa atcgaagac 1080 gtccatagca gataaaatag agggcactcc tactgtagt aattgatcac acttaacatg 1140 aaagagctat atgttagtt attcgttcgg acgaactcga taatttttgt ttaacttgta 1200 taggaaaatt father tattaattaca gactcatta cttaaaagaa 1260 gatatagact cattacatta aagagata tagattccaa cacaagttca aaattcataa 1320 acgtcaaatc ttggctaaat ttctgaacat gatgcattc ctttaaaata tagatataa 1380 gttaggatgt tgtcactttc ttaaagcata ttccgactga gtctggtaga atctcataaa 1440 ctttaggcct tatctctca attaggcaat tacttacctc cgcttactt tagaaatt 1500 caatggagta caccattatt aagttcattat aaaaaaaa ttataat tctgtctctt 1560 gttggttcgc tctatcttt tctgttttcc tgctcacc atacatata caagaactac 1620 attttccaag ctagatatat ctacatgac tgacttgta atttctttt gccaagttaa 1680 agaaaaaaaaaaaaaaaaaaaaaaatc caataata aggaagag ccctaatgaa aaaaatgatt 1740 tactattaga gttgttcagc taatcacatc aattatggtt ttcatcagt atgactaatg 1800 gcggctctta tctcacgtga tgtgacattg aaattctttg acttacac taatgtcata 1860 tgctttcaa ttaataatcc gataagtct gctacatgt gactttccaa ttttttctt 1920 ttacaaattg cagactttc aactcttatt ccctattaaa acccatccat actattcctt 1980 gttctcacc aaaacccaaaa 2001 <210> 14 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 14 ttcaaatta ctaagttgct aaaataata cggctaataa gtaccattat ttacatgagt 60 aaatactaaaaaaata gattcatttt atctaaacta tggaaaaact aaaaataga 120 tatccacac tgtttcatt catagtacaa tgaattgaa tgtcttta tttagta 180 ttagtatgga ttgatttg gtttagaatt tatttgagtt actaacattt atgactata 240 aaacttattg gagcatccaa aaattataag ttccaacttg aaataataca ttagagata 300 aaactatga aaacttaag aaatattatt aaactacact acaataata tttttagta 360 gtaaatatat ttaaaacttc tatacttata atgtcgggtt tgtttgattt cggtttgact 420 ttttttagtt agaaccaaat caaaccaaac catagtcggg tttttttctc ggtttggcgc 480 ggatttccgg gttgatgcga tttgtcgatt tcgtttgtac acccctaaat attacaatag 540 attttttaaa ttggcagcat atataagtta atttcttaag ttttgtatcc ctcagtataa 600 agaatttatt acactatcgg gacatctttc ctattatagc agaatttttt tcttgtttca 660 aaattaaaaa tctcacattt taagtaggct tgcccataat tatttgggtg acctaatagt 720 ataagaaatt cttcacattg acgagtattg aacttaaaac tcttttatta taaatttaac 780 cttgatgccg ttccatttac cgactcttca aaccacatga ccagaatcaa ttctggaatc 840 cttcatcact aatcaatatc tgttcgaggg catctcatag tcaaaatgtc gtagcaatat 900 cataaaggaa tgggaaaaaa aaatgaaaat aaatcgcctc tggtcgaagc tcataatgaa 960 aatttcggcc ccgcaaactt tatcaagttc tgctctcagg ggttattttg gtttgaggta 1020 taaaaagatt tgatctcggt ataaatgtc gtatattact tatataatgt ttggtttcta 1080 ttataaaatt cttcccataa ctaatataga tgtctaataa caaatgctaa tttccgaaag 1140 gaatatcggt cggaattcct cggaaattgg ctcgtcggta acgtcgctac cagattttcc 1200 atcgaaaatc cctcctcgat gagccaattt ccaatgggac attcgtcgga aatttacgtt 1260 tttggtagaa cttataacta atactacaca aattttggtt tccacctatc taaagacaaa 1320 aatgccttaa ataaggcagt cttacacaat gcttcaagca ttattctaca acaattcatg 1380 cattattaat attcactctt gtattattat tcccgatcca tgcatgtatt gtaattacgg 1440 catagctaga cgcgcgggaa accaaattaa cgacctctaa acaacaataa caacccagta 1500 gaatctcacc ggtggagttt ggggagggta gagcgtacgc agaccttacc cctatctcgg 1560 aggtatagag agactgtttc cgtgattgac gacgaccttt aaattatttg tttatgaggt 1620 ttgattaact tggacaagat tgtttgtatt catattttag gcttcagttc acttaattaa 1680 actacctata tgagaacatc acatgaagta ctaatactaa gagaaaagac tcaatgtaag 1740 gcggctttta aacaattctc acgtttaact gtctcattca caaaattaga ctgacttgta 1800 ttattcttt tataagttca actttttgcg tattcagaaa gattctttaa tttggccaac 1860 tggctactat agggactctt ttcttccagt tatataatcc ttgtctctca aattcaagat 1920 ttgtaaacca attcgttatc cctttcttca actttaactt ctatatactt gagattttat 1980 ctctatatat agctaaataa a 2001 <210> 15 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 15 actatactat agtgtgatga tccaattggt cattttgag atctaaaatt tctttctct 60 atttgagacc tctcatatgt tcattagtaa tatatgaatt gtgggtatgg tggcacgggt 120 tccgagggat ttgaagcctt atggaacact tgaactagaa cttaaagcct taaattacga 180 gaattgacca aagttaatat tttgagtaaa caaacttaga ttcatgattt gaaagtttca 240 ttaggttcgt atgacaattt tggacttaat tatatgttca aagtaggatc cgaggggtta 300 gggtataatt cgacactatc caaaaaagtt gtaaacttat gagttcataa attggatttg 360 aactttaatt ttgagttgtg atgtttctat atatgttttg aacccttgaa caagttcgta 420 tagaatattt agcaagtt caagtccaa attggactcg actaaattca gacttcttag 480 ctataactaa gtaaattgtg ttctttgcg tggaaaaagt atacacccc atgcaagaca 540 aaagtttgta attcctcggt cttaatttat gtagcagtaa tagattcagc atcgagtata 600 aaaagaaaat aaatttttga aatttatgat ctaagtaag ccatatacgt ttgcgtatt 660 acaaaccatc tcattaagat aaaaaaaa gtttaaagtt aaaatatttt taaaaaaaa 720 atatgtcat tctttttaga tagctatt aaagaaagt atcagata aaatggaaca 780 aaggaatacc agattaatt gatctacttt caattcaag tattaccca gctcacaag 840 aaattttt ttggggggt aagtaattaa ttttggtttt gtttagactt tacccttacc 900 tttgtgagc taaagaggct ggttccaata gaccgtcgat ttaaaaaagc cttttcaaaa 960 gaggttgta aatacagga attaaaaaa gatgaaata ctaaaaaaga aaaaaaaaaaaaaaaaaaaaaaaaaaaagg haing 1020 attattaat agtagtaag aaaaaaaagc aaaaagaagca acataagta taaaatttaa 1080 gagtagatg atgatggtga tgacaatgat atactaata atataata tatgatgat 1140 gatgatgatg atgatgatga tgatgatgat gatgatgatg atgatgatga tgatgatgat 1200 ggggagaaaa gggagaagat aaggtgatct aaactagact atgttcttcc acagaaaaga 1260 gagaaatcac tcgacgacct actaacattc tactctaatc ctcgactttc atgctcttct 1320 atctcgggtc gtgtcctagg tagttgaaa atgtggcatg tctaattacc tctctccaat 1380 tcttcttcgg tctacctcta ctctccttag acctatcatt gccaacctct cgcactaggg 1440 catccatgct cctcctctt acatactaaa agtatcccag tcgcacttct cgcatcttgt 1500 cctccacaga ggtcactccc actctgtcgt gaatatcttt gttcctattc ttatctctcc 1560 tatatgtcc gccatatcac ctgaaattac ttaatttttgt catctgtcac tcaccattta 1620 atttttaaa aggtccaaat ttaccccgat caacttttga gtatagttca gaattacaag 1680 ctagaaaaat aatagtatta aatcaaagtc tacggaggac gaagttgctc aatctcgcat 1740 gccgtatagt ataggggcaa cttcgcccct tctccgaata ttcgaccatt ttttctcata 1800 aaattctatg tctctccatc acaacatcag atttgaactt tctacatttt ttttttcttc 1860 acttgtgaca aaaaatacac tgttttaatt ccatgacgtg cttcactggg tgtgactttg 1920 gctttttaag tctttgtcgg tcatcttctg cttgtctata taagaagcag cctaatggtt 1980 ccttaaacac acaatttcag c 2001 <210> 16 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 16 ttatgtgaca tttttttct ttttatgatg tttaaaaaaa ctagtatctc attaattaat 60 taattatatg tctgaaaata ttaattttt tactttaaac tttctattct atctttagtg 120 ttatgatttt tatatataac catggaaatg ccatgactta tttagtatca cgcgttttaa 180 aaatttttct tttatttttt aaatttcat atattccagt caaatagatt cacataaaaat 240 gagacggatg gggtaaatag taaatcttaa agctagcaaa ctatgttcaa catcatttga 300 tgggtttctt ttttcaggat aatattttat gtgtatttgg tctttttgga ttgtttttt 360 aaaagaaaaa ctccttgaga tgcatggtaa gccaattgat cgtcattgtt attttgaaat 420 aacaagtacc atatcatatg aggccgtgat tatctaaaga cagataagga aattgggcta 480 tcaaaataaa tatgtaagag ttatgttcct catcattaag tatgtgaaac aaaattgtca 540 acttgtacaa cgattctgga atctacttgg cgttttcaaa gctctctgag ccacaacaag 600 ttcttgcaat taagttttat aaatatttc catgtcctca tatttcacta tcttccagat 660 atcccataag actacgtacg acaaacggca ccataaatat taatcataac aggaagacta 720 aactcaattt ctaatttccc tattaccaga aaaattagaa caaataacaa gaagactgtg 780 atactccatg aagaaaacca ttaaaacatt ccgggttctt actagaatgt ggagtaaatat 840 atgctttcct gttttggaaa gtgctaaacc cacaggctaa ggtaagaaaa gtagtcccac 900 atgctagaag cttcataggc cccgactatt ataagctact atacgttgct tgacaaaagt 960 ggaaatgcaa atcgaattct caaacttgca tctcactttc cagcctaggc cacaaaataa 1020 aagacgccat aaattaatta gttcgtggat caagaggtca caatttggac aacagtaaca 1080 aggttccatg tcaatctcct agttaatggt gttcctttgg atttccctat cccttttaat 1140 tagctactcc ctccgtctca aattatctgt cgtgatttct aaagttattg tctaaattta 1200 ttttcatat tagtagttca agactaaatt aattaatttct tttccattt acccttaata 1260 tgatattgtt cttgaagagatg agataatac attaatagga agattatta tatcttaaaa 1320 cataaatag gtaaaatag tccaaacctc ttctcattaa tattttctta attaagtggc 1380 gtgtaaaaaa gaacacgac agataatttg agggagaat atttgtaag aaaaaaacaaca 1440 atttgcttct aacagaccc aaaaggaatg ttagcccaat cctggtaaaa cataaatgtc 1500 agcagacag tgctatgttt aattacaga aattacagt actacttgca atcggacac 1560 gactattaaa aaaaaagg tattactac cagtacattt ctctttcatt aaattcctgt 1620 gtcagactt agttactgcc cctttgagaa ttcttgtcct actactcat cctcacttt 1680 ccgtccaata tattattctg gtcattgtt tattctgaa aagcttggaa ttacatatat 1740 acatcctagt ccatttaatt aagataaat ttcctcattc tccctgacat caatgtgc 1800 taaaagtcgc ccttgtcact cacctagtt cacactcgag ctttggtt ggcattctct 1860 ccattcatt ataatttcaa gccaccacac aacacagagt cacagagcta atatagcat 1920 fatherfather fatherfather fatherfather ctccctgcat atcttccctca gagtcaaatt 1980 aagcttcaag CAAACC A 2001 <210> 17 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 17 cataatgtat tttctcaag attatataa tatgtgtata ctattaaaat acattgtata 60 tgagtaat ccacaagtat atataatct atattacca ttaagatata ctagtatat 120 attcatatat accatcatca ttcatcatgt tttaataat tatacaacat aatgaataat 180 taaatttaat atagtactac gtataagtgt aaaaatagag gtacaatcag ttacttgag 240 gaggagtgga ataagaata attgaagac aaagttgga ttgaatagac gcaaaggaa 300 aggttttagg gtgaggaaaa tttataattg tacagtattc aaaagagga gaagtgagg 360 gttttaggtt acacggaatt aaatagggga gagaaaatta ttgggaact tcaaagttg 420 tggattacca ttattacta atcctatttt atgggattg gtccaacatt atggtttat 480 gctagaaata taacgtagtt aaagctgc catatttgtt actccctccg gtccacaata 540 tgtgatcaat ttacctttg atttttggtcc aaaataagtg ttaaatag cacggtctag 600 ccagttttcg gactggtcat tcaaaatag ccagcgttta ccaagtcaat gaaaaataac 660 cactatttg ctgcaacaga gaccggtcca acataatata ttggatttg gtgcacctgt 720 gtatgaactt ccagataata tactggagca ccggtgctcc aaactccagt atattatgct 780 agaccgatat attatactag aactccagta tattatgctg gagtattttt ccggatttg 840 aacaatattt tcgttaagat atatctttac atgaaagtg gctaaatttc gattaccttt 900 gaaactgtgg ctatttttga atgaccactt gtaaatctgg caatttttga atttctcccc 960 catttatata atcaagaaaa atttgattt tttttaaaa ttatccttat atacgtatcc 1020 ctaaaaagtt ttttactcct cacattaatt tatgctgcaa cattttatta agggtaattt 1080 agtcacacta actatttttg tctagaattt atatttcctt aatgggtgtg cccaaggtaa 1140 attgaccact tatactggac cggagagt aattgcttgc tgctactaga atttagtaaa 1200 attttcttaa atttgccaa attgtttttcacgtgtt atttggacg attchcagtaa 1260 attttgctta actttatatt tgtattaaaa aaattagtaa ctatatataa atattttaat 1320 tatggacccg gtaactaaaa cgaagataca aattccaaga caaattcaga aatcataaac 1380 atcaaatctt gtttgtacct atgaatgcat tccttaaaat atactacaag ttagggtgtt 1440 gtcactttct tgaagcatat tccgactgag tcttgtagaa tctcatgagc gttaggcctt 1500 atcgcttcaa ttaggcaatt acttacctcc tctgtacttt aagaaaattc aatgtagtac 1560 accattatta agttcatttc ataaataaaaa ttaattctgt cacctctata acatataaga 1620 acgtatattt tccaagctag atatatctaa catgaatgac tttgtgaaat tcttttgcca 1680 agttaaagaa aaaaaatggt gtccaaagaa taaaagaaa aggcccctaa taaaaaaata 1740 atttattaat tagagttgtt caaacaatca cgtcaataat ggttttcatc aagaatgact 1800 agtggcggct cttatctcga gcgatgtggc atgattttga ctttaacact aatatcaaat 1860 gctttctata tcaattatcc tatagagtct gctaacaagt aattcaattc tttaatttct 1920 tttacaaatt ccagacttt caagtcttct tccctattaa aacccaccca ctctattcct 1980 tgtttctcac caaaacccaa a 2001 <210> 18 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 18 atgaacgggt cgattttagg gtatttgaca tttaatcctc tcggtctcac ggtaggcatt 60 cggatcgata tttaaggaaa ataaaatata aacaaactaa tatatatata tatatatata 120 tacacgacac cttaaagat tagaagttgg ccaagaaatt taaatgaaca ataacaaaag 180 atttgctttt tgcatctcgt tgtccatgag attttctttg tctgctcacg acatttccac 240 cttaaccatc taaatcaaaa gttaatttgt tcctacaata cgatatcgca atcttattac 300 gccctccatt gcatttatg gaaggtatta ttttttgtgg agttatacta ttttttcttt 360 agttataatt ttcttatttt tttttaaaaa aacattttga atcattagct atgtagtact 420 480 ttcacatcga aaatcaagtg ttttgactat cctactccac accctgtcac ataaattagg 540 aaaaagaaag aaaaaagaa aagaaaagaa ataccttcca atttactgct tccctttaag 600 aacatgaaaa atcttgctaa tagattgcta gtagttgttt tctaataac tcacgtctct 660 atcttgtctg ccaccttgaa atatatgac tgtttctatc tttctttag ataatatag 720 ttgagcaatc atatctaaa actgtttttt tcttcatct taatctaatc attaagtaat 780 caatgtattt ttaccagtg ctttatttt gctttgggta agattgtttc atctatataa 840 cattgttcc tcaccatta ctaccattaa acatgaacaa atgtttcat ggacagtgca 900 ttcttttccc ttataaatca cgtatctatc tattctcca ccttaaatcc atatatatat 960 fatherfather fatherfather fathergttt catggacagt gcattctttt cccttataaa 1020 tcacgtatct atctatttct ccaccttaaa tccatatata tatatatata tatatatata 1080 father father father father father father father tactttttaat 1140 attgtatcct atttaggatc atatttttt cttctcgttt tctgcgttga gtaggtatt 1200 aggtagattg gtttaaagt tgtacctcc tcttactcc tcgtctttaa taacgttaaa 1260 1320 atctcttta ctaccttgaa tatatatat attgttatga agttaacta aaagaacaaa 1380 aaaataga gagaataac aacttttaaaaacataat agtaaacta attcatacat 1440 tgtgagactt gatctcttat gaagtctca aactttacag taaatgaag gaaaactacc 1500 ggttatatcc attattagt attattatta aaaattgt gattcataa attattatta 1560 attacktca attackactatt tgtaaccca aaaaggttaa agttttgctt ttatttgagt 1620 gtgtattatt agaatagatt aagtacatttt taagaagctt gatttcagt ttgggatga 1680 tttggtggag ttttaaggtg gtttgaatta aaaattaaa gtagaagagatg attaaaattt 1740 catggtaag gaacagta acttagcaag accttataca cgtaatgagc windows 1800 cttccatctc caataatgaa atcatgagt ttcgtggatc acgttttata ctagcttttc 1860 atgcagctaa ctagaacata attattatt fatherat aaaaactag atattaatct 1920 atataagac tacagcctct cagcactttc cttcaata cttactttct 1980 Actatattga Agagaatt A 2001 <210> 19 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 19 ataaagtaaa aatgataaag ttgaagaaca attgttgagc acggcaaacg agaaaagcag 60 agtagaatat tctattgaag taaataataa tgtgtttaca aatgattggg gtccccttta 120 tataggaggg aaaaacccta atatggtaca ttcccaacta tggtgaagaa ttctattggt 180 attgttgtat aacaacctag tacggactcg tactattttg tacaaatctt atcccataat 240 tttgccttg atccacgtgt tcttgagaaa ttcccgctct ttcttgagtg tcatcgaaat 300 tgtactgccc ttgaggcaga tcatgacggg tctccgattt tctcctcgag gtgcgcacat 360 cctggccagg gtcgattctt acttcgagct tcccgaactc gagctcgggg tatgatcaag 420 ccttcgaaat cgagctctcc aatttcgacc gtatacaatt ttaagaattg aatatacttt 480 gatctttct tgaaaaagta tttatttatt ttatcttctc gcctagcgca atgaaatcaa 540 tatttattat tttcaaaaac ttacattttt ctttagtttt atttaataa tatttttata 600 ttttttctaa aattatattc ttattaatat aggtacacgc gcagagcgca taccttaata 660 ctagcttgag ggtacgtgtt ttgcatgtgt atcccatatt ctatatctat atctatacta 720 tattaaaaac actaacgctc ttggcgaat gccgttcgct tattttacc ttaaaaaata 780 ttatatattg gatatattat cctttacat attaatcat cttcaggaac ttatattttt 840 attttattat taaataata atttttaata attagtact cattgagata gatatacacgc 900 gcatcgcgcg taccttgagg ctagtagaaa agaaaagtat gatattat gagtaacgtg 960 ttggaaatta agggaaggaa agaaattttt ctttacatcc aaatttgaaa gttatttgac 1020 gtcatcgaga tgacggccat gttcaagtttt tccacaata atgtgaaag aaaagaaga 1080 agacacacac tgtgttttggt ttttattag ttttcttt tagagaattg attgtacaaa 1140 ttattaag attagtata attaagtt taggaatag attattaga aaaaaaaaca 1200 tcaaaagta tttattttaa ttctttttc caatggacat tcccattctt ctgaacaac 1260 Atagataaa attgaaagc aaaaatttac agatcgttta atgcagataa tattatta 1320 cacattaacc ataccaata ttttatta aaaaagcaca actgctagat caaaaagtg 1380 tttaacttca tgcattgaca atttttaaa atattttgc agcatcaggt aaatatttt 1440 ttcttcgttt cccaccctgt gtacggtata cacgggtact tatattgggg cccacctaaa 1500 ttcggattcg tccggagaag tcccattg gggcataaag cgctccctga cgaggcgac 1560 tccataccca tggacttga cccgagacct tggttaagg atgaacgaga cctccggtgc 1620 caggtaaaat attggtaact gcttataata gtttaatatg gtaacctgag ccgaaggtact 1680 atcggaaaca gactttctgc cctatcaggg taggggtag gtctgcatac acagtacct 1740 ctccaaaccc cacttagtga gactttagtg ggtagttgtt gttgttattg ttatgtaac 1800 ctgggaaaca ggataataa ctatctaa caggatata tacattgata ttaccatgtc 1860 aaaaaattta gcaagtacat gatataatcgc cgtgaatct tcagatttc tcctataat 1920 acccttggta gtaaatctag ttttccatt CAAGTACA cattctcct atagtcatgg 1980 aatttgttct cttttcacaa a 2001 <210> 20 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 20 aaatttttgc taaagtactc tctttttatt agttgaaaaa gaaattactc tttctataac 60 atgaaaataa agtactcatt tgttgaaatg aaagaaaata tttttttcta catcatgaaa 120 agatactcgt tatggggaca tggcgaatag gggtgggttg gtggggatat ggggaatagg 180 gggaagattg aaaaagagtt ttgggaaagt ttttttttgt tttgataggg aaaatatttt 240 cctccaattt gagaaaaatg agttcatggg cgtggggtgg aggtgggtag ctggaggtgt 300 ggggtgggtt ggtggggata tgtggaatag gggaagattg gaaaagagtt ttgggaaagt 360 atttttttt gttttgatgg ggaaaacatt ttcctctaat tgatgaaaaa tgagttcact 420 agaaaaatat tttccaaaat atttaatcca accaaacatg ataaattaa aaaaatatta 480 aaaatttt cgttcgtacc aaacacacc acagtggaac tgattaatct gtgtgttacg 540 taatttgtgc cgcttcatgc atttatttcg tgcgacgatt tggaattctt caataaataa 600 ctaatagtga aagatcatat aatactagta atactagctt taaaaaaatg taagtgtcgg 660 gagggtgacg gaaatgacaa ttatgtcata aacacacgtt gttcatactt cacatagggg 720 cgactctaag gctttgggac cataatagta gcagcagtag taatagtagt cgtaatcata gtaacagtag tggtaataat cgtagtggtg atagtggtgg taatggtagt gatggtagtg gtagtaataa tagtagcagt agtgatagta fatheratatag tagtggtggt agtggtagta gtaatagtgg tagtagt tcaccaata gcgtgctact tcaccaata aactacaaca atcgtttaaa ttgatcagga gtaaatactt ttgacaccgt caatactcaa aacttaagct attacgttat atatgtacgc ttattctttt tctcgtttgt gatgatagcc 1080. aaatcaaaat tttcaatttg agttctagac ctcgacattc buy cactttattt tttgtgctct ttttcctaat ttgtttttga aattcgcttt tttgtcttaa atgatttaaa agtaaatttt attgttagtg taaatatttt ataaataaa tttaagagcc tctcaatatg atttcatctt aggccacgaa atccgttgag cacaggggcg gagccacctt atgggatgcg 1380. tgacaccgct tcatcggaa throwing atacatatat agacatatgc aaaaccaaat aatacataaa aacgataag gtgacaacac ttgaataa ataactcatt gtccaactgg ttaagcgttt caacctctta gtatgtcggg agtacgaatc cttttggttgg aacccttatg 1500 tttttattgtt tttgagaca tattatta aaaaagaatt aaaaatatt ctatattagt 1560 aaggacctct aaaaaatta agcaacaa aaagtcactt gaacagaat tcattgtta 1620 gtcaatttga cataaatat actcaatca ttctggaaa agacatatt tggtactagt 1680 atttctaca agattattat agaaataa aactcgttgt aagatttat 1740 agtaatgttt tgaattttat ttttttaat aaatacaatg tcattatagt tattcattg 1800 ttcactctt tgtttaccta ttacaaata tgatacggac tcacgaaaa tttgcgtac 1860 gandactggtt gagctgcccc tgtgttcaca ttggaagaat atatcatgg cacattctt 1920 ctcttaaat tcaggttag catggtcgaa taaagcatcc aaaaaaata tcgcatatcc 1980 aaaaaaaaa in 2001 <210> 21 <211> 2001 <212> DNA <213> Nicotiana sp. <400> 21 agggaaaaaaaaata gagagaat gcaagggttt gctttctctgt accaatatt 60 gaaagaaaaa aaatgttaca accatttcat ttgcaaaaaa aaaaaataaa aaaataaatt 120 gaaattgaaa ttcaaaagta aagctgtttg gttcggaaca gaagtcgatt ttgaaaatcg 180 aaccgacgcg tttacgaaa atgaaaacga ccatcgctag atttcacaa actaaaacaa 240 ttttttccag aaaccttata cccataagca aattcaacac ataaattctc cccaattatt 300 tttaagaaaa tttagaacta ttttttaaga attaaatta aaccaactca actattcaag 360 caacgcatta agtataacgg attcttaaag tctcgttctt aattctcgaa atgtgtcgag 420 aaatcacaac cgttaaatct aatgcctcaa agtaaagaaa atgaataagg agtgtagcaa 480 aaattcaat gtggacaaga tggtcgtata taatttgtac aaagaaaatt caaatgggaa 540 tctcttaccc agtcaaaaca tgcatattct cttggattct aggcaagctt tcccattcca 600 aagtcaatgg aacgaaccaa ttattgctct ctaagtcttt ttctttcact aaagagtaaa 660 ttcaatatct tgacaattag gcactaagta aactgaagaa atagaatccc aatatttttc 720 cttcctcgta acaataacat taagactca tcaatgtgac tcgaccaaag gttcagtagc 780 ttcattttca caaatagggg tgacaatttg aatccaaatc catctagccc gtccaaagat 840 taatggttga gctacaaaca tttaattta tgagttaatt taggctgagc ccaagttaac 900 tcattatttt tttataactc attctgaccc attaaacagc ccaaataataa ctcatgaaac 960 tcacgcaaa caaagaatct cagtccaatt tatctagaaa tttacttaat caccccaatt 1020 tcactttttt ttttgtattt ttaattttct gttcttttat ttttctgcac cacccaccct 1080 acccctatcc cccccaaacc ccctcaaaaa ttaatttta cctttttttt tttttaatat 1140 tttcaatttt tttttttgta tttctgcacc acccacccgc cctaaccccc taccccccggc 1200 aaaaaccctc aatttttttt actttttttg tttatttttt ttaattttt atttttttt 1260 tatttttcta caccacccta aaagtatagt acaaaattca gatttgaact cctttttatt 1320 ggtagattaa tcaaagtaga aaaaaaaaga cagtttgaaa actacctcat tctataaggt 1380 tttcagaact cgtttgctta ctgagaaaat gaattattca cagttaaaat atattttaat 1440 gttcaatata agtaatatca gcataaattt tataccacat ctaacgaggg ataacaattc 1500 agggattagc tataccgga taaaacaagt aaatgataa attgtcctt ctaccaagc 1560 cttttaaagg aaaatcagg ttattag aaaaaaca tttcaagt taatttagtt 1620 taaaaccaaa taaatgcttt atacgtatat cttattacta atgcagtaaa ccaaataaat 1680 cagaggtact aaatgatctc atattagta caatttagtt acgtactaaa atttctaca 1740 taattttatt ctcgccaacc ctacaagtat agtactccaa cccctctc ttggcaaat 1800 aatccaatag gaaataaga cggtaagaa attggcacac gttatatatg acttttgaca 1860 ctatttaagc cagccaatgg cattagtggt tgcatacttt gatgtagag aaataactaa 1920 taaagactgt tgagagttgt ttctcttac cccttttgaa gtttattc ctcagatttt 1980 cacagttcca agcaagcact a 2001 <210> 22 <211> 847 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: Synthetic polynucleotide <400> 22 gccattcttc agtccacaat aggcggcgga gcttcaccta cagcggcggc ggcggaaaac 60 ggtaccagaa aagtcatccc tctctcaaga gatgccctcc aagatttcat gttatcaatc 120 ataacccaaa aattacaaga tgagaaacaa cctttttacg tgttagattt gggtgaagtt 180 gtttctctta tggaccaatg gaaatctgct ctcccaaata tccgtccatt ttacgctgtt 240 aaatgtaacc ctgaaccgtc gttcctttca attttatctg ctatgggctc aaattttgat 300 tgtgctagcc gagctgaaat tgagtacgtt ttgtcccttg gcatttctaa taagatcttc 360 aacacctaca ccattttttt aatcactact acccattgca ttgaacaaac ttccaagttc 420 ttcttagctt cagattaaga aagtaccctt tcttggcttt gttgatgtgg taccattgtc 480 cattgtcttg tgtgtttcca gaaatgccaa gggacaaaac gtactcaatt tcagctcggc 540 tagcacaatc aaaatttgag cccatagcag ataaaattga aaggaacgac ggttcagggt 600 tacatttaac agcgtaaaat ggacggatat ttgggagagc agatttccat tggtccataa 660 gagaaacaac ttcacccaaa tctaacacgt aaaaaggttg tttctcatct tgtaattttt 720 gggttatgat tgataacatg aaatcttgga gggcatctct tgagagaggg atgacttttc 780 tggtaccgtt ttccgccgcc gccgctgtag gtgaagctcc gccgcctatt gtggactgaa 840 gaatggc 847 <210> 23 <211> 1302 <212> DNA <213> Nicotiana sp. <400> 23 atggccggcc aaacaatcat cgtttccggg ttgaacccgg cggccattct tcagtccaca 60 attggcggcg gagcttctc tacagcggcg gcggcggcgg aaaacggcac cagaaaagtc 120 atccctctt caagagatgc cttacaagat ttcatgttat caatcataac ccaaaaatta 180 caagatgaga aacaaccttt ttacgtgcta gacttgggtg aggttgtttc tcttatggac 240 caatggaaat ctgctctccc aaatatccgt ccattttacg ctgttaaatg taaccctgaa 300 ccgtcgttcc tttcaatttt atctgctatg ggctcaaatt ttgattgtgc tagccgagct 360 gaaattgagt atgttttatc tcttggcatt tcacctgacc gtattgtttt cgcaaatcca 420 tgcaaaccgg aatccgatat tatttttgca gcaaaagttg gggtgaatct tacaacctat 480 gattctgaag acgaggttta caagatccga aagcatcacc cgaaatccga actcttgctc 540 cgcatcaagc ccatgctcga cggcaacgcg agatgcccaa tgggcccgaa atacggcgcg 600 cttccagaag aagtcgaccc gctgctccgg gcagctcaag ccgcccgtct caccgtatcc 660 ggcgtctcat tccacatcgg tagcggagat gccgattcaa acgcttatct cggcgccata 720 gccgcggcta aggaagtgtt tgaaacagct gctaaactcg ggatgtcgaa aatgactgtt 780 ctagacgtcg gcggcgggtt tacatccggc caccagttca caaccgccgc cgtcgccgtt 840 aaatcagctt taaaacaaca cttcgatgac gaaccggagt tgacaatcat agctgaaccg 900 ggtcggtttt ttgcagagac ggcgtttact ttggcaacga cgattatagg gaaaagagtg 960 aggggtgaat tgagggagta ttggattaac gacgggctgt acggttcgat gaactgtgta 1020 ctttacgacc atgcgacggt gaatgcaacg ccgttagctg ttctgtcgaa tcgtagtaac 1080 gttacctgcg gcgggtcgaa aacgtttccg acgactgtgt ttgggcccac ttgtgatgct 1140 cttgatactg ttttaaggga ttaccagtta ccggagctgc aggttaatga ttggctggtt 1200 tttcctaata tgggtgctta tactaaagct gctgggtcca atttaatgg atttaatact 1260 tccgccattg ttactcacct cgcttattct tatccaagct ga 1302 <210> 24 <211> 1299 <212> DNA <213> Nicotiana sp. <400> 24 atggccggcc aaacaataat cgtttccggg ttgaacccgg cggccattct tcagtccaca 60 ataggcggcg gagcttcacc tacagcggcg gcggcggaaa acggtaccag aaaagtcatc 120 cctctctcaa gagatgccct ccaagatttc atgttatcaa tcataaccca aaaattacaa 180 gatgagaaac aaccttttta cgtgttagat ttgggtgaag ttgtttctct tatggaccaa 240 tggaaatctg ctctcccaaa tatccgtcca tttacgctg ttaaatgtaa ccctgaaccg 300 tcgttccttt caattttatc tgctatgggc tcaaattttg attgtgctag ccgagctgaa 360 attgagtacg ttttgtccct tggcatttca cctgaccgta ttgtttttgc aaatccatgc 420 aaaccggaat ccgatattat ttttgcagca aaagttgggg tgaatttaac aacgtacgat 480 tcagaagacg aggtttacaa gatccgaaag catcacccga aatccgaact cttgctccga 540 atcaagccaa tgttcgacgg caacgcgagg tgcccaatgg gtccaaaata cggcgcgctt 600 ccagaagaag tcgagccgct gctccgggca gctcaggccg cccggctcac cgtctccggt 660 gtctccttcc acatcggcag cggagatgcc gattcaaacg cttatctcgg cgccatagcc 720 gcggctaagg aagtgtttga aacagctgct aaactcggta tgtcgaaaat gactgttcta 780 gacgtcggcg gcgggtttac atccggccac cagttcacaa ccgccgccgt cgctgttaga 840 tcagctttaa aacaacactt cgatgatcaa ccggagttga caatcatagc tgaaccgggc 900 cggttttttg cggagactgc gtttacttta gcgacgacga ttatagggaa aagagtgagg 960 ggagaattga gggagtattg gattaacgac gggttgtacg gttcgatgaa ctgtgtactt 1020 tacgaccatg cgacggtgaa tgcaacgccg ttagctgttt tgtcgaatcg tactaacgtt 1080 acctgcggcg ggtcgaaaac gtttccgacg actgtgtttg ggcccacttg tgatgctctt 1140 gatactgttt taagggatta ccagttaccg gagctgcagg ttaatgattg gctagttttt 1200 cctaaatatgg gtgcttatac taaagctgct gggtccaatt ttaatggatt tatacgtcc 1260 gccattgtta ctcacctcgc ttatgcttat ccaagctga 1299 <210> 25 <211> 807 <212> DNA <213> Nicotiana sp. <400> 25 atgccagatt taatccgttc aattgcagag aaccatgaag ctggccagcc attttatctc 60 atggattgg ctataattga aaagctaatg gacaaatgga accattcttt tccaaatata 120 aaacctttct atgctgtgaa atgcaacacc gaacctgctc ttcttactaa ...
Claims
1. A tobacco plant comprising an inducible promoter operably linked to a transcribable DNA sequence encoding a non-coding RNA for repressing the ornithine decarboxylase (ODC) gene.
2. 2. The tobacco plant of claim 1, capable of producing leaves containing levels of one or more polyamines that are at least 20% greater than comparable leaves of a control plant that does not contain the mutation or transgene.
3. 2. The tobacco plant of claim 1, capable of producing leaves containing chlorophyll levels within at least 20% of comparable leaves of a control plant containing no mutation or transgene.
4. 2. The tobacco plant of claim 1, capable of producing leaves containing a number of mesophyll cells per unit leaf area that is at least 20% of that of a comparable leaf of a control plant that does not contain the mutation or transgene.
5. 2. The tobacco plant of claim 1, capable of producing leaves containing epidermal cell sizes at least within 20% of comparable leaves of a control plant containing no mutation or transgene.
6. 2. The tobacco plant of claim 1, comprising a leaf yield that is at least within 20% compared to a comparable leaf of a control plant that does not contain the mutation or transgene.
7. 2. The tobacco plant of claim 1, wherein the ornithine decarboxylase (ODC) gene encodes a polypeptide sequence having at least 80% identity to a sequence selected from the group consisting of SEQ ID NOs: 29, 30, 31, 32, 33, and 34.
8. 8. The tobacco plant of claim 7, wherein the ODC gene comprises a nucleotide sequence having at least 90% identity to a sequence selected from the group consisting of SEQ ID NOs: 23, 24, 25, 26, 27, and 28.
9. 2. The tobacco plant of claim 1, wherein the inducible promoter comprises a sequence selected from the group consisting of SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, and 21.
10. 2. The tobacco plant of claim 1, wherein the non-coding RNA comprises a nucleotide sequence having at least 90% identity to a sequence selected from the group consisting of SEQ ID NO: 35 and 36.
11. 11. The tobacco plant of claim 10, wherein the non-coding RNA is provided in an ODC RNAi construct comprising a nucleotide sequence having at least 90% identity to SEQ ID NO:
22.
12. Compared to control tobacco plants, a. a first genome modification that provides low levels of nicotine or total alkaloids; b. providing equivalent levels of one or more traits, the traits being: i. Whole leaf polyamine levels; ii. Whole root polyamine levels; iii. Total leaf chlorophyll levels; iv. number of mesophyll cells per unit leaf area, and v. Leaf epidermal cell size A second genome modification selected from the group consisting of:
1. A tobacco plant or part thereof comprising: The tobacco plant or part thereof, wherein the control plant does not have both the first genomic modification and the second genomic modification.
13. 13. The tobacco plant or part thereof of claim 12, wherein the tobacco plant comprises a reduced amount of total free polyamines in the leaves or roots compared to the control tobacco plant.
14. 13. The tobacco plant or part thereof of claim 12, wherein the tobacco plant is capable of producing leaves having a leaf grade equivalent to a leaf grade of leaves derived from the control plant.
15. A dried tobacco material derived from the tobacco plant of claim 1.
16. A tobacco product comprising the dried tobacco material of claim 15.
17. 17. The tobacco product of claim 16, selected from the group consisting of cigarettes, cigarillos, non-ventilated recess filter cigarettes, ventilated recess filter cigarettes, cigars, snuff, pipe tobacco, cigar tobacco, cigarette tobacco, chewing tobacco, leaf tobacco, shredded tobacco, loose leaf chewing tobacco, plug chewing tobacco, moist snuff, nasal snuff, and cut tobacco.
18. A dried tobacco material derived from the tobacco plant of claim 12.
19. A tobacco product comprising the dried tobacco material of claim 18.
20. 20. The tobacco product of claim 19, selected from the group consisting of cigarettes, cigarillos, non-ventilated recess filter cigarettes, ventilated recess filter cigarettes, cigars, snuff, pipe tobacco, cigar tobacco, cigarette tobacco, chewing tobacco, leaf tobacco, shredded tobacco, loose leaf chewing tobacco, plug chewing tobacco, moist snuff, nasal snuff, and cut tobacco.
Citation Information
Patent Citations
Methods for reducing polyamine biosynthesis and the plants and seeds produced thereby
WO2002018547A1
